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ABSTRACT OF THE DISSERTATION
Validation, Categorization, and Prediction of Upper limb Outcomes after Stroke
by
Jessica Barth
Doctor of Philosophy in Movement Science
Physical Therapy
Washington University in St. Louis, 2022
Professor Catherine E. Lang, Chair
The incidence and costs of stroke in the United States are projected to rise over the next
decade because of the aging population. Declining stroke mortality over the past few decades
means that more people survive stroke and live with physical, cognitive, and emotional
disability. Stroke remains one of the leading causes of disability in the United States because
very few survivors experience a full recovery of their upper limb. Upper limb recovery after
stroke is critical to performing activities of daily living and physical and occupational therapies
are one of the only treatment options to address these challenges. The World Health
Organization’s (WHO) International Classification of Functioning, Disability, and Health
Framework (ICF) informs our understanding of the importance of measuring upper limb changes
across measurement levels, showing that improvements seen in one level (i.e. domain) do not
directly transfer to another. Knowing this, it is important to evaluate existing prediction models
of motor outcomes after stroke while simultaneously developing novel tools available to
xi

researchers and clinicians to facilitate measurement of the upper limb across the ICF domains.
This dissertation work performs an external validation of an existing prediction model of upper
limb capacity (UL; capability measured in the clinic) after stroke, identifies and defines
categories of UL performance (actual UL use in daily life) in people with and without
neurological UL deficits, and explores how early clinical measures and participant demographic
information are associated with subsequent categories of UL performance after stroke.
Recently, prediction algorithms of upper limb capacity after stroke have been developed
to facilitate treatment selection, discharge planning, and goal setting for clinicians and their
clients. Prediction models have tremendous clinical utility because they aid in the clinical
decision making required to select the appropriate efficacious and emerging interventions that
afford improvements in upper limb functional capacity, measured by standardized assessments in
the therapy clinic. Prior to wide spread implementation of existing prediction algorithms into
routine rehabilitation care, however, it is necessary to understand how small healthcare system
differences and availability of neurophysiological assessments affect external validation of the
models. In Chapter 2, we test how well an algorithm with clinical measures, developed for use in
another country, applies to persons with stroke within the United States.
Knowing the importance of measurement across ICF domains, it is necessary to develop
tools that facilitate clinical decision making and implementation of upper limb performance data
into routine rehabilitation care. The use of wearable sensor technology (e.g., accelerometers) for
tracking human physical activity have allowed for measurement of actual activity performance of
the upper limb in daily life. Data extracted from accelerometers can be used to quantify multiple
variables measuring different aspects of UL activity in one or both limbs. A limitation is that
several variables are needed to understand the complexity of UL performance in daily life. As a
xii

solution to the multi-variable problem, it would be helpful to form categories of UL performance
in daily life. If natural groupings occur among multiple UL performance variables calculated
from accelerometry data, then these groupings could facilitate clinical decision making and
implementation of upper limb performance data into routine rehabilitation care. In Chapter 3 we
identify and define categories of UL performance in daily life in adults with and without
neurological deficits of the upper limb.
Prediction of motor outcomes after stroke have tremendous clinical utility, however there
have been limited efforts to develop prediction models of upper limb performance (i.e., actual
upper limb activity) in daily life after stroke. With advances in computing power, it is possible to
capitalize on machine learning techniques to predict upper limb performance after stroke. These
techniques allow for predicting a multivariate categorical outcome. This is important because it
provides more information about the expected upper limb outcome to people with stroke, their
families, and clinicians than a single continuous variable or a binary category (e.g., good or
poor). Chapter 4 of this dissertation explores how different machine learning approaches can be
used to understand the association between early clinical measures and participant demographics
to the UL performance categories from a later post stroke time point.
Our findings provide strong support for the importance of measuring recovery of the UL
across ICF domains, not just with impairment and capacity level measures. Collectively this
work provides preliminary measurement tools that could eventually be available to rehabilitation
clinicians following subsequent validation efforts. Additionally, this work provides a rich
exploration into the strengths, weaknesses, and limitations of analytical methods and their impact
on validation efforts.
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Chapter 1: Introduction
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This introductory chapter begins with an overview of stroke and its increasing burden on
the United States (US) health care system and survivors. It then discusses measurement of upper
limb (UL) outcomes using terms defined by the World Health Organization’s (WHO)
International Classification of Functioning Framework (ICF).1 Emphasis is placed on the
differences of measurement of UL impairment, capacity and performance after stroke along with
considerations for use in stroke rehabilitation. Next there is a discussion of the development of
prediction models of post stroke outcomes and their clinical utility. Finally, this chapter ends
with a discussion of the importance of expanding prediction models to UL performance after
stroke.

1.1 Stroke and UL impairment is a significant health
problem

Stroke is one of the most significant health problems facing the country and is the leading

cause of complex, long-term disability.2-5 The US spends approximately $50 billion healthcare
dollars annually on direct and indirect stroke care costs and this amount will increase because the
incidence of stroke is expected to rise in the coming years due to an increased aging of the
population.4,6 In fact, the projected stroke costs in the US are expected to increase over 200% to
$184 billion by 2030.4,6 Declining stroke mortality over the past few decades3 means that more
people are surviving stroke but remain with physical, cognitive, and emotional disability.7
UL paresis after stroke is a leading contributor to the substantial rates of disability in the
US and around the world.8,9 Of the 795,000 people who suffer a stroke per year in the US, a
staggering 80% of those individuals will incur some degree of initial impairment of the UL.10-12
At six months post stroke, 65% of individuals will still have difficulties incorporating their UL
2

into their daily tasks.13,14 In fact, only 5-20% will experience full neurological recovery of their
UL following a stroke.11,12 Post stroke UL problems may be caused by weakness, uncoordinated
movements, diminished sensation, and overall reduced speed of movement, which collectively
contribute to decreased independence, performance in daily tasks, and participation in life
roles.12,15-17 UL problems after stroke can lead to long-term functional deterioration, higher levels
of disability, and limited community reintegration.9,15 UL recovery after stroke is critical for
performing activities of daily living (ADL). Physical and occupational therapies are one of the
only treatment options to address these problems.18-24
Individuals with stroke have identified improving UL function as a top priority for stroke
rehabilitation.25 As a result, substantial time and research dollars have been invested to develop
efficacious, in-clinic UL interventions to improve UL function early26-29 and later30,31 after
stroke. UL impairment and loss of capacity has been a primary focus of stroke rehabilitation.
Clinicians use standardized assessments within the clinic to measure UL impairment and
capacity (see 1.2.1 and 1.2.2) to measure improvements made over the course of treatment.32,33
With many efficacious therapies available, individuals make improvements in their UL capacity
with the anticipation that those improvements translate into increased use of the limb during
daily tasks.34

1.2 Using the ICF model to conceptualize UL problems post
stroke
The World Health Organization’s (WHO) International Classification of Functioning,

Disability and Health Framework (ICF) is a comprehensive framework for measuring both
individual and population health.1,32 The ICF model is based on the biopsychosocial approach
used to integrate the biological, individual, and social dimension.35 The ICF has two parts: 1)
3

functioning and disability and 2) contextual factors.35-37 In the ICF, functioning and disability are
multi-dimensional concepts relating to 1) body functions and structures; 2) activities and
participation; and 3) personal and environmental factors.1,32,37 Despite these being separate
concepts, there is an important interplay and influence (represented by double sided arrows in
Figure 1.1) of both internal and external factors of each component that impact an individual’s
health status.1,32,35,37-39 Figure 1.1 outlines the three specific ICF components that apply to
rehabilitation of persons with stroke, and other health conditions including: body
structures/functions, activity, and participation. Within each ICF component contains
hierarchically arranged domains presented as chapters37,38,40 which include sets of related
physiological functions, anatomical structures, actions, tasks, areas of life, and external
influences.1,32,36,37 Table 1.1 provides the names of the ICF components, their definitions, and an
example of the domain aligned with the UL after stroke. The ICF model emphasizes an
individual’s health along these domains and serves as a useful tool for understanding functional
limitations following a health event, such as stroke.

Figure 1.1 Adapted International Classification of functioning, Disability, and Health Framework (ICF)

4

Table 1.1. ICF components, their contents, and examples of domains with respect to the UL after stroke.
ICF Component
Body functions
and structures

Definition
The physiological functions of body
systems and the anatomical parts of
the body such as organs, limbs and
their components

Impairments

Problems in body function and
structure such as deviation or loss
measured by clinicians with
standardized processes and
assessments.

Activity

The execution of a task or action by
an individual that represents the
individual perspective of functioning.
The activity domain is divided into
the capacity for activity and
performance of activity.
What someone is capable of doing in
a controlled environment measured by
standardized assessments in the clinic.

-Handling objects such as a brush, carrying a pot, or holding
a pen.
-Moving around and using transportation likedriving a car.
- Self-care tasks such as: bathing, dressing, and eating.
-Domestic life tasks such as cleaning the kitchen or holding
a child
-UL motor ability to bathe or complete self-feeding
-Functional ability of the paretic arm and hand.

What someone actually does in their
free-living environment. Perceived
performance is measured with selfreport questionnaires and direct
performance with wearable sensors.

-subjective measure of UL use in daily life.
-variables calculated from wearable sensor data measuring
the duration, magnitude, variability, and symmetry of UL
activity in daily life.

Participation

-Involvement in a life situation and
represents the societal perspective of
functioning. Measures evaluate the
degree to which an individual is
involved with roles and relationships
common to daily life that can include
separate subjective and objective
performance.

-Interpersonal interactions and reactions such as parent,
spouse or employee.
-Major life areas such as worker, student, and child caring.
-Community, social, and civic life including recreation and
leisure or religion and spirituality.

Activity
Limitations
Participation
restrictions
Environmental
factors

Difficulties an individual may have in executing activities.

Capacity

Performance

Functioning
Disability

Domain Example
-Sensory functions and pain including light touch
discrimination and shoulder pain due to subluxation.
-Neuromusculoskeletal and movement-related functions
including power of muscles of one side of the body.
-Structures of the nervous system such as, integrity of the
cortical spinal tract.
-Structures related to movement such as, the shoulder and
scapula.
-Hemiparesis or weakening of one UL
-Sensory loss

Problems an individual may experience in life situations.
The physical, social and attitudinal
-The individual’s immediate environment (workplace,
environment in which people live and home, or school).
-The societal environment of social structures, services, and
conduct their lives. These are either
approaches for systems.
barriers or facilitators of a person’s
functioning.
Umbrella term for body function, body structures, activities and participation. Denotes the positive or
neutral aspects of the interaction between a person’s health condition(s) and that individual’s
contextual factors (environmental and personal factors).
Is an umbrella term for impairments, activity limitations and participation restrictions. It denotes
negative aspects of the interaction between a person’s health condition(s) and that individual’s
contextual factors (environmental and personal factors).

5

1.2.1 Body structures and functions

The body structures and functions components are the anatomical and physiological

functions of body systems.1,32,37 The ICF definitions clearly differentiate physiologic functions
from anatomical structures of the body and two separate classification systems are offered. There
are eight hierarchical domains of body structures, the sensory functions and pain and
neuromusculoskeletal and movement-related functions are most considered after stroke.37 There
are also eight hierarchical domains of body functions, each can be affected by stroke however the
structure of the nervous system and structures related to movement are considered when
assessing the UL after stroke. Of equal importance, other domains within the body functions and
structures domains such as, mental functions may also affect the UL after stroke. For example, a
person’s mood and emotion, self-efficacy, and confidence may impact the movement related
functions of the UL after stroke demonstrating the interaction of these components during
recovery from stroke.35,41,42
UL impairments
The term impairment is associated with the body structure/function component of the ICF
(Figure 1.1 and Table 1.1) and is defined as the problems in body function or structures resulting
in a significant deviation or loss.1,37 Impairments of the UL after stroke results from strokerelated damage to the cortical and subcortical brain structures specifically, the primary motor
cortex, the primary somatosensory cortex, secondary sensorimotor cortical areas, and the
corticospinal tract.43,44 UL impairments in people who have had a stroke are well documented
and include paresis, loss of somatosensation, spasticity, muscle contracture, loss of dexterity or
fractionation of movement, decreased active joint range of motion, and lack of movement, speed,
precision, and bimanual coordination.45,46 Clinicians typically conduct evaluations of a person’s

6

UL movement after stroke to identify the impairments that limit normal movement.46 These
include goniometry measurement of active or passive range of motion,47 manual muscle
testing,48 grip and pinch strength.49,50 and somatosensory testing.51-53 Standardized processes and
assessments have been developed to measure specific stroke related UL impairments and include
the Fugl-Meyer (UEFM),54-56 the modified Ashworth,57,58 the Motricity index,59 the Motor
Assessment Scale,60,61 and the Shoulder Abduction Finger Extension (SAFE).62

1.2.2 Activity

The second ICF component is activity which defined as the execution of a task or action

by an individual. Activities are characteristics of people, and they can be assessed by examining
the functional performance of an individual in isolation.36,37 There are nine hierarchical domains
within the activity component, and each can be affected by stroke. The general tasks and
demands, mobility, self-care, and domestic life domains are most considered when assessing the
UL after stroke.37 Activities tend to be simplistic, performed alone, and are generally resultsoriented.1,32,36 Problems completing activities after a health condition, such as stroke, are
described as activity limitations. Activity limitations describe difficulties an individual may have
in executing tasks and activities. Activity limitations may or may not lead to participation
restrictions, depending on what activities are needed to participate in a social situation and what
environmental barriers or supports exist.35,36,63 The activity component is divided into the
capacity for and the performance of activity.1,37,63 These constructs provide a way to indicate
how the environment (where measurement occurs) impacts a person’s activities and how the
environmental change may improve a person’s functioning.37 Capacity refers to what an
individual can do in a standardized environment and performance is what someone actually does
in their usual environment.

7

UL capacity for activity
UL capacity for activity is defined as the ability to execute a task or action in a
standardized, or controlled, environment.1,32 A standardized environment has removed the
barriers within an individual’s environment that can interfere with their ability to complete a task
while simultaneously providing identical testing conditions for each person. There are several
standardized clinical assessments used for rehabilitation that quantify UL capacity within a clinic
or laboratory setting. Standardized assessments provide important information about the UL after
stroke to provide a greater understanding of a person’s ability to complete actions and tasks
aligned with the domains (e.g. general tasks and demands and mobility).32,37 These include the
Wolf Motor Function Test,64,65 the Box and Blocks,66 the Nine Hole Peg Test,67,68 the Jebsen
Taylor Hand Function Test,69 and the Chedoke Arm and Hand Activity Inventory (CAHAI).70-72
Some of these standardized measures include aspects of measurement of compensatory UL
movements in an attempt to determine their effects on a person’s UL capacity.64,65,71-73
Interestingly, the CAHAI is the only standardized measure of UL capacity that includes bilateral
tasks in their design. Given that most UL tasks involve bilateral involvement,74 it is important to
include bilateral assessments when measuring UL capacity. The most common standardized
assessment of UL capacity after stroke is the Action Research Arm Test (ARAT) which is a valid
and reliable, criterion-rated assessment of UL activity limitations.73,75-77

1.2.3 UL performance of activity in daily life
Performance of activity is defined as the execution of tasks or actions in an unstructured,
free-living (i.e., usual) environment.32,37,41 Performance is a measure of what someone actually
does when they are outside of the structured clinic or laboratory setting.1 The free-living
environment includes a combination of physical, social, and personal factors that may be either
8

barriers or facilitators to performance. Quantifying UL performance in daily life is challenging
and is typically measured by assessments of perceived performance or direct, objective measures
of performance.78,79 Similar to capacity for activity, the limitations in the performance of activity
after stroke is also related to participation restrictions depending on what activities are needed to
participate in a social situation and what environmental barriers or supports exist.35,36,63
Perceived Performance
Perceived performance is generally measured with standardized self-report measures,
such as, the Motor Activity Log80,81 or the Stroke Impact Scale (activities in a typical day
subscale).82 Self-report measures of perceived UL performance have been shown to improve
with rehabilitation therapies,41,83 however self-report measures are subject to inherent biases84,85
(e.g. social desirability, recall bias) which can compromise results.78 Because of these
limitations, objective measures of direct UL performance post stroke have been developed to
provide a more objective measure of UL activity after stroke.
Direct Performance
Over the past decade, the use of wearable sensor (e.g., accelerometers) technology has
emerged in rehabilitation to measure performance of activity in daily life.86,87 Accelerometry has
become an established, valid and reliable methodology to directly measure performance of UL
activity in daily life in several adult populations. 74,88-93
Data extracted from bilateral, wrist worn wearable sensors can be utilized to quantify UL
performance variables measuring the duration74,94, laterality and symmetry,74,79,89,95,96 magnitude
or intensity, and variability of one or both limbs.79,88,97-99 These variables collectively inform
clinician scientists about different aspects of real-world UL activity in daily life of nondisabled
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adults74,89 and adults with stroke.90,92,100,101 Each UL performance variable conveys slightly
different information about the collective nature of UL activity. Measuring UL performance after
stroke from wearable sensor data has led to a growing recognition that there is a disparity
between UL capacity and actual real-world UL use, individuals may have the ability to move
their affected UL but they may not actually use it for daily activities.9,89,102 UL capacity is a
prerequisite to UL performance, however, UL performance is not a direct consequence of good
or improved UL capacity.34,103,104 This has implications for rehabilitation because currently
clinicians only measure UL capacity to determine if improvements are made as a result of their
interventions. Clinicians need tools to measure UL performance to provide information about
what their clients actually do with their ULs, outside of the clinic to complement the in-clinic
measures of UL capacity that provide information about a client’s UL capability.105

1.2.4 Participation
Participation (Figure 1.1 and Table 1.1) is defined as involvement in a life situation and
represents a societal perspective of functioning.32,36,37,39,63,106 Unfortunately, the ICF does not
clearly differentiate activity from participation, and only one classification system of domains is
proposed for both.36,37,107,108 Participation is a broad and complex concept that can have different
meanings to different people.109 It has been suggested that participation is a relational construct
that can be assessed by considering other factors beyond simply the capabilities and limitations
of the individual. Therefore, participation is more sensitive to the characteristics of the social,
physical, and policy environments.32,36,37 The activity and participation domains are expressed as
a list over nine chapters that can be used to denote activities or participation or both.63 The
interpersonal interactions and restrictions, major life areas, and community, social, and civil life
domains are most important to consider after stroke.36,63 Problems or limitations in participation
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is termed “participation restriction” and is viewed as a negative aspect and are defined as
problems an individual may experience in involvement in life situations.36,37 Measures of
participation evaluate the degree to which an individual is involved with roles and relationships
common to daily life that can include separate subjective and objective ratings of performance.
Difficulty has been reported in applying the ICF concept of participation because of the diversity
of this concept36,39,63,107 resulting in a wide range of tools considered to measure participation.
Measuring participation is difficult for conceptual and methodological reasons.107 This is
especially complicated because the domains are the same within the activity and participation
concepts and it has yet to be decided if participation should be expected to be measured over all
nine domains.63 The most frequently measured domains of activity and participation belonged to
the Community, Social and Civic Life, Domestic Life, and Mobility.63 For example, a
participation measure might include items related to being a productive member of society such
as employment, being a student, and being a homemaker with each of these roles requiring
several activities for successful participation.37,63,107,108,110 Common validated assessments of
participation after stroke include the Frenchay Activities Index,111-114 the Activity Card Sort,115
the Assessments of Life Habits, Stroke Impact Scale (participation subscale),63,116 and the
Reintegration to Normal Living.117,118
With respect to the UL after stroke, UL capacity is a predictor of participation in life
roles post stroke. However, UL performance likely contributes as well because participation is a
latent trait that shows its impact through a series of indicators such as employment, parenting,
and churchgoing.107 Individuals report limitations with participating in meaningful life roles even
years after a stroke which can result in boredom, depression and worsening of function, affect,
and quality of life.14 Up to 50% of the community dwelling stroke population is living with the
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sequalae of stroke that places them at risk for a diminished activity level and social isolation can
result further compounding the negative health events.14 While measures of UL impairment,
capacity, and participation are important and convey useful information, they cannot provide
information about UL activity performance, or actual UL activity, in the free-living environment.
In summary, the ICF Framework allows for the ability to view the interconnectedness and
complexities of stroke related disability. Unfortunately for many years, stroke rehabilitation
assessments and interventions have tended to focus on one or a few UL impairments (e.g.
paresis, somatosensation) with the anticipation that changes in impairments will lead to
downstream changes in other levels of measurement (e.g. activity and participation). As our
understanding of these concepts grow, rehabilitation professionals are moving forward to take an
integrated approach to UL rehabilitation to improve overall outcomes for people after a stroke.
Additionally, as clinicians realize the importance of measurement across ICF components and
domains, it is necessary to develop tools that facilitate clinical decision making and
implementation of UL performance data into routine rehabilitation care.

1.3 Predicting outcomes improves post stroke care

Independence in activities of daily living and other meaningful activities after stroke

depends largely on the recovery of motor impairment (primarily paresis), specifically in the
UL.17,119 In general, greater initial UL impairment is associated with worse UL capacity
outcomes later after stroke.120 The estimated recovery of motor impairment is one of several
factors that influence the clinical decisions regarding the type and duration of rehabilitation, and
goals set for each person after stroke. Unfortunately, these decisions are usually made without
objective information about a person’s likelihood of recovery of UL impairments after stroke.119
Clinicians typically make decisions about the discharge destination from the acute care setting
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based on their perception of persons post stroke prognosis for recovery.121,122 Post stroke
prognosis and discharge disposition are greatly influenced by the clinicians initial impression
along with incorporating clinical and demographic factors such as initial stroke severity and
age.123 Unfortunately, even experienced clinicians have difficulty making accurate predictions
of UL capacity outcomes for people with stroke.123-125 In most US healthcare settings, clinicians
have no way to know if their prognoses at the acute stage were correct, unless their system
routinely conducts follow up assessments several months later. This situation creates an
immediate need for standardized tools to support less variable and more equitable decisionmaking of post stroke prognoses for clinicians and their clients.122,126

1.3.1 Prediction of UL capacity

Recent efforts have explored predicting eventual UL capacity outcomes after stroke

which has the potential to facilitate treatment selection, discharge planning, and goal setting for
clinicians and clients.103,125,127 To date, several factors are thought to be related to subsequent UL
capacity including initial motor and sensory impairments, and measures of sensorimotor system
structure and function obtained with neuroimaging120,128-131, or neurophysiological
techniques.120,128-130,132 Several studies have demonstrated that recovery of UL capacity occurs
mainly within the first three months post stroke,133-135 and several prediction models have been
developed to guide clinical decision-making.62,136 Most of these prediction algorithms have been
proposed and evaluated on participant cohorts from clinical trials, and they are mostly accurate
for persons with mild to moderate UL impairment.102,127,129,132,137-139 The most well-known
algorithm was developed in New Zealand and allows for prediction of UL capacity around three
months post stroke based on measures taken within the first week. PREP, the original algorithm
developed in 2012, used both clinical measures and neurological biomarkers in the initial days
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after stroke to determine UL capacity categories around three months with 64% accuracy.119
PREP2, published in 2017, is the refined version, which predicts a category of UL capacity
around three months with 75% accuracy using clinical measures and a single neurophysiological
measure.62 The PREP2 algorithm classifies individuals into one of four clinically meaningful
categories (Excellent, Good, Limited, or Poor) in anticipation of subsequent UL capacity
outcomes.62,140 Predicting a category for an eventual UL outcome is useful because persons with
stroke are more interested in what they can generally expect in recovery of the UL, not a specific
numerical score on a standardized test.123,141-143 Each of the four categories from PREP2 are
defined by boundaries on the ARAT, a standardized assessment of UL capacity.62 PREP2
categories describe an expected UL outcome and associated rehabilitation focus, providing
individuals with stroke, their care givers, and clinicians with more interpretable
information.142,143
Despite its accuracy and ease of use, there are some challenges to implementing PREP2
in the US. The rehabilitation structure of New Zealand differs somewhat from the US, with
respect to who, how much, where, and when individuals receive UL therapy after stroke. A lot of
young people in the US are having strokes4,6,144-146 and many have other comorbidities that are
poorly managed.147 Another hurdle to implementation of the PREP2 in the US is the limited
accessibility to the neurophysiologic measurement of corticospinal tract function, via transcranial
magnetic stimulation (TMS).148 Access to this neurophysiologic assessment may be available
for research purposes and/or in some major academic medical centers, but is not available in
routine rehabilitation care.148,149 Anticipating this, the PREP2 algorithm was shown to still be
71% accurate using clinical measures only.62,140 In the version with only clinical measures, a
measure of stroke severity150 replaces the neurophysiologic measure for participants with less
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initial strength in their affected UL.62 Prior to widespread implementation of this useful
algorithm into routine rehabilitation care, it is necessary to understand how small healthcare
system differences, differences in the stroke population, and lack of the neurophysiologic
assessments affects the accuracy of the PREP2 algorithm in individuals who have suffered a
stroke in the US. Aim 1 of this dissertation evaluates the accuracy of the PREP2 algorithm with
clinical measures only here in a US healthcare system.

1.3.2 Prediction of UL performance

As seen in the ICF Framework, (Figure 1.1) UL capacity for activity is a different but

related construct to UL performance of activity.1 Data from wearable sensors are analyzed to
produce variables that capture aspects of UL performance in daily life after stroke. With the
ability to measure UL performance, researchers have learned that improvements in UL capacity
seen in the clinic often do not lead to improved performance of the UL in daily life.34,89,102,103 In
other words, individuals improve their capability to use their arm measured by in clinic
assessments, but are not transferring these improvements into better use of their limb in daily
life.9,34,90,102,103,151,152 These findings have solidified our understanding that UL functional
capacity and UL performance are two separate constructs.94,153 Knowing this information, it is
important to explore prediction models of UL performance to complement existing prediction
tools of UL capacity.
There have been limited efforts to develop prediction models of UL performance or
actual activity of the UL in daily life after stroke. To date, two studies have explored early
predictors of UL use at three months102 and one year103 after stroke. A longitudinal study by
Rand and Eng103 used multiple linear regression to predict daily use of each UL, measured with a
single continuous variable (mean total activity counts of the paretic UL), 12 months after stroke
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from motor and non-motor clinical measures and participant demographic information assessed
at discharge from subacute stroke rehabilitation centers. They found that better UL capacity at
discharge predicted increased UL use 12 months after stroke.103 More recently, Lundquist et.
al.102 also used multivariate linear and logistic regression to examine the factors two weeks after
stroke that could predict future UL performance, quantified by a single continuous variable (use
ratio), three months after stroke.102 They found that better UL capacity (ARAT) early after stroke
predicted increased UL performance at three months. When they dichotomized UL performance
as “normal” vs “non-normal”, the absence of a motor evoked potential (MEP) along with the
presence of visual neglect predicted “non-normal” UL use.102 A strength of both of these studies
was the inclusion of non-motor clinical assessments and participant demographic information in
addition to the UL impairment and capacity measures as potential predictors of UL performance.
Including these predictors was useful in determining how other post stroke problems (e.g. visual
neglect, depression) influenced eventual UL use in daily life after stroke. In the Rand & Eng
study the outcome of UL performance was measured one year post stroke which is a limitation
because UL performance stabilizes within six weeks after stroke therefore,105 one year post
stroke is likely too late to intervene to improve the outcome.105 There are two limitations of both
studies; first was the analysis choice of multiple linear regression techniques and second was
selecting a single continuous variable for the outcome of UL performance. Multiple linear
regression techniques are statistical processes used for estimating the relationships among the
dependent and independent variables. These techniques require that specific assumptions about
the predictors and the outcome be met which limits the type of predictors that can be included.154
Also, as more cutting edge methods emerge the term “prediction” can be misused because the
results of regression models are expressed as the proportion of variance (R2) explained, not
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accuracy.155 The second limitation was that the outcome of UL performance was a single
variable (mean total activity counts of the paretic UL and the use ratio). Therefore, significant
predictors can only be associated with the single variable measuring only one aspect of UL
activity after stroke. From these two studies it is unknown how the included predictors were
associated with other aspects of UL performance in daily life, such as the duration, magnitude or
intensity, and variability of UL activity.
UL performance is likely a multivariate construct because a complete measure of UL use
in daily life requires knowledge of the duration, magnitude or intensity, symmetry and variability
of UL movements.87 Currently, several variables must be calculated from wearable sensor data
because each provides different information about UL activity in the free-living environment.156
A single variable may not be not sufficient in understanding the scope of UL performance in
daily life.156 A limitation of the multivariate approach is that calculating several variables adds
complexity to the interpretation of UL performance data for clinical decision making. A potential
solution to the multi-variable problem would be the formation of categories of UL performance
in daily life. If there were natural groupings that occur among multiple UL performance
variables calculated from accelerometry data,157 then these groupings could help to facilitate
clinical decision making and implementation of UL performance data into routine rehabilitation
care. Aim 2 of this dissertation investigates if categories of UL performance can be identified in
adults with and without neurological UL deficits.
With the advances in computing power, it is possible to capitalize on machine learning
techniques to predict UL performance after stroke. Machine learning algorithms have several
advantages over regression models including 1) requiring fewer assumptions about the
distributions of the data, 2) numerous options for non-parametric models, and 3) strong
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predictive capabilities.158-162 Machine learning techniques allow for the possibility of predicting a
multivariate categorical outcome. This is important because categories provide more information
about the expected UL outcome to the person with stroke, their families, and clinicians than a
single continuous variable or a binary category (e.g. good or poor).62,102,141,155,163 Aim 3 of this
dissertation explores how different machine learning techniques can be used to understand how
clinical measures and participant demographics captured early after stroke are associated with
the UL performance categories from a later post stroke time point.

1.4 Summary and critical next steps

The incidence and costs of stroke in the US are projected to rise over the next decade

because of the aging population. Declining stroke mortality over the past few decades3 means
that more people are surviving stroke but remain with physical, cognitive, and emotional
disability.7 Stroke remains one of the leading causes of disability in the US because very few
survivors experience a full recovery of their UL. Recently, prediction algorithms of UL capacity
after stroke have been developed to facilitate treatment selection, discharge planning and goal
setting for clinicians and their clients. However, prior to widespread implementation of existing
prediction algorithms into routine rehabilitation care, it is necessary to understand how small
healthcare system differences and availability of neurophysiological assessments affect external
validation of the models. Aim 1 will be the first study to externally validate an algorithm with
clinical measures only on a US population of persons with first stroke.
Prediction models have tremendous clinical utility because they aid in the clinical
decision making required to select the appropriate efficacious and emerging interventions that
afford improvements in UL functional capacity,32 measured by standardized assessments in the
therapy clinic.26,27,30 The ICF Framework, however, informs our understanding of the importance
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of measuring UL changes across measurement levels. The literature has shown that
improvements seen in one measurement level do not directly transfer to another.34,101 Aims 2 and
3 of this dissertation investigate each of these gaps in an effort to move the field of stroke
rehabilitation forward by contributing to the development of novel clinical tools that are
available to stroke rehabilitation providers in the US and around the world to facilitate
measurement and prediction of UL performance after stroke.

1.5 Specific Aims
Aim 1: Test how well an algorithm with clinical measures, developed for use in New
Zealand, applies to persons with stroke within the US. This is a secondary analysis of data
collected from a prospective, observational, longitudinal cohort tracking UL change over time.105
Hypothesis 1a: UL functional capacity will be predicted, and algorithm accuracy will
fall in a range of 70-80% in a cohort of stroke participants in the US.
Hypothesis 1b: Those with inaccurate predictions will be within one category of their
expected category at 3 months.
Recent efforts have explored predicting eventual UL capacity outcomes after stroke which has
the potential to facilitate treatment selection, discharge planning, and goal setting for clinicians
and clients.102, 111, 113 Several prediction models have been developed to guide clinical decisionmaking,55, 122 the most well-known algorithm is PREP2 and it was developed in New Zealand.62
PREP2 predicts a category of UL capacity around three months after stroke with 75% accuracy
using clinical measures and a single neurophysiological measure.55 The algorithm classifies
individuals into one of four clinically meaningful categories (Excellent, Good, Limited, or Poor)
in anticipation of subsequent UL capacity outcomes.55, 126 Most people with inaccurate
predictions were only one category away from their actual at 90 days.62,140 Despite the merits of
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this algorithm, there are some challenges to implementing it in the US including participant
factors (e.g., age of stroke and number of comorbidities)144-146 and the rehabilitation
structure.141,149 Anticipating this, the algorithm was shown to still be 71% accurate at 90 days
post-stroke using clinical measures only. Prior to widespread implementation of this algorithm
into routine rehabilitation care, it is necessary to understand how small system differences and
lack of the neurophysiologic tests (TMS) affects the overall accuracy of the algorithm in
individuals who have suffered a first stroke in the US. The current study determines the accuracy
of an algorithm on a sample of persons with first ever stroke, using clinical measures only, at
time points that are most feasible in the US health care system.
Aim 2: Identify and define categories of UL performance, as quantified from accelerometer
recordings. This is an analysis of data from three completed studies: 1) the same prospective,
observational cohort as Aim 1;105 2) a sample of persons with chronic stroke who participated in
a clinical trial;31 and 3) a sample of neurologically-intact adults of similar age, race, ethnicity,
and socioeconomic status.74
Hypothesis 2a: Three categories of UL performance will be identified across a host of
accelerometer variables, spanning the possible ranges of UL performance in daily life.
Hypothesis 2b: The categories that emerge will have clinical meaning of expected UL
performance.
The use of wearable sensor technology (e.g., accelerometers) for tracking human physical
activity have allowed for measurement of actual activity performance of the UL in daily
life.79,100,156,164-166 Data extracted from accelerometers can be used to quantify multiple variables
measuring different aspects of UL performance in one or both limbs such as: 1) duration; 2)
magnitude; 3) variability; and 4) symmetry or laterality. Each UL performance variable conveys
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slightly different information about the collective nature of UL use, with a single variable
providing only part of the picture.156 One reason wearable sensor technology for measurement of
UL performance has remained largely confined to rehabilitation research with limited ventures
into clinical practice is because the current output from accelerometers is not easily accessible
for rehabilitation professionals.100 A potential solution to the multi-variable problem would be
the formation of categories (or groups) of UL performance in daily life. Statistical analysis
methods such as a k-means hypothesis-free cluster analysis can be used to determine
categorizations of UL performance indexed by accelerometer variables in samples of persons
with stroke and neurologically intact adults (adult controls). Including cohorts of people with and
without stroke will capture a wide range of the variables, extracted from accelerometer data that
quantify different aspects of UL performance in daily life. Thus, the emerging categories would
group individuals with similar ranges of the performance variables and provide a simpler method
to interpret UL performance in daily life for clinicians and persons with health conditions whom
they treat. The purpose of this study is to identify categories of UL performance in daily life in
adults with and without stroke using data from previously collected cohorts. If there were natural
groupings that occur among multiple UL performance variables calculated from accelerometry
data,157 then these groupings could help to facilitate clinical decision making and implementation
of UL performance data into routine rehabilitation care.
Aim 3: Determine if a model can be developed to predict UL performance in daily life at 3
months post stroke. This aim is an analysis of data collected from a prospective, observational,
longitudinal cohort study tracking UL change over time and is the same cohort used in Aim 1.105
Hypothesis 3a: A model can be derived from a collection of clinical measures to predict
UL performance post-stroke.
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Hypothesis 3b: The developed model will predict UL performance with a minimum of
70% accuracy.
Early prediction of motor outcomes after stroke has tremendous clinical utility 136,167 because
predictive knowledge of subsequent outcomes can inform the delivery and specification of
individualized rehabilitation services.162,168 Several prediction models have been developed to
guide clinical decision-making,5, 122 however, the majority predict UL impairment or capacity.
119-121

UL capacity for activity is a different but related construct to UL performance of

activity.103,105,169 Prediction models of UL performance can be informed by models of UL
capacity, such as PREP2,62 which has demonstrated that prediction of an UL capacity category
provides clinically-useful information to people with stroke and their families. The PREP2
prediction model was originally built and validated with a CART which resulted in the easy to
interpret decision tree with an overall accuracy of 71% to 75%.62 Recent efforts to predict an
individual’s subsequent UL impairment or capacity category, measures of UL impairment and
capacity emerge as the most important predictors. Advances in computing have improved upon
old and led to new analysis techniques for building prediction models of UL outcomes after
stroke. An alternative to creating a single decision tree is to use ensemble classifier methods.170
which tend to have higher predictive power and reduce the risk of over-fitting relative to other
CART methods, but at the expense of interpretability.159,170 In the present study, different
machine learning techniques will be used to understand how clinical measures and participant
demographics captured early after stroke are associated with the UL performance categories
from a later post stroke time point.171 Using different machine learning methods to build
predictive models with different input variables as predictors will determine how each method
yields similar versus different results. Capitalizing on the advantages of ensemble machine

22

learning algorithms by applying them for prediction of UL performance outcomes could yield
key insights into UL recovery post stroke.
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2.1 Abstract

Objective: To determine the accuracy of an algorithm, using clinical measures only, on a
sample of persons with first ever stroke in the US. It was hypothesized that algorithm accuracy
would fall in a range of 70-80%.
Design: Secondary analysis of prospective, observational, longitudinal cohort; two assessments
were done, (1) within 48 hours to 1 week post stroke and (2) at 12 weeks post stroke.
Setting: Recruited from a large acute care hospital and followed over first 6 months after
stroke.
Participants: Adults with first ever stroke (N=49) with paresis of the upper limb (UL) at <48
hours who could follow 2-step commands and were expected to return to independent living at
6 months.
Intervention: NA
Main Outcome Measure(s): The overall accuracy of the algorithm with clinical measures was
quantified by comparing predicted (expected) and actual (observed) categories using a correct
classification rate (CCR).
Results: The overall accuracy (61%) and weighted kappa (62%) were significant. Sensitivity
was high for the Excellent (95%) and Poor (81%) algorithm categories. Specificity was high for
the Good (82%), Limited (98%) and Poor (95%) categories. PPV was high for Poor (82%) and
NPV was high for all categories. No differences in participant characteristics were found
between those with accurate or inaccurate predictions.
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Conclusions: The results of the present study found that use of an algorithm with clinical
measures only is better than chance alone (chance = 25% for each of the 4 categories) at
predicting a category of UL capacity at 3 months post stroke. The moderate to high values of
sensitivity, specificity, PPV and NPV demonstrates some clinical utility of the algorithm within
healthcare settings in the US.

2.2 Introduction

Of the many people who suffer a stroke each year, a staggering 80% of those individuals

will incur some degree of impairment of the upper limb (UL).1 The ability to predict UL
outcomes for an individual facilitates treatment selection, discharge planning and achievable goal
setting for clinicians and persons with stroke.2-4 Several prediction algorithms have been
proposed and evaluated in clinical trials with the limitation that most are only accurate for
persons with mild to moderate UL impairment.2, 4-9 The Predict Recovery Potential (PREP2)
algorithm, developed in New Zealand, allows for prediction of UL functional capacity at 90 days
post stroke based on measures taken within the first week.5 PREP2 was developed from a
retrospective analysis of data from two previous studies (n=207) to improve upon a previously
developed prediction model (PREP). 5, 10 The goal of PREP2 was to determine if two of the tests
(Transcranial magnetic stimulation (TMS) and Magnetic resonance imaging (MRI)) could be
used with fewer patients or completely eliminated, while maintaining a high level of overall
accuracy.5, 10 When developing PREP2, the authors used a hypothesis-free, data-driven analysis
method (CART)5 to determine which factors (patient demographic, clinical measures,
neurobiomarker and neurophysiological measures) best predicted the outcome category.5 The
result, was a new algorithm that is sequential in nature. Variables selected were: a measure of
strength in the paretic UE (SAFE score)5, participant age, a measure of stroke severity (National
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Institute of Health Stroke Scale (NIHSS))11 and TMS to determine the presence of a motor
evoked potential (MEP) for patients with less initial strength in their paretic UE.5 The algorithm
classifies individuals into one of four clinically meaningful categories (Excellent, Good, Limited
or Poor) of eventual UL functional capacity that can guide rehabilitation (Table 2.1).5, 12 With
these variables, a category of expected UL outcome at 90 days after stroke is predicted with an
overall accuracy (proportion with correct predictions to the total sample) of 75% using clinical
measures and a single neurophysiological measure (TMS).5 The best accuracy (78%) of the
prediction model is for persons with greater initial strength in their paretic UE (SAFE > 5) who
are predicted to the top half of the model (Excellent and Good), the accuracy drops to 70% for
patients with less strength in the paretic UE (SAFE <5) who are predicted to Good, Limited or
Poor categories.5 Prediction of a category rather than a test score for an individual has high
clinical utility 13 and is separate from the debated issue of the proportional recovery rule of
neurobiological recovery.6, 7, 14, 15 Of critical importance for clinical practice, the predictions of
the algorithm maintained accuracy for 83% (n=71/86) of individuals at 2 years post stroke.12
External validation studies are required to test the algorithm on other populations of persons with
stroke outside of New Zealand.16 Lundquist et. al. have replicated the PREP2 at a slightly later
time point and within a European country.9
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Table 2.1. Description of categories of UL capacity
ARAT
Category Name
Score
Expected UL Outcome5, 17
17
Ranges
Potential to make a complete, or
Excellent
51-57
near complete recovery of affected
arm and hand within 3 months.

Rehabilitation Focus5, 17
Promote normal use of the affected hand
and arm with task-specific practice.
Minimize compensatory and adaptive
movements of the affected arm and hand
during daily tasks.

Good

34-50

Potential to use the affected hand
and arm with clumsiness, slowness
and weakness for most daily
activities within 3 months.

Promote function of the affected hand
and arm. Minimize use of the other hand
and trunk in task specific practice.

Limited

13-33

Potential to regain some use of the
affected hand and arm, daily
activities are likely to be completed
with significant modification.

Promote adaptation in daily activities
using the affected arm and hand as a
“helper hand” whenever safely possible.

Poor

0-12

Limited return of useful movement
of the affected hand and arm at 3
months.

Prevent secondary complications such
as pain, spasticity and shoulder
instability, learn to complete daily
activities with stronger hand.

Despite the merits of this algorithm, there are some challenges to implementing it in the
United States (US). The rehabilitation structure of New Zealand differs somewhat from the US,
with respect to who, how much, where, and when individuals receive UL therapy after stroke.
People in the US have strokes at younger ages (mean age US = 64 years; NZ = 71 years) 18-20 and
many have additional comorbidities that are poorly managed.21 Another hurdle to
implementation of the algorithm is the limited accessibility to the neurophysiologic measurement
(TMS) of corticospinal tract function. Access to this test in the US can be present for research
purposes and/or in major academic medical centers, but is not available in routine rehabilitation
care.13, 22 It has been acknowledged that making predictions with clinical measures alone is
inaccurate and difficult.12, 23 Anticipating this, the algorithm was shown to still be 71% accurate
at 90 days post-stroke using clinical measures only, with a measure of stroke severity (NIHSS)11
being adjusted to replace the neurophysiologic measure (TMS) in participants with little or no
strength (SAFE< 5) in their affected UL.5 The algorithm with clinical measures only maintains
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similar overall accuracy (95% CI = 55%-78%); however, the prediction accuracy drops to 55%
for patients with a SAFE score <5.5
Prior to widespread implementation of this algorithm into routine rehabilitation care, it is
necessary to understand how small system differences and lack of the neurophysiologic tests
(TMS) affects the overall accuracy of the algorithm in individuals who have suffered a first
stroke in the US. The current study is a secondary analysis (R01 HD068290) of data from a
prospective, observational, longitudinal cohort tracking UL change over time. The analysis in
this paper determined the accuracy of the algorithm on a sample of persons with first ever stroke,
using the clinical measures only,5 at time points that are most feasible in the US health care
system. We hypothesized that algorithm accuracy would fall in a range of 70-80%.

2.3 Methods

This study was a secondary analysis of data collected from a prospective, observational,

longitudinal cohort tracking UL change over time. Sources of data utilized were clinical
measures and participant demographics at two time points: (1) between 48 hours to 7 days of
stroke onset and (2) 12 weeks post stroke.

2.3.1 Participants

Participants were included in the prospective, observational, longitudinal cohort if the

following criteria were met: (1) within two weeks of a first-ever ischemic or hemorrhagic stroke,
confirmed with neuroimaging; (2) presences of UL motor deficits within the first 24 to 48 hours
post stroke, as indicated by a NIHSS11 Arm Item scores of 1 to 4 or documented manual muscle
test grade of <5 anywhere on the paretic UL; (3) able to follow a 2-step command, as measured
by a NIHSS Command Items score of zero; and (4) anticipated return to independent living (i.e.
not institutionalized), as indicated by the acute stroke team. Participants were excluded from the
43

study if any of the following criteria were met: (1) history of previous stroke, other neurological
condition, or psychiatric diagnoses; (2) presence of comorbid conditions that may limit recovery
(e.g., end-stage renal disease or stage IV cancer); (3) lives more than 90 minutes from study
location; and (4) currently pregnant by self-report. The Human Research Protection Office at
Washington University in St. Louis Missouri approved this study and all participants provided
written informed consent.
Cohort participants completed eight assessment sessions over the 24 weeks post stroke.
This analysis used the assessment data at the first assessment (48 hours to 7 days), and at 12
weeks. Assessments were administered by trained personnel (licensed PT or OT, range of
experience with measures was 2-15 years). The majority of people received their first
assessments in the acute hospital setting or inpatient rehabilitation. The 12 week assessments
were completed where the participant was located at that time and includes: sub-acute
rehabilitation facility, research lab, or home. Since this was an observational cohort study, we did
not provide or control for the amount or type of rehabilitation services delivered to enrolled
participants. Participants received rehabilitation services as prescribed by their medical team.

2.3.2 Algorithm Measures

Evaluation of accuracy of the algorithm in this US cohort used early clinical measures

and participant age to predict the category (Excellent, Good, Limited or Poor) of UL capacity at
12 weeks. Assessments to predict the expected UL category were: 1) the Shoulder Abduction
Finger Extension (SAFE) score 5, 12 at time of consent (mean time post-stroke = 7 + 3 days, range
= 2-14 days); 2) participant age; and 3) NIHSS11 total score captured around 48 hours post
stroke. The first step in the algorithm is a calculation of the SAFE score to quantify impairment
24, 25

of the paretic UL. The total SAFE score is a sum of the Medical Research Council 26
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(MRC) strength grades (0 = no strength to 5 = full strength) for shoulder abduction and finger
extension in the paretic UL. The SAFE score of 10 indicates full strength in both movements on
the paretic limb. A SAFE score >5 places individuals into the upper half of the prediction model,
with age predicting the final categorization of Excellent (< 80 years). For individuals equal to
and older than 80 years, SAFE score is used again to determine predictions to either the
Excellent (SAFE > 8) or Good (SAFE < 8) categories.5 A SAFE score < 5 places individuals into
the lower half of the prediction model, where the NIHSS total score11 is then used to predict the
final outcome categorization. The NIHSS is a global measure of stroke severity11, and captures
stroke impairment across multiple domains.11, 24 Scores range from 0 to 42, where higher scores
indicate more severe stroke.11 In the version of the algorithm with clinical measures only,
persons with an NIHSS total score < 9 are predicted to have a Good outcome and NIHSS >10 a
Poor outcome.5
The dependent variable for this study was category of UL functional capacity, as
determined by the Action Research Arm Test (ARAT) score,5, 10 a standardized measure of
activity limitation.25, 27 The ARAT is a valid and reliable measure of UL capacity24, 28 (grasp,
grip, pinch and gross motor) in adults with UL paresis; scores range from 0-57 with higher
scores indicating greater functional capacity of the UL.29-32 The actual category of UL capacity
was determined from the ARAT score at 12 weeks post stroke.5, 17 Ranges of ARAT scores
dictated how people were divided into one of four clinically meaningful categories: “Excellent
“(51-57), “Good” (34-50), “Limited” (13-33) and “Poor” (0-12) based on a previously published
report (see Table 2.1).17
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2.3.3 Analysis

All data were analyzed in R (version 4.0.1), an open source statistical computing

program. The packages caret, gridExtra, yardstick, and vcd were used for the contingency table
(CCR) and the packages ggalluvial and alluvial were used for the alluvial plot in Figure 2.2. Data
were visually inspected to determine normality of the distribution. Continuous participant
characteristics and 12 week clinical measure scores are summarized by mean, standard deviation
(SD) and ranges when normally distributed, otherwise by median and ranges.
The algorithm using only the early clinical measures 5, 12 was used to assign predicted
categories. In the process, we had to modify the algorithm slightly to account for participants
with an NIHSS of 9, which was not included in the PREP2 algorithm, where the only choices
were > 9 or < 9.5 Here, individuals with an NIHSS total score = 9 were predicted to have a
“Limited” outcome. The remaining decision points of PREP2 were unaltered.
The overall accuracy of the algorithm with clinical measures was quantified by
comparing the predicted (expected) and actual (observed) ARAT categories using a correct
classification rate (CCR). CCR calculates accuracy of the algorithm as a whole and other
statistics for each category. Overall accuracy in this analysis is the proportion of individuals with
correct predictions with respect to the total sample. Sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) were calculated for each category.
Additionally, a weighted kappa was calculated to determine the classification accuracy of the
whole algorithm. In order to interpret the sensitivity, specificity, PPV and NPV, we classified
values from 0.75 and above as being “high”, 0.50-0.74 as “moderate” and anything 0.49 and
below as “low”. We chose these words to avoid confusion with the names on the categories. The
weighted kappa was selected instead of the non-weighted version because there was not an
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equal, random chance (chance = 25% for each of the 4 categories) of prediction for each
category. Following categorical analyses, data were explored further to see if any participant
characteristics distinguished between persons with accurate versus inaccurate predictions. Due to
the nonparametric nature of the samples, a Wilcoxin signed-rank test was calculated to explore
differences in age, initial SAFE score and NIHSS total score, number of days post stroke to
SAFE score, and number of comorbidities.

2.4 Results

Overall, the sample of persons with first ever stroke were generally in their sixties and

had mild to moderate stroke (90% with NIHSS 0-15). At the time of this analysis, a total of 69
subjects had been enrolled in the study. Enrollment in the prospective, observational,
longitudinal cohort study was suspended and then closed due to the on-going COVID-19
pandemic. Only participants with complete initial and 12 week assessment time points were
included here (n=49). Reasons for exclusion include: missing initial or week 12 clinical measures
(n=14) and data collection suspended due to COVID (n=6). Demographics of the participants
are provided in Table 2.2.
Table 2.2 Participant Characteristics. Values are median (range) or number (%).
n=49
Demographic Characteristics
Age (years)
Median age (range)
66 (43-81)
< 80 years n (%)
47 (96%)
Sex
Male
28 (57%)
Female
21 (43%)
Ethnicity
Non-Hispanic/ Non-Latino
49 (100%)
Race
White
27 (55%)
African American
21 (43%)
Asian
1 (2%)
Common Co-morbidities (self-report)
Diabetes (% yes)
16 (33%)
High Blood Pressure
37 (76%)
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Heart Disease

15 (31%)

First stroke

49 (100%)

Ischemic
Hemorrhagic

43 (88%)
6 (12%)

Cortical
Subcortical
Cortical & Subcortical
Post. Circ./ Cerebellar

31 (63%)
17 (35%)
1 ( 2%)
0

Right
Left
Both
% Concordant

42 (86%)
6 (12%)
1 ( 2%)
39%

Mild (NIHSS score 0-4)
Moderate (NIHSS score 5-15)
Severe (NIHSS score > 16)
Paretic Upper Limb Measures
Initial SAFE score
Excellent outcome median (range)
Good outcome median (range)
Limited outcome median (range)
Poor outcome median (range)

19 (39%)
25 (51%)
5 (10%)

Stroke Characteristics
Stroke Type
Stroke Location

Handedness

Stroke Severity

8 (2-10)
7 (2-8)
2 (0-8)
1 (0-2)

Figure 2.1 Frequency of participants predicted to each category (A) and then actual category observed (B).
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Table 2.3: Contingency table of predicted and actual categories
Contingency Table Showing Numbers
Actual Category
Predicted Category
Excellent
Good
Limited
Excellent
19
8
1
Good
0
2
5
Limited
0
1
0
Poor
1
0
1
Sum
20
11
7
Contingency Table Showing Percentages
Actual Category
Predicted Category
Excellent
Good
Limited
Excellent
39%
16%
2%
Good
0%
4%
10%
Limited
0%
2%
0%
Poor
2%
0%
2%
Sum
41%
22%
14%

Poor
0
2
0
9
11
Poor
0%
4%
0%
18%
22%

Sum
28
9
1
11
49
Sum
57%
18%
2%
22%
100%

Frequencies of participants predicted and confirmed within each category are presented
graphically (Figure 2.1) and as a 4x4 contingency table (Table 2.3). The colors of each bar graph
are the colors used in the PREP2 analysis: 5 Excellent (green); Good (blue); Limited (orange);
and Poor (red). The predicted categories were weighted to the extremes (Excellent and Poor)
where the actual categories at 12 weeks were more balanced among the groups.
The algorithm is overall better than chance (chance = 25% for each of the 4 categories)
and most useful in determining the category someone will not end up in at 12 weeks. Table 2.4
presents the accuracy and other calculated statistics. The overall accuracy (0.61) and the
weighted kappa (0.62) were significant, but lower than hypothesized. Sensitivity, specificity,
PPV, and NPV differed across categories. Note that the small numbers within some cells, e.g.
only one person was predicted into the Limited category have a large effect on the calculation of
these values. Further, a total of 20 people in this sample had an initial SAFE score <5 and the
model was accurate for 50% of them.
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Table 2.4. Overall statistics (top) and per category statistics (bottom)
Statistic
Value
95% CI Range
Overall Accuracy
0.61
0.46
0.75
Weighted Kappa
0.62
0.46
0.78
Per Category Values
Statistic/ Category
Excellent
Good
Limited
Sensitivity
0.95
0.18
0
Specificity
0.69
0.82
0.98
PPV
0.67
0.22
0
NPV
0.95
0.77
0.85

p-value
0.003
<.0001
Poor
0.81
0.95
0.82
0.95

People with inaccurate predictions were typically inaccurate within one category of their
prediction. Figure 2.2 is an alluvilial plot providing a visual representation of participants who
were accurately and inaccurately predicted. The top axis is the predicted category and the bottom
axis is the actual category, with the width of the category box representing the frequency of
individuals who were within that category for the predicted and actual time points. The colored
alluvium in the center of the plot are filled with the predicted category colors: Excellent (green),
Good (blue), Limited (orange) and Poor (red). The most movement between categories is seen
within the middle of the plot. One can see that the majority of inaccuracies were only off by one
category (n=15/19), the remaining were inaccurate by two (n=3) or three (n=1) categories. Those
inaccurate by two categories included: (a) two people who were predicted to the Good and ended
up in the Poor category (ARAT at 90 days = 0 & 11); and (b) one person who was predicted to
the Excellent and ended up in the Limited category (ARAT at 90 days = 26). The one person
inaccurate by three categories ended up with a better outcome; predicted to the Poor and ended
up in the Excellent category (ARAT at 90 days = 53). This is a good example of an individual
where correct classification would likely have been enhanced with TMS. Of those inaccurately
predicted, the algorithm was too optimistic for 16 people and too pessimistic for 3 people. The
most movement between predicted to actual categories was seen between those predicted to be in
Excellent and ended up in Good (n=8).
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Figure 2.2: Alluvial plot displaying accurate and inaccurate categorizations. The predicted (top) and actual (bottom)
axes are scaled such that the width of the box represents the frequency of each category. Note that the narrow width
of the Limited category on the predicted axis (top) is due to only one person being predicted to end up in this
category. The fill of the color bands are the predicted category. Inaccuracies tended to be one category off, with the
exception of a few individuals who had better than expected (e.g. thin red line, Poor to Excellent) or worse than
expected (e.g. thin green line, Excellent to Limited) outcomes.

Further exploration of the data revealed that participants with inaccurate predictions were
not different from those with accurate predictions on clinical or demographic measures. We
found no significant differences between inaccurately vs. accurately categorized individuals with
respect to strength in the paretic UL (SAFE score median: inaccurate=5, accurate= 8, p=0.18),
the day the SAFE score was captured (day median: inaccurate= 5.5, accurate= 6.3, p=0.33),
stroke severity (NIHSS median: inaccurate=5, accurate = 6, p=0.45), age (median: inaccurate: 65
yrs, accurate: 67 yrs, p=0.69), or number of reported comorbidities (mean number ± SD:
inaccurate=2.35 ±1.9, accurate = 3.03 ±1.8, p=0.11).

2.5 Discussion

The algorithm, with clinical measures only, on a sample of persons with first ever stroke

in the US had an overall accuracy of 61%, which was less than hypothesized. The predicted
categories were more weighted to the best and worst categories than the actual categories at 12
weeks. Some of the values of sensitivity, specificity, PPV and NPV were high, but not all.
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Participants with inaccurate predictions were most often only one category away from their
actual category and no differences were found between those with accurate or inaccurate
predictions on days of assessments, clinical or demographic measures.
Implementation of prediction models into routine clinical practice requires external
validation studies such as this one.13, 33 Statistical methods used to evaluate predictive models
arise from evaluating diagnostic medical tests,34 referenced to a gold standard.35 Medical
diagnostic tests must be highly accurate 35, due to the potentially serious downstream
consequences of inaccuracy on outcomes (e.g. mortality).32 In the field of psychology, accuracy
statistics of diagnostic tests have been identified as: > 0.90 are considered “excellent”, 0.80-0.89
are “good”, 0.70 to 0.79 are “adequate” and < 0.70 “may have limited applicability”.36 The
rehabilitation field has not yet identified values considered to be good enough for
implementation of predictive models into standard of care. Accuracy statistics of rehabilitation
prediction models could theoretically be looser than values used to diagnose a life threatening
condition or interpret lab values, since the consequences of inaccuracy are not as serious. While
the present accuracy values were lower than desirable (61%, 95%CI: 46%-75%), the confidence
intervals overlap with the PREP2 models (CI 45%-84%) 5, 10 and with the other external
validation study (accuracy: 60%, with CI 50%-71%).9 These overlapping confidence intervals
occurred despite the use of neurophysiologic test (TMS) included in other analyses 5, 9 and the
timing differences of the initial assessment ranging from 2-3 days 5 out to two weeks9. Thus, the
current study and others confirm that use of this algorithm is better than chance alone (chance =
25% for each of the 4 categories) at predicting a category of UL capacity at 3 months from
measures taken in the early days after stroke. Given these results, it may be realistic to
implement the algorithm, with clinical measures only, into US clinical practice. Implementation
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would require the caveat that for persons with less initial strength in their paretic UE (SAFE<5),
the prediction is likely less accurate5 and repeat assessments and predictions will be required.
In the sample used to develop PREP2, 67% of the people were younger than 80 years
old,5 while 96% of people in this US sample were younger than 80. This is likely a function of
the average age of stroke in the US vs. New Zealand18-20 (see Introduction). Having fewer
people older than 80 years of age reduced the number of people who could be predicted to end
up in the Good category. It is therefore not surprising that in this analysis the most inaccurate
predictions were those predicted to Excellent but ended up in Good. Another potential reason for
inaccuracies in this analysis could be because of our decision that an NIHSS=9 would be
predicted to the Limited category. One person in this sample had an NIHSS=9 and was predicted
to the Limited category but ended up in Good (ARAT=39 at 90 days), illustrating an added
benefit of TMS, if that had been available and the person had positive motor evoked potentials.
In PREP2, no one in their sample had an NIHSS=9, and thus it was not an option in the decision
tree.5 The variables and their ranges in PREP2 were selected by an atheoretical approach that
arrives on an algorithm that is dependent on the sample.5 Lundquist et. al.9 had similar values of
overall accuracy as those observed in this analysis, however with the same data driven analysis
method (CART) the same variables were selected but with different ranges for the NIHSS total
score.9 It is anticipated that within the US, different ranges of the variables (SAFE, age and
NIHSS) may be needed. It is possible that future prediction models could increase the predictive
accuracy, as more is known about differences around the world in populations of persons with
stroke.
In the present study, the PPV for all categories was lower than PREP2 but the NPV was
higher.5 Additionally, the categories of Excellent and Poor demonstrated greater overall
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accuracy, sensitivity and NPV. The high NPV means the model does well at predicting which
categories someone will not end up in. In this analysis 10/19 people with inaccurate predictions
had an initial SAFE score <5, contributing to the high PPV and NPV observed in the Poor
category. Similar to the PREP2 papers,5, 12 and other replications9 of the algorithm, most people
with inaccurate predictions were only one category away in the current study. Having a patient
who winds up one category away from the original prediction is much easier to manage
clinically than one who is two or three categories off.
Predictive models or algorithms are not designed to take over the job of the clinician, but
are intended to assist in the clinical decision-making process by providing more objectivity.37, 38
PREP2 was developed as a tool to provide clinicians, caregivers and persons with stroke more
information in the early days after a stroke of the anticipated UL outcome.33 Predicting a
category of the UL outcome rather than a score on a test has clinical utility, as persons with
stroke are more interested in what they can generally expect in recovery of the UL.13, 38-40 A
challenge with category boundaries is that a one point difference in the ARAT score at 3 months
might be the difference between an accurate vs. inaccurate prediction. In this analysis, four
people had a total ARAT score between 47 to 49 points at 90 days, placing them in the Good
category when they were predicted to Excellent (bottom ARAT limit = 51). Experienced
clinicians might not consider this problematic because a point on a standardized test likely will
not change the persons UL ability at 3 months. The predictive algorithm with clinical measures
only is clinically efficient and does not require expensive equipment or extensive training,
making it possible to use within the confines of the US healthcare system. Additionally, the true
PREP2 provides resources41 to aide clinicians about providing prediction information to persons
with stroke. These resources will be extremely important for clinicians in the US to deliver
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prediction information from this algorithm, especially to people with an initial SAFE score<5.
Even with less than optimal accuracy, we speculate that using this algorithm with information
routinely captured during stroke rehabilitation can provide useful information for clinicians and
persons with stroke. In the US, discharge disposition is largely dictated by patient insurance,
availability of support upon discharge and current mobility status.42 The predictions provide
clinicians with an objective tool and language to efficiently evaluate potential UL outcome,
communicate results to the person with stroke and begin the appropriate therapy interventions to
meet the outcome.5, 13, 17 Since the therapy process is fluid, clinicians can modify therapy content
appropriately as the individual’s progress unfolds.17

2.5.1 Study limitations

There are two key limitations to consider when interpreting the results of this analysis.

First, our sample size is small which limits generalizability and produces wide confidence
intervals. This sample size, however, is similar to that in the initial algorithm (n= 40).10 A large
sample size of 200-300 would be needed to produce enough data within each cell and understand
the difference between those who are accurately or inaccurately classified. Second, the inclusion
criteria used to enroll participants with first ever stroke excludes persons with substantial
cognitive and language deficits. This is similar to the samples used to develop PREP2 which
excluded people with impaired UL somatosensation, vision, visuospatial attention and
cognition.5 We only included people with first stroke, but one of the samples used in PREP2
included persons with second stroke. We recognize that future studies will need to include
people with these impairments and with second stroke. While it is unknown how the algorithm
would work on the full spectrum of stroke survivors, the population enrolled here is typical of
those who receive rehabilitation services in the US.
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2.6 Conclusions

The present study found that the algorithm, with clinical measures only, is better than

chance alone at predicting a category of UL capacity at 3 months post stroke. The values of
sensitivity, specificity, PPV and NPV of this study and others demonstrate the potential clinical
utility of this predictive algorithm. Until there are agreed upon values of statistics calculated
from predictive models for use in the rehabilitation field, we would continue to advocate for the
clinical utility of this tool.
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3.1 Abstract

Background: The use of wearable sensor technology (e.g., accelerometers) for tracking human
physical activity has allowed for measurement of actual activity performance of the upper limb
(UL) in daily life. Data extracted from accelerometers can be used to quantify multiple variables
measuring different aspects of UL performance in one or both limbs. A limitation is that several
variables are needed to understand the complexity of UL performance in daily life.
Purpose: To identify categories of UL performance in daily life in adults with and without
neurological UL deficits.
Methods: This study analyzed data extracted from bimanual, wrist-worn, triaxial accelerometers
from adults from three previous cohorts (N=211), two samples of persons with stroke and one
sample from neurologically intact adult controls. Data used in these analyses were UL
performance variables calculated from accelerometer data, associated clinical measures, and
participant characteristics. A total of twelve cluster solutions (3-, 4- or 5-clusters based with 12,
9, 7, or 5 input variables) were calculated to systematically evaluate the most parsimonious
solution. Quality metrics and principal component analysis of each solution were calculated to
arrive at a locally-optimal solution with respect to number of input variables and number of
clusters.
Results: Across different numbers of input variables, two principal components consistently
explained the most variance. Across the models with differing numbers of UL input performance
variables, a 5-cluster solution explained the most overall total variance (79%) and had the best
model-fit.
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Conclusion: The present study identified five categories of UL performance formed from five
UL performance variables in cohorts with and without neurological UL deficits. Further
validation of both the number of UL performance variables and categories will be required on a
larger, more heterogeneous sample. Following validation, these categories may be used as
outcomes in UL stroke research and implemented into rehabilitation clinical practice.

3.2 Introduction

The use of wearable sensor technology (e.g., accelerometers) for tracking human

movement has allowed for efficient measurement of activity of the upper limb (UL) in daily
life.1-6 Accelerometry has become an established, valid and reliable methodology to directly
measure performance of UL activity in daily life in neurologically intact adults7, 8 and adults with
stroke.9-13 Per the World Health Organization International Classification of Functioning,
Disability and Health (ICF) model,14 activity performance, defined as what a person does in the
unstructured, free-living environment, is a different but related construct to the capacity for
activity (i.e. functional capacity), which is measured by standardized assessments in the
structured clinical or laboratory setting. Clinicians and researchers typically assess a person’s
functional capacity for activity in the structured clinic or laboratory environments with
standardized assessments. However, people seek out rehabilitation services because they want to
be able to perform better in their daily lives,15 and improvements in UL capacity seen in the
clinic do not necessarily translate to improvements in UL performance in daily life.13, 16-19
Therefore, assessment of UL activity performance in an individual’s unstructured, free-living
environment is critical to evaluating effectiveness of rehabilitation services and determining if
the services provided have achieved the goal of improving performance in daily life.
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Data extracted from bilateral, wrist-worn accelerometers can be used to quantify
variables measuring different aspects of UL performance in one or both limbs. These variables
collectively inform clinician scientists about the real-world activity performance. The numerous
variables calculated from accelerometers measure different aspects of UL performance, such as:
1) duration;7, 20 2) magnitude;12, 21, 22 3) variability;12, 23 4) symmetry or laterality;3, 7, 10 and 5)
quality of movement.5, 24-26 Each UL performance variable conveys slightly different information
about the collective nature of UL use, with a single variable providing only part of the picture.5
Furthermore, some variables are narrowly distributed in neurologically-intact (adult controls)
individuals (e.g. use ratio, an index of duration of activity of one limb versus the other), while
other variables are widely distributed (e.g. bilateral magnitude, a measure of magnitude of
bilateral UL activity).3 Thus, multiple variables quantifying different aspects of movement along
with heterogeneous distributions of those variables can make it difficult to interpret UL
performance data for clinical decision-making.
One reason wearable sensor technology (e.g. accelerometry) for measurement of UL
performance has remained largely confined to rehabilitation research with limited ventures into
clinical practice is because the current output from accelerometers is not easily accessible for
rehabilitation professionals.4 A potential solution to the multi-variable problem would be the
formation of categories (or groups) of UL performance in daily life. If there were natural
groupings that occur among multiple UL performance variables calculated from accelerometry
data,27 then these groupings could help to facilitate clinical decision making and implementation
of UL performance data into routine rehabilitation care. In other biomedical science fields,
formation of categories which encompass multi-dimensional measures have facilitated clinical
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decision making for persons with health conditions such as, spinal cord injury,28 heart failure,29,
30

and chronic obstructive pulmonary disease.31
The purpose of this study, therefore, was to identify categories of UL performance in

daily life in adults with and without stroke using data from previously collected cohorts. Cluster
analyses were performed with variables of UL performance calculated from 24 hour
accelerometer recordings from three cohorts, two samples of persons with stroke and one from
neurologically-intact adult controls. We hypothesized that at least three categories (low, medium,
and high) of UL performance would be identified across the UL performance variables
quantified by accelerometer data, spanning the possible ranges of UL performance in daily life.
We also anticipated that the emerging categories would group individuals with similar ranges of
the performance variables and provide a simpler method to interpret UL performance in daily life
for clinicians and persons with health conditions whom they treat.

3.3 Methods

This study analyzed accelerometer data from adults from three previous cohorts, using

the same accelerometry methodology.32 Data used in these analyses were UL performance
variables calculated from accelerometer data over one day, associated clinical capacity measures,
and participant characteristics.

3.3.1 Participants

The three cohorts in this analysis include; 1) people with stroke (stroke cohort 1, n=57 )

from a prospective, observational, longitudinal cohort tracking UL change over time;19 2) people
with chronic stroke (stroke cohort 2, n=78) who participated in a clinical trial; 33 and 3) a sample
of neurologically-intact adults (adult controls, n=76) of similar age, race, ethnicity, and
socioeconomic status of persons in the clinical trial (stroke cohort 2).7 All participants provided
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signed informed consent to participate in the individual studies. Inclusion and exclusion criteria
for each sample are described elsewhere (stroke cohort 1,19 stroke cohort 2,33 and adult
controls7). In general, persons in the stroke cohorts had documented UL motor impairments and
diminished functional capacity as measured by the Action Research Arm Test (ARAT)34, 35 at the
time of the study enrollment. UL motor severity ranged from mild to severe, as indicated by the
National Institute of Health Stroke Scale (NIHSS)36 arm item scores of 1 to 4. Persons with
stroke had to be able to follow two-step commands to enroll, and were enrolled even if they had
other, mild, stroke-induced, non-motor deficits such as hemispatial neglect, aphasia, or mild
cognitive impairment. Neurologically intact community-dwelling older adults had to be willing
to participate and be able to follow two-step commands. Combining the three cohorts provided a
broad sampling of UL performance variables. With respect to power analyses, there is no agreed
upon sample required for a cluster analysis,37, 38 however the combined cohorts yield a sample
size of over 200 individuals, which was deemed sufficient to proceed with a cluster analysis.39

3.3.2 Data collection

UL performance was captured using data from bilateral, wrist-worn accelerometers.7, 8, 40-

42

A single time point was chosen for participants in each of the three cohorts. In stroke cohort 1

(assessments from two – 24 weeks post stroke), data from the latest assessment time point
available between weeks six and 24 were used in the analysis, since UL performance appears to
stabilize between three and six weeks post stroke.19, 43 In stroke cohort 2 (assessments at baseline
and weekly for eight or more weeks), data from the earliest available assessment time point was
used in the analysis. Data points later than the baseline (when baseline was unavailable) were
included because UL performance did not change as a result of this treatment.18, 33 The adult
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control cohort completed a single assessment in the cross-sectional study and this time point was
used.8

3.3.3 Upper limb performance variables

Participants wore the Actigraph GT3X-BT or GT9X-Link accelerometers on both wrists

for the three cohorts, with methods described previously.32 Briefly, tri-axial acceleration data are
sampled at 30 Hz for 24 or more hours continuously. Once the accelerometers were returned to
the lab, data were uploaded, visually inspected, and processed using Actilife 6 (Actigraph Corp.,
Pensacola, FL) proprietary software. For most variables, data were band-pass filtered (0.25 and
2.5 Hz) and down sampled into 1-second epochs with ActiLife proprietary software, where each
second is the sum of the 30 Hz values in that second and converted to activity counts (1 count =
0.001664g). For a few variables, (see Table 1) calculations were done directly on the 30 Hz
data.5, 24-26 Similar to previous work,7, 12, 19-21 accelerometery data was processed using custom
written software in MATLAB (Mathworks, Inc, Natick, MA) to calculate UL performance
variables which qualify various aspects of UL activity in everyday life. Table 1 presents the
twelve UL performance variables included in the analysis along with their description and the
source of accelerometer data for calculation (1 Hz versus 30 Hz). The variables independently
measure duration, magnitude, variability, symmetry and quality of movement of one or both
ULs.
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Table 3.1 Upper limb performance variables.
Upper limb performance
variable name
Duration
Hours of paretic/nondominant limb activity7, 8
Hours of non-paretic/
dominant limb activity7, 8
Isolated paretic/nondominant limb activity8
Isolated nonparetic/dominant limb
activity8
Magnitude
Median acceleration of
paretic/non-dominant limb*
3, 8, 21

Bilateral Magnitude* 3, 8, 21
Variability
Acceleration variability of
paretic/non-dominant limb
activity* 12, 23
Symmetry
Use Ratio† 7, 10, 40
Magnitude Ratio† 8, 12, 23

Quality of Movement
Jerk asymmetry index 26

Description

Time, in hours, that the paretic/non-dominant limb is
moving.
Time, in hours, that the non-paretic/dominant limb is
moving.
Time, in hours, that the paretic/non-dominant limb is
moving, while the non-paretic/dominant limb is still.

Data source

Included
in final
solution

1 Hz



1 Hz



1 Hz

Time in hours that the non-paretic/dominant limb is
moving, while the paretic/non-dominant limb is still.

1 Hz

Magnitude of accelerations of the paretic/non-dominant
limb, in activity counts or gravitational units.

1 Hz

Intensity, or magnitude of accelerations of movement
across both arms, in activity counts.

1 Hz

Standard deviation of the magnitude of accelerations
across the paretic/non-dominant limb, reflecting the
variability of paretic/non-dominant limb movement, in
activity counts.

1 Hz



1 Hz



Ratio of hours of paretic/non-dominant limb movement,
relative to hours of non-paretic/dominant limb
movement.
Ratio of the magnitude of paretic/non-dominant UL
accelerations relative to the magnitude of the nonparetic/dominant UL accelerations. This ratio reflects
the contribution of each limb to activity, expressed as a
natural log.



1 Hz

Ratio of the average jerk magnitude between the
paretic/non-dominant limb and the nonparetic/dominant limb. Higher jerk represents less
30 Hz
smooth movement, and an index of 0 represents similar
smoothness of movement in the paretic/non-dominant
and non-paretic/dominant limbs. Values are bounded
between -1 to +1.
Spectral arc length of
A measure of movement smoothness that quantifies
30 Hz
paretic/non-dominant and
movement intermittencies independent of the
non-paretic/dominant limb 5,
movement’s amplitude and duration. Longer spectral
24, 25
arc lengths are reflective of less smooth or less
30 Hz
coordinated movement in either the paretic/nondominant or non-paretic/dominant limb respectively
* Variables that are quantified in activity counts, computed by the Actilife proprietary software such that 1 activity
count = 0.001664g.
† For persons with stroke, ratios are paretic to non-paretic, while for neurologically-intact adults, ratios are nondominant to dominant.
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3.3.4 Analysis

All data were analyzed in R (version 4.0.1), an open source statistical computing

program. A k-means hypothesis-free cluster analysis was used to determine categorizations of
UL performance indexed by accelerometer variables in samples of persons with stroke and
neurologically intact adults (adult controls). A cluster analysis is a robust statistical algorithm
that groups similar objects into sub-groups called clusters,27, 44, 45 with identified clusters
becoming the categories of UL performance. The end point is a set of clusters where individuals
within each cluster are more similar to each other, on average, than they are to other members of
the other clusters formed.44 A k-means method was chosen over other methods (e.g. hierarchical
clustering or partial around the medeoid) to use an iterative approach to qualitatively explore the
effect of adding more input variables and increasing the number of clusters on the dataset used in
the analysis.45, 46
First, several steps were completed prior to the cluster analysis. The dataset of UL
performance variables were standardized (using z-scores) as each variable is on a different
measurement scale (e.g., hours, counts, and ratios). Then, a Hopkins statistic was calculated to
determine if ursing a cluster analysis on these data was appropriate. The Hopkins statistic ranges
from 0 to 1, and values >0.5 indicate clusters exist in the dataset.47 The distributions of all twelve
UL performance variables and pairwise spearman scatterplots of variables with both strong and
weak relationships were examined using the GGally package.48 Distributions and scatterplots
were used to understand the relationships between UL performance variables in preparation for
additional analyses and for later simplification of the cluster solutions that emerged.
Second, a principal component analysis (PCA) was conducted using the factoextra
package on datasets that included 12, 9, 7 or 5 of the UL performance variables.49 Principal
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components can be thought of as the underlying dimensions of the individual UL performance
variables.45 PCAs were calculated including all 12 performance variables, then variables were
systematically eliminated to exclude the variables that are complex to calculate (e.g. used 30 Hz
vs 1 Hz data) and the variables with less straight forward clinical interpretation. Scree plots were
examined for each of the models (5, 7, 9, and 12 UL performance variables) to determine how
many principal components explained variance in the UL performance variables. Further, we
examined the loadings of the input variables on each of the resulting PCs.
Third, different numbers of clusters were evaluated and the solutions were calculated
using the NbClust and clusertend packages.50, 51 A k-means cluster analysis expects the number
of clusters to be specified prior to the analysis. Thus, we started with 3-clusters as a reasonable
solution to produce clusters of low, medium and high UL performance. There are multiple
statistical methods for determining the optimal number of clusters. We evaluated potential
solutions using: 1) the elbow method,52 2) the silhouette method,53, and 3) the gap statistic.27
Although there was no clear single “elbow” where adding clusters led to diminishing returns in
variance explained, these methods indicated that 3-,4-, and 5-cluster solutions were progressively
better explanations of the data (see Results). Thus in the interests of parsimony, we focused on
these three different cluster sizes in subsequent analyses.
A total of twelve cluster solutions (3-, 4- or 5-clusters with 12, 9, 7, and 5 input variables)
were calculated to systematically eliminate UL performance variables to create the most
parsimonious solution.50, 51 The most complex model was calculated first (including all 12
performance variables) for a 3-, 4-, and 5-clusters. The second most complex model included 9
UL performance variables, excluding the three variables calculated from the 30Hz data that are
proposed to measure quality of UL activity5, 24-26 (see Table 3.1). These variables were removed
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because they are more complex to calculate, have not been validated in clinical populations54,
and did not add relevant information to the analysis. For the seven and five input variable
models, the decision was made to maintain at least one performance variable from each of the
other four aspects of UL performance (duration, magnitude, variability and symmetry) to capture
the dimensionality of UL performance in daily life. Variables that were simpler to calculate (1
Hz versus 30 Hz) and interpret were retained over those that required more complex calculations
and/or are more difficult to interpret for ease of eventual integration into rehabilitation clinics.4
For example, both the bilateral magnitude and the median acceleration of the paretic/nondominant limb activity quantify the magnitude or intensity of UL activity. These two variables
are highly correlated to each other and the loadings from the PCA indicate that these two
variables had moderate, positive loadings on PC1, primarily. For the five variable solution, the
median acceleration of the paretic/non-dominant limb was selected to remain because it had a
higher contribution to PC1 than the bilateral magnitude and it is a simpler variable to calculate
and interpret.
Fourth, we examined model fit metrics for each of the 12 solutions calculated to avoid
overfitting as additional variables and clusters were added. The total variance explained by the
models were extracted for each of the cluster-variable solutions (3-, 4- or 5-clusters with 12, 9, 7,
and 5 input variables). Models that had a higher % of total explained variance were deemed to
have a better model-fit.45 Additionally, a multivariate analysis of variance (MANOVA) was
calculated to re-fit the cluster classifications (3-, 4-, and 5-clusters) to the multi-dimensional
space of all the UL performance variables (5, 7, 9, and 12 variables). This allowed for the Akaiki
information criterion (AIC) to be extracted to compare the model-fit for each of the cluster
solutions with respect to the variables included.45 As the AIC imposes a penalty for additional
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model parameters, selecting the model with the lowest AIC value helps avoid overfitting and
improve generalizability.
Fifth, the means and ranges of the UL performance variables, concordance, and UL
capacity (e.g. ARAT score) were computed for each cluster in the final solution. Given
statistically significant omnibus effects from the multivariate analyses described above,
univariate ANOVAs were computed to determine how the means of the UL performance
variables differed from each other across the clusters (alpha = 0.05).55, 56 Post-hoc comparisons
(using a Tukey HSD correction) of each cluster to other clusters for five different performance
variables were calculated (alpha = 0.05). Additionally, we looked at how the input cohorts
(stroke cohort 1, stroke cohort 2, adult controls) were distributed across the cluster solutions.
Finally, coxcomb charts were created. Coxcomb charts are a two-dimensional chart type
designed to plot one or more series of values over multiple quantitative variables. The 5 UL
performance variables are divided into equally segmented wedges on the radial chart. The area of
each individual wedge is proportional to the magnitude of the score on that dimension. Coxcomb
charts were created from the standardized performance variables to provide a visual
representation of the UL performance variable scores in each cluster both at the group and
individual level.

3.4 Results

A sample of 211 participants were included in the analyses. Demographic and participant

characteristics for the three cohorts are provided in Table 3.2. UL capacity was measured by the
ARAT and indicated that both stroke cohorts had moderate deficits in UL functional capacity.
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Table 3.2. Demographics and participant characteristics of the three cohorts
Stroke Cohort 1
(n=57)

Stroke Cohort 2
(n=78)

Adult Controls
(n=76)

Age, years

66.5 + 8.8

59.7+ 10.9

54.3 + 11.3

Sex, female

42% (24)

35% (27)

51% (39)

40% (23)
58% (33)
2% (1)
--

47% (36)
51% (40)
1% ( 1)
1% ( 1)

59% (44)
41% (30)
---

Time post-stroke, weeks

12
(7-12)

52
(21-960)

NA

Hand dominance, right

82% (47)

88% (68)

82% (62)

Concordance*

42% (24)

51% (40)

NA

22.46 + 20.76

31.3 + 11.9

NA

Variable

Race

African American
Caucasian
Asian
Other

Action Research Arm Test †

Values are Mean + SD or Percentage (n) except for Time-post stroke which are median (range).
* Concordance is where dominant limb = paretic limb.
† Action Research Arm Test is a measure of UL functional capacity. Higher scores are better, with a maximum total
score of 57 indicating normal performance.

The Hopkins statistic was H=0.78, indicating that clusters exist in the sample. Table 3.3
summarizes the range of solutions evaluated including 12, 9, 7, and 5 UL performance variables
in either a 3-, 4-, or 5-cluster solutions. Across the different numbers of input variables, two
principal components explained the majority of the variance, PC1 and PC2. There were similar
loadings of the input variables onto these principal components, regardless of the number of
variables entered. Interestingly, adding more performance variables (e.g.12 versus 5) was
associated with both PC1 and PC2 explaining less of the total variance (see the first column of
Table 3.3). Thus, across different numbers of input dimensions, the number of principal
components was relatively stable. PC1 and PC2 appeared to be explaining similar variance in all
models. We therefore proceeded with including only 5 input variables. When including 5 UL
performance variables, the first principal component (PC1) explained the most variance (76.4%)
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and was comprised of variables that all had moderate to strong, positive loadings, including;
paretic/non-dominant hours, median acceleration of paretic/non-dominant limb activity,
acceleration variability of paretic/non-dominant limb activity and the use ratio. The second
principal component (PC2) explained less variance (17.6%) and was comprised of primarily the
non-paretic/dominant hours, a single variable that had a strong, negative loading. See Appendix
A for the loadings of all factors of PC1 and PC2 for the final chosen solution.
Across the models with differing numbers of UL performance variables, a 5-cluster
solution explained the most overall total variance when compared to a 3- or 4-cluster solution as
seen in the middle portion of Table 3.3 and visually in Figure 3.1A and 3.1B (including five
performance variables). We then examined several metrics to determine how many clusters were
appropriate for the 5-variable solution. Figure 3.1A supports that there are > at least two clusters
in this dataset and the flattened slope on Figure 3.1A indicates that the reduction of withincluster variance is minimal and there are no further improvements after 5-clusters for this
dataset. We therefore explored a 3-, 4-, and 5- cluster solutions. Figure 3.1B displays the effect
of increasing numbers of clusters on the total explained variance when including 5 UL
performance variables and confirms that a 5-cluster solution explains more total variance than
the 3- or 4-cluster solutions. Examining the AIC values seen in the last three columns of Table
3.3, also confirmed that a 5-cluster solution produced the best model fit compared to the 3- and
4-cluster solutions across the different number of input variables (5, 7, 9, and 12 UL performance
variables). Although each solution was statistically feasible, the chosen final solution was 5clusters, from 5 UL performance variables including: 1) hours of use of paretic/non-dominant
limb; 2) hours of use of non-paretic/dominant limb; 3) median acceleration of paretic/nondominant limb; 4) acceleration variability of paretic/ non-dominant limb activity; and 5) use
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ratio. Figure 3.1C presents the location of the 5-clusters across the two dimensional space.
Dimension 1 (x-axis) is the first principal component and dimension 2 (y-axis) is the second
principal component. The two clusters with the lowest overall UL performance are represented
by clusters numbered 1 and 2 with the highest in number 5. Figure 3.2 shows a scatterplot
matrix of how the five input variables relate to each other and to the 5-clusters.
Table 3.3 Selection of clusters based on variance explained and model-fit
Number of
Variables

Variance explained
by each PC

Total variance by # of clusters

AIC value by # of clusters

PC1

PC2

3

4

5

3

4

5

12

57.4%

13.1%

53%

58%

62%

2683.7

2442.2

2149.8

9

68.5%

16.5%

64%

69%

73%

1426.4

1114.7

879.2

7

75.6%

14.1%

70%

76%

79%

734.3

452.9

228.0

5

76.4%

17.6%

68%

75%

79%

475.6

229.1

44.7

Explained variance is presented in %. Values closer to 100% indicate greater variation explained.
AIC = Akaike’s Information Criterion. A lower AIC value indicates a better model when the clusters were used as
predictor variables in multivariate ANOVAs based on the different outcome variables (of 12, 9, 7, and 5
dimensions).

74

Figure 3.1. (A) Scree plot representing how the within-cluster variance changes as increasing numbers of clusters
are formed with 5 UL performance variables. (B) Line plot representing how the total explained variance changes
with increasing numbers of clusters on dataset including 5 UL performance variables. The dashed lines represent the
total variance explained for a 3- (blue), 4- (red), or 5- (green) cluster solution. (C) Visual representation of the 5clusters with 5 UL performance variables across dimension 1 (x-axis) and dimension 2 (y-axis). The cluster number
is presented in the location of the centroid of each cluster. The shape of the point within the cluster represents if a
participant was from a stroke (triangle) or control (+ sign) cohort.
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Figure 3.2: Scatterplot matrix of the 5 input variables as a function of the 5 different clusters. The diagonal shows
density plots (i.e., the univariate distribution) of each input variable as a function of the different clusters. The lower
left panels’ show the bivariate distributions for each pair of variables with the point shapes and gray scales
corresponding to the different clusters (see legend). The upper right panels show the Spearman rank order
correlations for each pair of variables (on the whole, ignoring clusters). *** = p<0.001

The means and ranges of each UL performance variable, percentage concordant, and UL
capacity for each of the 5-clusters in the final solution are presented in Table 3.4. The clusters
are presented with the “lowest” overall UL performance within the first column and the
“highest” overall UL performance in the last column. The 5-clusters become categories of UL
performance and are named based on a synthesis of information from other publications that
have described UL performance in daily life,45, 56-58 not on the underlying PCA dimensions. The
cluster names were chosen as intuitively as possible and represent the overall amount of UL
activity and integration of the ULs into daily life activities (see Discussion for further
interpretation). We refer to these clusters/categories as: 1) Minimal Activity/Rare Integration; 2)
Minimal Activity/Limited Integration; 3) Moderate Activity/Moderate Integration; 4) Moderate
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Activity/Full Integration; and 5) High Activity/Full Integration. The cluster with the lowest UL
performance is the Minimal Activity/Rare Integration, this cluster has the lowest mean values on
variables that quantify duration, magnitude and variability of UL activity. People in this cluster
use their non-paretic UL approximately 2.5 times more than their paretic UL and have little to no
magnitude or variability of their paretic UL activity in daily life. People in the Minimal
Activity/Limited Integration cluster use both the paretic and non-paretic limb for more overall
hours than the Minimal Activity/Rare Integration cluster, but the non-paretic limb is still active
twice as much as the paretic UL. Additionally, people in this cluster have slightly higher mean
values on performance variables that quantify both the magnitude and variability of the paretic
limb when compared to the Minimal Activity/Rare Integration cluster. Both of these clusters
have little integration of the ULs into activity, as suggested by a mean use ratio below 0.50 the
Minimal Activity/Rare Integration cluster and a mean use ratio just above 0.50 in the Minimal
Activity/Limited Integration cluster. The cluster with overall, moderate UL performance is the
Moderate Activity/Moderate Integration cluster. In this cluster, people have more symmetrical
UL use compared to the two lower clusters, which is reflected in the in the use ratio (0.85) and
the mean values of both duration variables (4.5 hrs vs. 5.3 hrs). People in this cluster have
moderate values on variables that quantify both the magnitude and variability of paretic/nondominant limb activity. The two clusters with the highest overall UL performance are the
Moderate Activity/Full Integration and the High Activity/Full Integration clusters. These clusters
have progressively higher mean values of variables quantifying duration, magnitude and
variability of UL activity with those in the High Activity/Full Integration cluster having the
highest mean values compared to the other clusters. Both of these clusters however, have similar
mean values of the use ratio, which is approaching 1.0 indicating that people in these two
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clusters have relatively equal contributions of both ULs. Interestingly, if only the use ratio was
used to examine these two clusters it could be assumed that they are relatively equal, but the
other variables show they are not. The two clusters with the highest overall UL performance also
had the highest % of people with concordant stroke. It is also noteworthy that participants within
each of the 5 clusters have wide, overlapping ranges of UL capacity, as indicated by the mean
and ranges of ARAT scores in the bottom row of Table 3.4, consistent with the premise that UL
capacity and UL performance are different, but related constructs. Figure 3.3 presents how the
three included cohorts separated into the 5-clusters. The two clusters with the lowest overall UL
performance (Minimal Activity/Rare Integration and Minimal Activity/Limited Integration) are
comprised of only persons from the stroke cohorts. The cluster with moderate UL performance
(Moderate Activity/Moderate Integration) contains mostly people with stroke but there are also a
few neurologically intact adult controls in this cluster too. The two clusters with the highest
overall UL performance (Moderate Activity/Full Integration and High Activity/Full Integration)
contains the neurologically intact adult controls and some persons with stroke. Finally, there was
a statistically significant omnibus effect of cluster in each of the univariate ANOVAs for the five
UL performance variables (p values for each variable <0.001). Note that not all clusters were
statistically different from all other clusters in each variable, based on post-hoc t-tests. However,
this speaks to the multivariate nature of the cluster analyses; across all dimensions, these clusters
group similar observations together, but along any single dimension there will likely be overlap
in the neighboring clusters.
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Table 3.4. Means (ranges) of UL performance and capacity variables by cluster.
Minimal
Minimal
Moderate
Variable name
Activity/
Activity/
Activity/
Rare
Limited
Moderate
Integration
Integration
Integration
(N=29)
(N=41)
(N=43)
Duration
Paretic/ND Hrs
1.5
4.6
4.5
(0.0-2.8)
(2.1-8.0)
(1.9-6.5)
Non-paretic/D Hrs
4.1
8.4
5.3
(0.1-6.7)
(6.2-11.6)
(2.4-8.0)
Magnitude
Median acceleration
0
5
25
paretic/ND (counts)*
(0-6)
(5-24)
(7-53)
Variability
Acceleration variability of
27.3
34.8
58.9
paretic/ND (counts)*
(11.9-49.4)
(21.6-57.3)
(40.0-89.3)
Symmetry
Use Ratio
0.38
0.55
0.85
(0.04-0.70)
(0.22-0.78)
(0.60-1.32)

Moderate
Activity/
Full
Integration
(N=57)

High
Activity/
Full
Integration
(N=41)

7.4
(5.2-9.1)
8.0
(5.1-11.0)

10.2
(8.6-15.5)
10.7
(8.5-14.2)

47
(21-76)

61
(33-92)

75.9
(46.5-102.6)

80.3
(53.0-100.8)

0.94
(0.75-1.15)

0.96
(0.81-1.10)

Additional data about the clusters
Concordance †
38% (11)
39% (16)
50% (19/38)
70% (14/20)
57% (4/7)
Action Research Arm Test ‡
18.5
27.8
45.3
48.4
44.1
(0-43)
(6-57)
(22-57)
(33-57)
(24-55)
*Data are reported in activity counts computed by the Actilife proprietary software, such that 1 activity count =
0.001664 gravitational units (g).
† Dominant limb= paretic limb, computed for persons in stroke. Percentage is expressed relative to only persons
with stroke, not controls, in the upper three categories.
‡ Action Research Arm Test is a measure of UL functional capacity. Higher scores are better, with a maximum total
score of 57 indicating normal capacity.
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Figure 3.3: Bar plot of the counts of participants from each of the 3 cohorts that separated into the 5-clusters. The
two clusters with the lowest overall UL performance are comprised of persons from the stroke cohorts only. The
cluster with moderate UL performance contains primarily persons with stroke and a few neurologically intact adult
controls. The two clusters with the highest overall UL performance include primarily neurologically intact adult
controls, as well as persons with stroke.

Figure 3.4 presents the group and individual coxcomb charts for each of the 5-clusters.
The rows (A, B, C, D, E) are presented in order of increasing overall UL performance, with
group data in the first column in dark gray and then individual examples of people in that cluster
in columns two and three (A-E, numbered 2 and 3 respectively) in light gray. Each of the five
standardized UL performance variables are represented by wedges within the plot, and the area
of the wedge reflects the standardized value on that single variable. Figure 3.4A and 3.4B present
the two clusters with the lowest overall UL performance (Minimal Activity/Rare Integration and
Minimal Activity/Limited Integration), the wedges in these two clusters are small with the
exception of the non-paretic/D hours of use, indicating that people in these two clusters use their
non-paretic UL out of proportion to their paretic UL. As you move down each row from Minimal
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Activity/Rare Integration (3.4A) to High Activity/Full Integration (3.4E) one can see that the
wedges get larger and begin to fill more area of the radial plot, however some variables are still
out of proportion to the others as seen in 3.4C-3.4D. By the final group plot in Figure 3.4E1, the
wedges for each variable span the largest area and almost form a perfect circle, compared to the
clusters with lower UL performance (3.4A and 3.4B), indicating people in this cluster have the
highest values across all five performance variables.
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Figure 3.4: Coxcomb charts of the five clusters, illustrating the contribution of the UL performance variables on a
standardized scale. The first column plots group data, while the 2nd and 3rd columns plot individual participant
examples.
(A) Minimal Activity/Rare Integration cluster; (A1) group chart of people within this cluster; (A2) is a person from
stroke cohort 1, ARAT=4; and (A3) is a person from stroke cohort 2, ARAT=10.
(B) Minimal Activity/Limited Integration cluster; (B1) group chart of people within this cluster; (B2) a person from
stroke cohort 2, ARAT=10; and (B3) a person from stroke cohort 1, ARAT=6.
(C) Moderate Activity/Moderate Integration cluster. (C1) group chart of people within this cluster; (C2) a person
from stroke cohort 1, ARAT=36; and (C3) a person from the adult controls.
(D) Moderate Activity/Full Integration cluster; (D1) group plot for this cluster; (D2) a person from stroke cohort 2,
ARAT=42; and (D3) a person from the adult controls.
(E) High Activity/Full Integration cluster; (E1) group chart of people within this cluster; (E2) a person from stroke
cohort 1, ARAT=55; and (E3) a person from the adult controls.

3.5 Discussion

In a large sample of persons with and without neurological UL deficits, we used a k-

means cluster analysis with multiple UL performance variables, captured via accelerometry, to
derive a 5-cluster categorization that included 5 UL performance variables. Two principal
components explain most of the variance in the input variables and 5-clusters explained the most
total variance and had the best model fit. In this 5-cluster solution, two groups with what might
be considered “normal” UL performance (Moderate Activity/Full Integration and High
Activity/Full Integration) emerged, as indicated by the presence of many neurologically intact
adult controls in those categories. One category in the middle had moderate UL performance
(Moderate Activity/Moderate Integration), while two categories had low, overall UL
performance (Minimal Activity/Rare Integration and Minimal Activity/Limited Integration). The
names of each of the 5 categories were chosen for their overall UL activity and integration, with
the future goal that these categories could be evaluated for their application to other clinical
populations, not just persons with stroke.
The 5-category solution from five UL performance variables, derived from this statistical
analysis, leads to a clinically-logical interpretation of UL performance in daily life. In this
analysis we purposefully included three cohorts of persons with and without stroke in order to
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capture a wide range of the variables, extracted from accelerometer data that quantify different
aspects of UL performance in daily life. In Figure 3.3, the two categories with the highest overall
UL performance (Moderate Activity/Full Integration and High Activity/Full Integration) contain
most of the neurologically intact adult controls indicating that people without neurological
impairments display a wide range of UL activity that can be considered unimpaired or normal.
This is important because these people have integrated their ULs, as indicated by the use ratio
variable, but people in these categories have different levels of overall UL activity, ranging from
moderate to high UL activity. This is not unusual when we consider the wide range of activities
and behaviors of people.59-61 For example, when walking performance is quantified by
pedometers, neurologically-intact adults walk symmetrically but present with a wide range of
variability in the total number of steps-per-day that can all be considered “normal” walking
performance.59, 62-66 Based on the current results, it appears that people without neurological UL
impairments similarly display a wide range of UL activity that can also be considered
unimpaired or normal. For example, two neurologically intact older adults may have very
different activities of daily living and leisure activities (e.g. swimming versus knitting) but would
both be considered to have “normal” UL performance. In other efforts to categorize UL activity,
some groups have found four categories,55, 56, 58 and others have found six.57 These analyses
however tended to examine only the separation of UL activity of persons with stroke. In this
analysis, the goal was not to form categories to differentiate between those who had a stroke and
those who did not. Instead, the goal was to categorize people based on their overall UL use in
daily life. In the 5-category solution here, we see that the two categories with the lowest UL
activity and integration are comprised of only persons with stroke, but there are also people with
stroke in the three categories with the highest overall UL performance too. This is a positive
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finding, showing that some people with stroke use their ULs similarly to neurologically intact
adults. Persons with stroke who ended up in the two categories with the highest overall UL
performance have likely experienced either full recovery of their ULs following their stroke, or
have figured out how to use the wide range of capacity that they have to integrate their paretic
limb and be active in daily life.19 An example of this is shown in Figure 4E2 which is an
individual from stroke cohort 1 who ended up in the High Activity/Full Integration category.
Categories of UL performance have tremendous research and clinical potential. Within
other biomedical science fields, formation of categories which encompass multi-dimensional
measures have facilitated clinical decision making for persons with health conditions (See
Introduction). Specific to rehabilitation, categories of ambulation (based on the capacity measure
of walking speed) have been validated, shown to be sensitive to change,67-69 used to set goals in
clinical practice, and have been used as a primary outcome in a Phase III clinical trial.70 In that
trial, the primary outcome was the percentage of people who changed (leaped) to a higher
ambulation category after the intervention. The identified categories of UL performance that
emerged in this analysis could be useful for future trials of persons with UL impairments
following subsequent, future validation studies. Categories that emerged in this analysis have
stratified participants into groupings with similar overall UL performance, representing a profile
of arm activity in daily life.38, 56, 71 Individuals within each category have similar ranges of each
performance variable included (e.g., duration, magnitude, variability and symmetry) that formed
the 5-clusters. Interestingly, in this analysis people with stroke within each of the five clusters
display a wide range of UL capacity across the clusters. Additionally, more people in the two
clusters with highest overall UL performance have concordant stroke compared to the three
clusters with lower UL performance. These findings are consistent with prior work indicating
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that people with concordant stroke (dominant limb=paretic limb) tend to have differences in the
patterns of UL use 57, 72 and experience better recovery.19 One can envision that these categories
could be used in future trials to analyze smaller subsets of individuals based on their UL category
and to better understand how UL performance variables quantify change during rehabilitation
therapy.
From a clinical perspective, the categories that emerged offer the future opportunity to
transition measurement of UL performance in daily life for persons receiving UL rehabilitation
away from the current confines of rehabilitation research labs, and into standard of care.4, 73 The
results of this analysis are a first step in simplifying measurement of UL performance in daily
life by exploring the underlying structure in the set of observed variables.74 A future option could
be to offer a user-friendly, software package to rehabilitation clinicians that would calculate the 5
UL performance variables included in this analysis from data extracted from bilateral wrist-worn
accelerometers. Based on a person’s values across the variables, a category of UL performance
could be determined and used to communicate current UL performance and used to set goals for
future UL performance. Based on the aspects of movement (duration, magnitude, variability,
symmetry) selected to form the categories, it is possible that these categories could be highly
relevant for many clinical conditions affecting UL performance in daily life, not just those with
stroke. Just as with mobility, there are plenty of biological and psychological reasons why people
could have limited UL performance in daily life.59, 75, 76 Thus, the names selected for each
category might be applicable to other clinical populations that have similar or different UL
impairments and capacity limitations, beyond the typical asymmetrical deficit which is a major
aspect of stroke UL movement.3
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3.5.1 Limitation

There are a few limitations to consider when interpreting the results of this study. First,

the three cohorts used in this analysis generated a sample of over 200 people with stroke and
neurologically intact adult controls. While our sample size was large and had wide distributions
of each UL performance variable, validation on another large, independent sample is needed for
generalization and implementation into clinical practice. Future studies, including people with
other clinical diagnoses beyond stroke are needed in order to understand how the number of UL
performance variables and subsequently the number of clusters generalize to other populations.
Second, the Moderate Activity/Moderate Integration category is less straightforward to
understand than the other four categories that emerged in this analysis. This category is
comprised primarily of persons from both stroke cohorts, however there are a few neurologically
intact adult controls who ended up in this category as well. Unfortunately, we do not have
enough information about other cognitive, socioeconomic, physical, emotional or behavioral
reasons why these few people without neurological UL impairments ended up in this category
with reduced overall UL activity and integration. This category specifically will need to be
externally validated in a larger sample.

3.6 Conclusions

The present study identified five categories of UL performance in a combined cohort of

neurologically impaired and unimpaired adults. These categories can be formed with a minimum
of 5 UL performance variables, extracted from bilateral wrist-worn accelerometers that span the
possible ranges of UL activity and integration. Further validation of both the number of UL
performance variables and categories will be required on a larger, more heterogeneous sample.
Following validation, these categories may be used as outcomes in UL stroke research and
implemented into rehabilitation therapies.
87

3.7 References
1.

Uswatte G, Miltner WHR, Foo B, Varma M, Moran S, Taub E. Objective measurement
of functional upper-extremity movement using accelerometer recordings transformed
with a threshold filter. Stroke 2000;31(3):662-7.

2.

Uswatte G, Taub E. Participant-centered and objective measures of real-world arm
function in persons with stroke. Circulation 2004;109(20):E243-E.

3.

Smith BA, Lang CE. Sensor Measures of Symmetry Quantify Upper Limb Movement in
the Natural Environment Across the Lifespan. Arch Phys Med Rehabil
2019;100(6):1176-83.

4.

Lang CE, Barth J, Holleran CL, Konrad JD, Bland MD. Implementation of Wearable
Sensing Technology for Movement: Pushing Forward into the Routine Physical
Rehabilitation Care Field. Sensors 2020;20(20).

5.

David A, Subash T, Varadhan SKM, Melendez-Calderon A, Balasubramanian S. A
Framework for Sensor-Based Assessment of Upper-Limb Functioning in Hemiparesis.
Front Hum Neurosci 2021;15:667509.

6.

Che Bakri NA, Kwasnicki RM, Dhillon K, Khan N, Ghandour O, Cairns A et al.
Objective Assessment of Postoperative Morbidity After Breast Cancer Treatments with
Wearable Activity Monitors: The "BRACELET" Study. Ann Surg Oncol
2021;28(10):5597-609.

7.

Bailey RR, Lang CE. Upper-limb activity in adults: referent values using accelerometry.
J Rehabil Res Dev 2013;50(9):1213-22.

8.

Bailey RR, Klaesner JW, Lang CE. Quantifying Real-World Upper-Limb Activity in
Nondisabled Adults and Adults With Chronic Stroke. Neurorehabil Neural Repair
2015;29(10):969-78.

9.

Uswatte G, Taub E, Morris D, Light K, Thompson P. The Motor Activity Log-28
assessing daily use of the hemiparetic arm after stroke. Neurology 2006;67(7):1189-94.

10.

Uswatte G, Giuliani C, Winstein C, Zeringue A, Hobbs L, Wolf SL. Validity of
accelerometry for monitoring real-world arm activity in patients with subacute stroke:
evidence from the extremity constraint-induced therapy evaluation trial. Arch Phys Med
Rehabil 2006;87(10):1340-5.

11.

Gebruers N, Truijen S, Engelborghs S, Nagels G, Brouns R, De Deyn PP. Actigraphic
measurement of motor deficits in acute ischemic stroke. Cerebrovascular Diseases
2008;26(5):533-40.

12.

Urbin MA, Bailey RR, Lang CE. Validity of body-worn sensor acceleration metrics to
index upper extremity function in hemiparetic stroke. Journal of neurologic physical
therapy : JNPT 2015;39(2):111-8.
88

13.

Barth J, Geed S, Mitchell A, Lum PS, Edwards DF, Dromerick AW. Characterizing
upper extremity motor behavior in the first week after stroke. PLoS One
2020;15(8):e0221668.

14.

WHO. International Classification of Functioning, Disability and Health (ICF). World
Health Organization 2018(06/01/2021).

15.

Waddell KJ, Birkenmeier RL, Bland MD, Lang CE. An exploratory analysis of the selfreported goals of individuals with chronic upper-extremity paresis following stroke.
Disabil Rehabil 2016;38(9):853-7.

16.

Andrews K, Steward J. Sroke recovery: He can but does he? Rheumatology
1979;18(1):43-8.

17.

Hidaka Y, Han CE, Wolf SL, Winstein CJ, Schweighofer N. Use It and Improve It or
Lose It: Interactions between Arm Function and Use in Humans Post-stroke. Plos
Computational Biology 2012;8(2).

18.

Waddell KJ, Strube, M. J., Bailey, R. R., Klaesner, J. W., Birkenmeier, R. L., Dromerick,
A. W., Lang, C. E. Does task-specific training improve upper limb performance in daily
life poststroke? Neurorehabil Neural Repair 2017;31(3):290-00.

19.

Lang CE, Waddell KJ, Barth J, Holleran CL, Strube MJ, Bland MD. Upper limb
performance in daily life plateaus around three to six weeks post stroke.
Neurorehabilitation and Neural Repair 2021;35(10):903-14.

20.

Waddell KJ, Strube MJ, Tabak RG, Haire-Joshu D, Lang, C. E. Upper Limb Performance
in Daily Life Improves Over the First 12 Weeks Poststroke. Neurorehabilitation and
Neural Repair 2019;33(10):836-47.

21.

Bailey RR, Klaesner JW, Lang CE. An accelerometry-based methodology for assessment
of real-world bilateral upper extremity activity. PLoS One 2014;9(7):e103135.

22.

Barth J, Klaesner JW, Lang CE. Relationships between accelerometry and general
compensatory movements of the upper limb after stroke. Journal of Neuroengineering
and Rehabilitation 2020;17(1).

23.

Urbin MA, Waddell KJ, Lang CE. Acceleration metrics are responsive to change in upper
extremity function of stroke survivors. Arch Phys Med Rehabil 2015;96(5):854-61.

24.

Balasubramanian S, Melendez-Calderon A, Burdet E. A robust and sensitive metric for
quantifying movement smoothness. IEEE Trans Biomed Eng 2012;59(8):2126-36.

25.

Balasubramanian S, Melendez-Calderon A, Roby-Brami A, Burdet E. On the analysis of
movement smoothness. Journal of Neuroengineering 2015;12(1):112.

26.

de Lucena DS, Stoller, O., Rowe, J. B., Chan, V., & Reinkensmeyer, D. J. Wearable
sensing for rehabilitation after stroke: Bimanual jerk asymmetry encodes unique
89

information about the variability of upper extremity recovery. . Proceedings of the In
2017 International Conference on Rehabilitation Robotics (ICORR); 2017.
27.

Tibshirani R, Walther G, Hastie T. Estimating the number of clusters in a data set via the
gap statistic. J Roy Stat Soc B 2001;63:411-23.

28.

Kirshblum SC, Burns SP, Biering-Sorensen F, Donovan W, Graves DE, Jha A et al.
International standards for neurological classification of spinal cord injury (revised
2011). J Spinal Cord Med 2011;34(6):535-46.

29.

Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA et al.
Forecasting the future of stroke in the United States: a policy statement from the
American Heart Association and American Stroke Association. Stroke 2013;44(8):236175.

30.

Schlotter F, Orban M, Rommel KP, Besler C, von Roeder M, Braun D et al. Aetiologybased clinical scenarios predict outcomes of transcatheter edge-to-edge tricuspid valve
repair of functional tricuspid regurgitation. Eur J Heart Fail 2019;21(9):1117-25.

31.

Pauwels R. Global initiative for chronic obstructive lung diseases (GOLD): time to act.
Eur Respir J 2001;18(6):901-2.

32.

Lang CE, Waddell KJ, Klaesner JW, Bland MD. A Method for Quantifying Upper Limb
Performance in Daily Life Using Accelerometers. Jove-J Vis Exp 2017(122).

33.

Lang CE, Strube MJ, Bland MD, Waddell KJ, Cherry-Allen KM, Nudo RJ et al. Dose
response of task-specific upper limb training in people at least 6 months poststroke: A
phase II, single-blind, randomized, controlled trial. Ann Neurol 2016;80(3):342-54.

34.

Van der Lee JH, De Groot V, Beckerman H, Wagenaar RC, Lankhorst GJ, Bouter LM.
The intra- and interrater reliability of the action research arm test: a practical test of upper
extremity function in patients with stroke. Arch Phys Med Rehabil 2001;82(1):14-9.

35.

Yozbatiran N, Der-Yeghiaian L, Cramer SC. A standardized approach to performing the
action research arm test. Neurorehabilitation and Neural Repair 2008;22(1):78-90.

36.

Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother
2014;60(1):61-.

37.

Dolnicar S. A review of unquestioned standards in using cluster analysis for data-driven
market segmentation. 2002.

38.

Varley BJ, Shiner CT, Johnson L, McNulty PA, Thompson-Butel AG. Revisiting
Poststroke Upper Limb Stratification: Resilience in a Larger Cohort. Neurorehabil Neural
Repair 2021;35(3):280-9.

90

39.

Skalski JR, Richins SM, Townsend RL. A statistical test and sample size
recommendations for comparing community composition following PCA. PLoS One
2018;13(10):e0206033.

40.

Uswatte G, Taub E, Morris D, Vignolo M, McCulloch K. Reliability and validity of the
upper-extremity Motor Activity Log-14 for measuring real-world arm use. Stroke
2005;36(11):2493-6.

41.

Rand D, Eng, J. J., Tang, P. F., Jeng, J. S., Hung, C. How active are people with stroke?
Use of accelerometers to assess physical activity. Stroke 2009;40:163-8.

42.

Bailey RR, Birkenmeier RL, Lang CE. Real-world affected upper limb activity in chronic
stroke: an examination of potential modifying factors. Topics in stroke rehabilitation
2015;22(1):26-33.

43.

Waddell KJ, Tabak RG, Strube MJ, Haire-Joshu D, Lang CE. Belief, confidence, and
motivation to use the paretic upper limb in daily life over the first 24 weeks after stroke.
Journal of Neurologic Physical Therapy 2019;43(4):197-203.

44.

Beauchaine TP, Beauchaine RJ. A comparison of maximum covariance and k-means
cluster analysis in classifying cases into known taxon groups. Psychol Methods
2002;7(2):245-61.

45.

James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning. New
York: Springer; 2013.

46.

Davisdson I. Understanding K-means non-hierarchical clustering. SUNY Albany
Technical Report 2002;2:2-14.

47.

Banerjee A, Dave RN. Validating clusters using the Hopkins statistic. Proceedings of the
2004 IEEE International Conference on Fuzzy Systems (IEEE Cat No04CH37542);
2004.

48.

GGally: Extension to 'ggplot2'. R package version 2.0.0.; 2020.

49.

factoextra: Extract and Visualize the Results of Multivariate Data Analyses. R package
version 1.0.7.; 2020.

50.

NbClust: an R package for determining the relevant number of clusters in a data set. .
2014.

51.

clustertend: Check the Clustering Tendency. 2015.

52.

Bholowalia P, Kumar A. EBK-means: A clustering technique based on elbow method
and k-means in WSN. International Journal of Computer Applications 2014;105(9).

53.

Rousseeuw PJ. Silhouettes - a Graphical Aid to the Interpretation and Validation of
Cluster-Analysis. J Comput Appl Math 1987;20:53-65.
91

54.

Barth J, Klaesner JW, Lang CE. Relationships between accelerometry and general
compensatory movements of the upper limb after stroke. J Neuroeng Rehabil
2020;17(1):1-10.

55.

Stinear CM, Byblow WD, Ackerley SJ, Smith MC, Borges VM, Barber PA. PREP2: A
biomarker-based algorithm for predicting upper limb function after stroke. Ann Clin
Transl Neurol 2017;4(11):811-20.

56.

Woytowicz EJ, Rietschel, J. C., Goodman, R. N., Conroy, S. S., Sorkin, J. D., Whitall, J.,
Waller, S. M. . Determining levels of upper extremity movement impairment by applying
a cluster analysis to the Fugl-Meyer assessment of the upper extremity in chronic stroke.
Archives of physical medicine and rehabilitation 2017;98(3):456-62.

57.

Simpson LA, Eng JJ, Backman CL, Miller WC. Rating of Everyday Arm-Use in the
Community and Home (REACH) scale for capturing affected arm-use after stroke:
development, reliability, and validity. PLoS One 2013;8(12):e83405.

58.

Demartino AM, Rodrigues LC, Gomes RP, Michaelsen SM. Manual dexterity is
associated with use of the paretic upper extremity in community dwelling individuals
with stroke. Journal of Neurologic Physical Therapy 2021.

59.

Bassett DR, Jr., Wyatt HR, Thompson H, Peters JC, Hill JO. Pedometer-measured
physical activity and health behaviors in U.S. adults. Med Sci Sports Exerc
2010;42(10):1819-25.

60.

Hayward KS, Eng JJ, Boyd LA, Lakhani B, Bernhardt J, Lang CE. Exploring the Role of
Accelerometers in the Measurement of Real World Upper-Limb Use After Stroke. Brain
Impair 2016;17(1):16-33.

61.

Waddell KJ, Patel MS, Clark K, Harrington, T. O., Greysen SR. Leveraging insights
from behavioral economics to improve mobility for adults with stroke: Design and
rationale of the BE Mobile clinical trial. Contemporary Clinical Trials 2021;107.

62.

Dwyer T, Pezic A, Sun C, Cochrane J, Venn A, Srikanth V et al. Objectively Measured
Daily Steps and Subsequent Long Term All-Cause Mortality: The Tasped Prospective
Cohort Study. PLoS One 2015;10(11):e0141274.

63.

Fukushima N, Inoue S, Hikihara Y, Kikuchi H, Sato H, Tudor-Locke C et al. Pedometerdetermined physical activity among youth in the Tokyo Metropolitan area: a crosssectional study. Bmc Public Health 2016;16.

64.

Tudor-Locke C, Schuna JM, Jr., Han HO, Aguiar EJ, Green MA, Busa MA et al. StepBased Physical Activity Metrics and Cardiometabolic Risk: NHANES 2005-2006. Med
Sci Sports Exerc 2017;49(2):283-91.

65.

Kraus WE, Janz KF, Powell KE, Campbell WW, Jakicic JM, Troiano RP et al. Daily
Step Counts for Measuring Physical Activity Exposure and Its Relation to Health. Med
Sci Sports Exerc 2019;51(6):1206-12.
92

66.

Holleran CL, Bland MD, Reisman DS, Ellis TD, Earhart GM, Lang CE. Day-to-Day
Variability of Walking Performance Measures in Individuals Poststroke and Individuals
With Parkinson Disease. Journal of neurologic physical therapy : JNPT 2020;44(4):2417.

67.

Fritz S, Lusardi M. White Paper: "Walking Speed: the Sixth Vital Sign". Journal of
Geriatric Physical Therapy 2009;32(2):2-5.

68.

Nadeau SE, Wu SS, Dobkin BH, Azen SP, Rose DK, Tilson JK et al. Effects of taskspecific and impairment-based training compared with usual care on functional walking
ability after inpatient stroke rehabilitation: LEAPS Trial. Neurorehabil Neural Repair
2013;27(4):370-80.

69.

Nadeau SE, Dobkin B, Wu SS, Pei Q, Duncan PW, Team LI. The Effects of Stroke Type,
Locus, and Extent on Long-Term Outcome of Gait Rehabilitation: The LEAPS
Experience. Neurorehabil Neural Repair 2016;30(7):615-25.

70.

Duncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE et al. Bodyweight-supported treadmill rehabilitation after stroke. N Engl J Med 2011;364(21):202636.

71.

Rosso C, Lamy JC. Prediction of motor recovery after stroke: being pragmatic or
innovative? Current Opinion in Neurology 2020;33(4):482-7.

72.

Rinehart JK, Singleton RD, Adair JC, Sadek JR, Haaland KY. Arm use after left or right
hemiparesis is influenced by hand preference. Stroke 2009;40(2):545-50.

73.

Lang CE, Cade WT. A step toward the future of seamless measurement with wearable
sensors in pediatric populations with neuromuscular diseases. Muscle Nerve
2020;61(3):265-7.

74.

Suhr DD. Exploratory or confirmatory factor analysis? Proceedings of the SUGI 31;
2006.

75.

Peel C, Sawyer Baker P, Roth DL, Brown CJ, Brodner EV, Allman RM. Assessing
mobility in older adults: the UAB Study of Aging Life-Space Assessment. Phys Ther
2005;85(10):1008-119.

76.

Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years.
N Engl J Med 2007;357(4):370-9.

93

Chapter 4: Predicting later categories of
upper limb activity from earlier clinical
assessments following stroke: An exploratory
analysis

This chapter is under has been submitted and is in review at the Journal of NeuroEngineering
and Rehabilitation
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4.1 Abstract
Background: Accelerometers allow for direct measurement of upper limb (UL) activity.
Recently, multi-dimensional categories of UL performance have been formed to provide a more
complete measure of UL use in daily life. Prediction of motor outcomes after stroke have
tremendous clinical utility and a next step is to determine what factors might predict someone’s
subsequent UL performance category.
Purpose: To explore how different machine learning techniques can be used to understand how
clinical measures and participant demographics captured early after stroke are associated with
the subsequent UL performance categories.
Methods: This study analyzed data from two time points from a previous cohort (n=54). Data
used was participant characteristics and clinical measures from early after stroke and a
previously established category of UL performance at a later post stroke time point. Different
machine learning techniques (a single decision tree, bagged trees, and random forests) were used
to build predictive models with different input variables. Model performance was quantified with
the explanatory power (in-sample accuracy), predictive power (out-of-bag estimate of error), and
variable importance.
Results: A total of seven models were built, including one single decision tree, three bagged
trees, and three random forests. Measures of UL impairment and capacity were the most
important predictors of the subsequent UL performance category, regardless of the machine
learning algorithm used. Other non-motor clinical measures emerged as key predictors, while
participant demographics predictors were less important across the models. Models built with the
bagging algorithms outperformed the single decision tree.
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Conclusions: UL clinical measures were the most important predictors of the subsequent UL
performance category in this exploratory analysis regardless of the machine learning algorithm
used. Interestingly, cognitive and affective measures emerged as important predictors when the
number of input variables was expanded. These results reinforce that UL performance, in vivo, is
not a simple product of body functions nor the capacity for movement, instead being a complex
phenomenon dependent on many physiological and psychological factors. Utilizing machine
learning, this exploratory analysis is a productive step towards prediction of UL performance.
Trial Registration: NA

4.2 Introduction
Wearable movement sensors allow for direct measurement of upper limb (UL) activity in
daily life, i.e. performance.1 Performance is operationally defined in the World Health
Organization’s (WHO) International Classification of Function (ICF) model as activity in the
unstructured, free-living environment, and is distinguished from capacity, operationally defined
as the capability for activity in a structured or standardized environment. 2,3 The most common
wearable sensors used are accelerometers, from which numerous clinically relevant variables
about UL activity can be computed to provide insight into how people with or without
neurological impairment use their ULs in daily life.4-7 Data extracted from bilateral, wrist worn
wearable sensors can be used to quantify UL performance variables measuring the duration,8,9
symmetry,6,10-12 magnitude,5,7,13 and variability of one or both limbs.4,5,7,13 Each UL performance
variable conveys slightly different information about the collective nature of UL use; multiple
variables may provide a fuller understanding of the scope of UL performance in daily life.14 As a
solution to the multi-variable problem, we recently categorized UL performance in adult cohorts
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with and without stroke.15 The most parsimonious solution was five categories of UL
performance formed from five UL performance variables. The UL performance categories are
multi-dimensional, with each category providing information about UL activity with respect to
the different movement characteristics in adults with and without neurological UL deficits. Thus,
the five categories of UL performance may provide a more complete measure of UL use in daily
life.14,15
Early prediction of motor outcomes after stroke has tremendous clinical utility.16,17 Our
next step, therefore, was to determine what factors might predict someone’s subsequent UL
performance category. Predictive knowledge of subsequent outcomes can inform the delivery
and specification of individualized rehabilitation services.18,19 This effort to predict an
individual’s subsequent UL performance category is informed by the development of the PREP 2
algorithm, which has demonstrated that prediction of an UL capacity (i.e. activity a person has
the capability to do) category provides clinically-useful information to people with stroke and
their families. Advances in computing have improved upon old and led to new analysis
techniques for building prediction models of UL outcomes after stroke. Recently, machine
learning techniques of support vector machines (SVM) and tree-based methods (e.g.,
Classification and Regression Trees [CARTs]) have been used to classify people with stroke into
categories with different ranges of UL capacity.18,20-23 The PREP 2 prediction model was
originally built and validated with a CART which resulted in the easy to interpret decision tree.21
Machine learning techniques have the advantages of: 1) requiring fewer assumptions about the
distributions of the data, 2) numerous options for non-parametric models, and 3) strong
predictive capabilities.19,22-25 There are strengths and weaknesses to each machine learning
technique. For example, the CART algorithm yields a single, easy to interpret decision tree
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(strength), but lower predictive accuracy on new, external samples because of high variance
(weakness).26 An alternative to creating a single decision tree is to use ensemble classifiers like
bootstrap aggregation (called “bagging”) or random forests.27 These ensemble techniques rely
on the collective judgement of many decision trees (hundreds or even thousands) in order to
make a classification. These ensemble methods tend to have higher predictive power and reduce
the risk of over-fitting relative to other CART methods, but at the expense of interpretability (as
there is no longer one single decision tree to follow, but a whole forest of trees).22,27 Capitalizing
on the advantages of ensemble machine learning algorithms by applying them for prediction of
UL performance outcomes could yield key insights into UL recovery post stroke.
The purpose of this study, therefore, was to explore how different machine learning
techniques can be used to understand how clinical measures and participant demographics
captured early after stroke are associated with the UL performance categories from a later post
stroke time point. We utilized the same data set from which we had previously predicted the
trajectory of single, continuous UL performance variables with regression techniques.28 In this
analyses, we attempt to predict the subsequent multivariate categories of UL performance that
people with stroke fell into. We explicitly tested different machine learning methods to build
predictive models with different input variables as predictors (also called feature sets) to
determine how each method yields similar versus different results. We hypothesized that
measures of UL impairment,21 UL capacity,18,28 and other non-motor clinical measures, would
be the most important predictors of the subsequent UL performance category.
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4.3 Methods
This study was a secondary analysis of data collected from a prospective, observational,
longitudinal cohort tracking UL change over time.28 Sources of data from two time points were
participant characteristics, clinical measures from early after stroke, and subsequent categories of
UL performance (from a previous report)15 later after stroke.

4.3.1 Participants

Participants were included in the prospective, observational, longitudinal cohort if the

following criteria were met: (1) within two weeks of first-ever ischemic or hemorrhagic stroke,
confirmed with neuroimaging; (2) presence of UL motor deficits within the first 24-48 hours post
stroke, as indicated by a NIHSS29 Arm Item scores of one to four or documented manual muscle
test grade30 of <5 anywhere on the paretic UL; (3) ability to follow a two-step command, as
measured by a NIHSS29 Command Items score of 0; and (4) anticipated return to independent
living (i.e., not institutionalized), as indicated by the acute stroke team. Persons with stroke were
excluded if any of the following criteria were met: (1) history of previous stroke, other
neurologic condition, or psychiatric diagnoses; (2) presence of comorbid conditions that may
limit recovery (e.g., end-stage renal disease or stage IV cancer); (3) lived more than 90 minutes
from the study location; and (4) currently pregnant by self-report. The Human Research
Protection Office at Washington University in St. Louis approved this study, and all participants
provided written informed consent.

4.3.2 Data Collection

Cohort participants completed eight assessment sessions over the first 24 weeks post

stroke. This analysis used data from the first assessment (within two weeks of stroke onset) to
predict the subsequent category of UL performance15 from the latest time point between six and
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24 weeks post stroke. We retained any person in the cohort whose last measurement was
between six and 24 weeks post stroke because UL performance appears to stabilize between
three and six weeks.28,31 Participants were excluded from this analysis if they were missing any
of the predictor variables from the first assessment point (see Table 4.1). Assessments were
administered by trained personnel (licensed physical therapists or occupational therapist, range
of experience with measures was two-15 years). Since this was an observational cohort study, we
did not provide nor control for the amount or type of rehabilitation services delivered to enrolled
participants. Participants received rehabilitation services as prescribed by their medical team.

4.3.3 Dependent variable used for the models

The dependent variable (outcome or class in machine learning) in this analysis was a

category of UL performance established in previous report.15 These were derived from UL
performance variables quantified via accelerometer data.15 Participants in the prospective,
longitudinal, observational, cohort wore Actigraph GT9X-Link accelerometers on both wrists at
each time point with methods previously described.1 Briefly, tri-axial acceleration data are
sampled at 30 Hz for 24 or more hours continuously. Once the accelerometers were returned to
the lab, data were uploaded, visually inspected, and processed using ActiLife 6 (Actigraph Corp.,
Pensacola, FL) proprietary software. For most variables, data were band-pass filtered (0.25-2.5
Hz) and down sampled into one-second epochs with ActiLife proprietary software, where each
second is the sum of the 30 Hz values in that second and converted into activity counts (1 count
= 0.001664 g). Similar to previous work,7,11,28,32 accelerometry data was processed using custom
written software in MATLAB (Mathworks, Inc., Natick, MA) to calculate UL performance
variables which quantify various aspects of UL activity in everyday life. The variables measure
the duration, magnitude, variability, and symmetry of one or both ULs. Five UL performance
90

variables were used to create the five categories of UL performance; the participant’s category
assignment in the prior report was the outcome in this analysis.15 The names of each of the five
categories were chosen for their overall level of UL activity and the integration of both ULs into
activity in daily life and are named: A) Minimal Activity/Rare Integration; B) Minimal
Activity/Limited Integration; C) Moderate Activity/Moderate Integration; D) Moderate
Activity/Full Integration; and E) High Activity/Full Integration, see Figure 4.1 for visual
representation of the categories for the participants included in this analyses. The categories are
presented in order of increasing overall UL performance.15

4.3.4 Independent predictor variables

The input variables (also known as feature sets in machine learning) were participant

demographics and clinical measures. In the prospective, longitudinal, observational cohort, 15
demographic variables and nine clinical measures were administered at the first assessment time
point, within two weeks post stroke. Of the 24 variables available, seven were excluded because
of multi-collinearity and extremely low (or no) variability.31 In the case of multi-collinearity, we
retained the variables that were more likely to be available in routine post-stroke clinical care.33
Table 4.1 presents the 17 predictors selected for this analysis organized into three main
categories: 1) UL clinical measures; 2) non-motor clinical measures; and 3) participant
demographics.
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Table 4.1. Predictors included in the analysis
Predictor Name
UL Measures

Action Research Arm Test
(ARAT)34-36
Shoulder Abduction Finger
Extension (SAFE)21
Upper Extremity FuglMeyer (UEFM)37,38

Description

Construct

Scoring

Standardized measure assessing UL
functional ability for activity
Sum of two Medical Research
Council strength grades from the
shoulder abductors and the finger
extensors.
Standardized measure assessing
movement in and out of synergies of
the affected UL

UL capacity

Scores range from 0-57, higher
values indicate greater UL function
Scores are whole numbers and range
from 0-10, higher values indicate less
impairment in the affected UE

Non-motor clinical measures

UL impairment

UL impairment

Scores range from 0-66, higher
values indicate less impairment in the
affected UL

Depression
screen

Scores range from 0-60, higher
scores indicative of greater
depressive symptomatology
Scores are calculated by subtracting
the omissions from the total score of
60 (0-30 on both sides), >4 omissions
on one side are considered
pathological
Scores range from 0-30, scores < 26
indicate cognitive impairment
Scores range from 0-42, lower scores
indicate less severe stroke overall

Center for Epidemiological
Studies Depression Scale
(CES-D)39,40
Unstructured Mesulam41,42

Questionnaire asking about the
frequency and severity of symptoms
associated with mood
Paper, pencil test measuring visual
spatial ability

Montreal Cognitive
Assessment (MOCA)43
National Institute of
Health Stroke Scale
(NIHSS)29

Brief tool to screen for cognitive
impairment across multiple domains
Standardized measure of global
stroke severity

Cognitive screen

Area deprivation index
(ADI)44-46

Multi-dimensional evaluation of a
region’s socioeconomic conditions

socioeconomic
disadvantage

Age
Concordance
Ethnicity

Participant age at time of testing
Affected UL is dominant UL
Participant report of ethnicity

----

Living status pre-stroke

Participant report of prior living
situation

--

Living status 2-weeks post
stroke

Participant location at 2-week time
point

--

Race

Participant reported racial
identification

--

Sex
Stroke type

Participant report of sex
Cause of disruption of blood flow,
from medical record
Number of days from stroke-onset to
2-week testing, from medical record

---

Demographics

Time-post stroke

Abbreviations: * Activities of daily living (ADL)

Hemispatial
neglect

Stroke severity

--

Scores are % rankings and range
from 1 to 100, lower values indicate
lowest level of “disadvantage”
Minimum age of 18
Categorized as: Yes/No
Categorized as: Non-Hispanic/NonLatino or Latino
Categorized as*: Living alone,
independent ADLs/ Living alone,
assist ADLs/ Living with others,
independent ADLs/ Living with
others, assist ADLs
Categorized as: Inpatient / Skillednursing facility / Assisted living /,
Home / Other
Categorized as: White/ Black or
African-American/ Asian/ American
Indian or Alaska Native/ Hawaiian or
other Pacific Islander
Categorized as: Male/ Female
Categorized as: Ischemic/
Hemorrhagic/ Unknown
Difference in days between date of
testing and stroke onset

4.3.5 Statistical Analysis
All data were analyzed in R (version 4.1.2), an open source statistical computing
program.47 Distributions and pair-wise scatterplots of the correlations between the variables were
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examined to understand the variability in the sample and the relationships among the variables.
We tested a series of supervised machine learning algorithms with different numbers of input
variables to predict subsequent activity of the UL measured via accelerometry as a function of
clinical and demographic variables collected within two weeks of stroke. These algorithms were
a single decision tree48, bagged trees, and random forests.49 We present several different
measures of classification accuracy and the importance of different predictor variables.50
Classification Using Supervised Learning Algorithms
In this analysis, different machine learning techniques were explored to understand how
clinical variables captured early after stroke best predicted an subsequent category of UL
performance. Given the smaller sample size (n=54) we lacked the capability to partition the data
into training, validation, and testing sets. As such, our focus is on the accuracy of in-sample
prediction (how well the model explains the data on which it was trained), cross-validation
accuracy (the out-of-bag error estimate, defined below), and measures of variable importance (to
identify the most important predictors).24,25 The models were built with different machine
learning algorithms as described in the steps below.
First, a single unpruned classification tree was built48 using the CART algorithm.26,48 If
one thinks of the dataset as a matrix, each person (or observation) is a row and each predictor (or
feature) is a column. The algorithm looks at all predictors and selects the one that best explains
the outcome, creating a “branch” in the growing tree (if the predictor is > a certain value, go left,
otherwise, go right). Moving down each branch, the algorithm then looks at all remaining
predictors, selecting the one that explains the most variance (i.e., creates the most separation in
predictions based on the Gini-index, a measure of node purity).25,51 In our analysis, we built a
single decision tree based on all 17 predictors (Table 4.1) to predict the UL performance
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categories (outcomes).25,51 The process then repeats, creating a tree made up of many branches
that ends in the “leaves”, the final prediction at the end of that branch.24,26
Second, we used bootstrap aggregation (bagging) as an ensemble method to reduce the
likelihood of overfitting the data with a single tree.24 Bagging works identically to the single tree
algorithm above, but rather than building one tree out of all available data, samples are
bootstrapped: made by randomly sampling individuals (rows) from data with replacement. Each
sample then gets its own tree based on the individuals who made it “in the bag”. Critically, this
also means that the accuracy of each individual tree can be cross-validated against the
observations left “out-of-bag”, yielding out-of-bag error as measure of cross-validation
accuracy.24 The bagged model is thus the aggregated vote of all of the different trees when given
input data for classification.
Finally, we also used random forests as a slightly more complicated ensemble
method.24,51 The random forest is constructed similarly to the bagged trees, building bootstrapped
samples and fitting trees within each sample. However, in order to avoid potential bias and
correlations between trees (i.e., a dominant predictor always being selected first), the random
forest only considers a random subset of predictors (columns) at each node.51 Thus, the random
forest model allows for a similar calculation of cross-validation accuracy with the out-of-bag
error, but generally leads to trees being less similar than in bagging, because only a subset of
predictors are considered at each node. This more diverse forest of uncorrelated trees can then be
used to get an aggregate vote when given input data for classification.24,51
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Table 4.2. Model names and specifications of the six ensemble models.
Predictors Included in Input Data Set
Model
# Trees
Non-motor
UL clinical
clinical
Demographics
measures
measures

Small bagged
2,000
X
X

Small random forest
2,000
X
X


Medium bagged
2,000
X


Medium random forest
2,000
X



Large bagged
2,000



Large random forest
2,000
* m is a tuning parameter for the bagged trees and random forest models

# Predictors
considered at
each node
(m=)*
3
√3 = 2
7
√7 = 3
17
√17= 4

A total of six models were built with the two bagging algorithms and by systematically
changing the model specifications, known as tuning parameters. Table 4.2 presents the model
names and specifications for the six models built. Each of the six models were built with the
number of trees held constant at 2,000. A high number of trees was chosen to ensure that all of
the models would stabilize regardless of the data set used.25 Three different input data sets were
formed from the list of predictors (Table 4.1). The small data set included the UL clinical
measures, the medium included the small data set + other non-motor clinical measures, and the
large data set included the medium data set + demographic predictors. The bagged and random
forest models were built by changing the tuning parameter m, which is the number of predictors
available at each split. In the bagged models, m is equal to the total number of predictors in the
data set whereas in random forests, m is equal to the square root of the number of predictors in
the data set (last column Table 4.2).
Model performance and variable importance
An iterative process was used to quantify the explanatory power (in-sample accuracy),
predictive power (out-of-bag estimate of error), and variable importance of the single decision
tree, bagged models, and random forests. For all seven models, the full data set was fed back into
the fitted model and the “in-sample” accuracy was quantified by comparing the predicted
category and the actual UL performance categories.24,51 As in-sample accuracy uses the same
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data the model is trained on, it is best thought of as the “explanation” rather than “prediction”
(because prediction requires an independent test data set). Second, for the bagged and random
forest models the average out-of-bag error was used as a measure of cross-validation accuracy.
This out-of-bag error is genuine prediction because each individual tree is independent of its outof-bag data.25 (Note that out-of-bag error cannot be calculated for the single tree, as all data are
included in the training set for that tree.) Finally, the importance of each predictor for the six
models was evaluated in two ways: 1) mean change in accuracy, and 2) mean change in the Gini
index.24,25 The mean change in accuracy is the improvement or decrease in the in-sample
accuracy when each predictor is included in the model, predictors with higher accuracy values
are more important for the successful classification (accuracy) of the outcome. Predictors with
negative accuracy values decrease the model performance (accuracy), and are considered
unimportant in predicting the outcome. The mean change in the Gini index is a measure of how
each predictor contributes to the purity of the nodes and leaves in the models. The mean change
in the Gini index is a positive integer, higher values of the mean change in the Gini index
indicate greater importance of that predictor for the models.
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4.4 Results
Table 4.3. Participant characteristics and demographics: Total sample and UL performance category
Characteristic

Total
Sample
N=54

Age

66.3 + 8.8

Sex, n (%)

Male
Female

31 (57)
23 (43)

A: Min
Activity/
Rare
Integration
N=20
69.0 + 7.8
10 (50)
10 (50)

B: Min
Activity/
Limited
Integration
N=4
63.3 + 8.1
1 (25)
3 (75)

C: Mod
Activity/
Moderate
Integration
N=16
65.4 + 10.1

D: Mod
Activity/
Full
Integration
N=10
65.6 + 8.6

E: High
Activity/
Full
Integration
N=4
61.3 +10.4

10 (63)
6 (11)

7 (70)
3 (30)

3 (25)
1 (25)

Ethnicity, n (%)
Non-Hispanic/Non-Latino 57 (100)
20 (100)
4 (100)
16 (100)
10 (100)
4 (100)
Race, n (%)
White
32 (59)
12 (60)
4 (100)
6 (38)
7 (70)
3 (75)
African-American
21 (39)
8 (40)
9 (56)
3 (30)
1 (25)
Asian
1 (2)
1 (6)
Stroke type, n (%)
Ischemic
48 (89)
20 (100)
4 (100)
11(69)
9 (90)
4 (100)
Hemorrhagic
6 (11)
5 (31)
1 (10)
Concordance, n (%)
23 (43)
8 (40)
1 (25)
4 (25)
7 (70)
3 (75)
Time post stroke in days
13 (12,15)
13 (12,14)
14 (13,15)
13 (12,14)
15 (13,16)
16 (13, 18)
Living status pre-stroke n (%)
Alone, independent
1 (20)
5 (25)
1 (25)
5 (31)
Others, independent
43 (80)
15 (75)
3 (75)
11 (69)
10 (100)
4 (100)
Living status 2-weeks post stroke, n
(%)
Inpatient
47 (87)
20 (100)
3 (75)
14 (87)
7 (70)
3 (75)
Home
7 (13)
1 (25)
2 (13)
3 (30)
1 (25)
ADI
75 (39, 86)
80 (41, 88)
66 (48, 78)
76 (45, 87)
67 (31, 84)
31 (21, 47)
Upper limb measures
ARAT
20 ( 0, 43)
0 (0, 3.3)
4 (0, 20)
37 (23, 48)
45 (30, 53)
37 (28, 41)
SAFE
7 (1, 8)
1 (1, 4)
5 (1, 8)
8 (7, 8)
8 (8, 8)
8 (7, 8)
UEFM
37 (10, 57)
10 (8, 21.3)
23 (9, 43)
54 (36, 56)
59 (48, 61)
54 (43, 57)
Non-motor clinical measures
CES-D
14.0 + 9.5
18.2 + 10.3
14.0+ 9.1
15.5 + 8.2
7.0 + 6.1
4.8 + 1.7
Mesulam
0 (0, 3)
1 (0, 7)
1 (0, 4)
1 (0, 4)
0 (0, 1)
-1 (-1, 1)
MOCA
17.6 + 7.1
14.6 + 7.9
20.3 + 8.3
18.3 + 7.1
20.5 + 4.1
20.3 + 4.4
NIHSS
6 (4, 10)
10 (6, 15)
5 (4, 9)
5 (3, 8)
4 (4, 6)
3 (3, 4)
Summary statistics for demographic information and the predictors as means and standard deviations when normally distributed,
otherwise by medians and the 1st and 3rd inter-quartile values. Categorical variables are presented as counts (n) and % of the total
sample and by category. Abbreviations: Area deprivation index (ADI), Action Research Arm Test (ARAT), Shoulder Abduction
Finger Extension (SAFE), Upper Extremity Fugl-Meyer (UEFM), Center for Epidemiological Studies Depression Scale (CESD), Montreal Cognitive Assessment (MOCA), National Institute of Health Stroke Scale (NIHSS).

Overall, the sample of persons with first-ever stroke were generally in their 60’s and had
mild to moderate stroke (83% with NIHSS 0-15). Of the 67 participants enrolled in the
prospective, observational, longitudinal cohort study,28 54 had the necessary data to be included
in this secondary analyses. Participant assignment into the five UL performance categories was
pulled from our previous report.15 Demographics of the 54 participants and for the subsets
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assigned to the UL performance categories are provided in Table 4.3. Figure 4.1 is included for
descriptive purposes as a visual representation of the five UL performance categories. In Figure
4.1, categories (4.1A-4.1E) are represented by Coxcomb plots, where the individual variables
used to define the categories are wedges. As one moves from Figure 4.1A to Figure 4.1E, the
wedges take on different relative proportions, generally getting larger, with the best UL
performance represented by category E, High Activity/Full Integration.
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Figure 4.1. Coxcomb charts of the five UL performance categories of the 54 participants in this analysis (categories
assigned in Barth et.al 2021). The five UL performance variables are divided into equally segmented wedges on the
radial chart and the area of each wedge is proportional to the magnitude of the score on that dimension relative to the
sample that created the categories. Each chart illustrates the contribution of the five UL performance variables on a
standardized scale and are anchored to the minimum and maximum value of each variable in the prior analysis used
to establish the categories. The categories are presented in order of increasing overall UL performance and are
named: (A) Minimal Activity/Rare Integration; (B) Minimal Activity/Limited Integration; (C) Moderate
Activity/Moderate Integration; (D) Moderate Activity/Full Integration; (E) High Activity/Full Integration.
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The single, unpruned decision tree (Figure 4.2) allocated participants into only three of
the five UL performance categories. The predictors that were selected for this tree included all
three UL clinical measures (SAFE, ARAT, and UEFM) and two non-motor clinical measures
(CES-D and Mesulam). This tree has a misclassification rate of 29%, meaning that 16/ 54 people
were misclassified into a different category than their actual. In this tree, the SAFE score is the
root node. For participants with less overall strength in their paretic UL (SAFE <7.5), the left
side of the tree is used, with the ARAT, Mesulam, and UEFM scores used to assign people into
either category A (Minimal activity/rare integration) or C (Moderate Activity/Moderate
Integration). For participants with more overall strength in their paretic UL (SAFE >7.5), the
right side of the tree is used, with participants assigned to either category C (Moderate
Activity/Moderate Integration) or D (Moderate Activity/Full Integration) based on their scores
on the depression scale (CES-D).

Figure 4.2. Single unpruned decision tree predicting a category of UL performance from all 17 predictors. In
reading the tree, if the argument is true, go left; if the argument is false, go right. This model predicts three out of
five UL performance categories (A, C, and D) from 3 UL clinical measures and 2 other non-motor clinical measures.
The categories are: (A) Minimal Activity/Rare Integration; (B) Minimal Activity/Limited Integration; (C) Moderate
Activity/Moderate Integration; (D) Moderate Activity/Full Integration; (E) High Activity/Full Integration.
* Measures with a red asterisk are counter-intuitive results. For example, UEFM score above 25.5 indicates less
impairment in the paretic UL and with this tree, people with less UL impairment would be predicted to category A ,
the lowest UL performance category. Abbreviations: Shoulder Abduction Finger Extension (SAFE), Action
Research Arm Test (ARAT), Upper Extremity Fugl-Meyer (UEFM), Center for Epidemiological Studies Depression
Scale (CES-D)
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Table 4.4. Model performance of models built with different machine learning algorithms.
Model Name
Model
Small
Medium
Large
Single
Performance
Bagged
Random
Bagged
Random
Bagged
Random
Decision
Statistic
model
forest
model
forest
model
forests
Tree
In-sample
Accuracy*
Mean
0.70
0.96
0.96
1.0
1.0
1.0
1.0
IQR (0.56, 0.82) (0.87, 1.0) (0.87, 0.99)
(0.93, 1.0)
(0.93, 1.0)
(0.93, 1.0)
(0.93, 1.0)
Out-of-bag
estimate
of error†
na
0.55
0.52
0.47
0.46
0.48
0.48
Mean
(0.54, 0.56) (0.52,0.54) (0.46, 0.48) (0.44, 0.46) (0.46, 0.48) (0.48, 0.48)
95% CI
*
In-samle accuracy is a measure of the explanatory power of the model and was quantified for all seven models by
comparing the predicted category and the actual UL performance categories. Values closer to 1.00 indicate better
model performance.
† Out-of-bag estimate of error is a measure of the predictive power of the models and was quantified for the six
bagging models as cross-validation accuracy. Lower error-rate values indicate better model performance.
Abbreviations: confidence interval (CI), inter-quartile range (IQR)

Our next step was to explore the use of bagging methods to build the six models (Table
4.2). The statistics used to evaluate model performance of the single decision tree, bagged
models, and random forest models are presented in Table 4.4. The in-sample accuracy of all the
models is better than chance (chance=0.20 for each of the five categories) alone. The single
decision tree has an in-sample accuracy of 0.70 whereas the in-sample accuracy of the bagged
and random forest models ranges from 0.96 to 1.00, indicating better performance. Predictive
power of the six models was better than chance, with the medium and large models being better
than the small models and having mostly overlapping 95% confident intervals.
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Figure 4.3. Variable importance computed as the mean change in accuracy. Variable importance plot for the six
models built with bagging algorithms from different input datasets and tuning parameters. Variable importance is
computed using the mean change in accuracy, and is expressed relative to the maximum. Higher values indicate
greater importance of the specific predictor in the model and values < 0 indicate these predictors decrease the overall
accuracy of the model. The shape represents the algorithm used and color represents the size of the input dataset.
The small data set that includes UL clinical measures, the medium sized data set includes UL clinical measures +
non-motor clinical measures, and the large sized data set includes UL clinical measures + non-motor clinical
measures + demographics. The bagged models were built with all predictors available in the data set and random
forests were built with the square root of the number of predictors.

Figures 4.3 and 4.4 present the variable importance plots for the six models using the
mean change in accuracy (Figure 4.3) and the mean change in the Gini index (Figure 4.4). The
two red lines on the y axis are placed to separate the predictors relative to the data sets with UL
clinical measures first, non-motor clinical measures second, and the demographics last. In these
plots, shape represents the algorithm, which was either bagged (triangle) trees or random forests
(circle) and the three colors represent the size of the input data set as: small (green), medium
(orange), or large (purple). In Figure 4.3, one can see that two UL clinical measures (ARAT and
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SAFE) are the most important predictors regardless of the algorithm used or input data set size.
Additionally, the UEFM and CES-D emerge as important predictors to maintain accuracy of the
models, specifically with the medium and large input data sets. Interestingly, a few of the
demographic predictors (sex, living status pre-stroke, living status 2-weeks post stroke, and time
post stroke) all have negative values indicating including these predictors decrease the accuracy
of the models. In Figure 4.4, the UL clinical measures and non-motor clinical measures are most
important with respect to the mean change in the Gini index regardless of the algorithm or input
data set size. All UL clinical measures (ARAT, SAFE, and UEFM) have the highest values of
the mean change in the Gini index for the small data set only compared to the models built with
the medium and large data sets. For most of the predictors, the circles and triangles of the same
color are close together indicating similar values for mean change in the Gini index regardless of
if the bagged or random forest algorithm was used. Additionally, some of the demographic
predictors have a mean change in the Gini index close to 0 indicating less importance of these
predictors similar to the mean change in accuracy (Figure 4.4).
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Figure 4.4. Variable importance computed as the mean change in the Gini Index. Variable importance plot for the
six models built with different input datasets and tuning parameters. Variable importance is computed using the
mean change in the Gini index, and is expressed relative to the maximum. The shape represents the algorithm used
and color represents the size of the input dataset. The small data set that includes UL clinical measures, the medium
sized data set includes UL clinical measures + non-motor clinical measures, and the large sized data set includes UL
clinical measures + non-motor clinical measures + demographics. The bagged models were built with all predictors
available in the data set and random forests were built with the square root of the number of predictors.

4.5 Discussion

The purpose of this study was to explore how different machine learning techniques

could be used to understand the association between clinical measures and participant
demographics captured early after stroke and the subsequent UL performance category. Our
hypothesis was supported, such that measures of UL impairment and capacity were the most
important predictors of subsequent UL performance category, regardless of the machine learning
algorithm used. Other non-motor clinical measures emerged as key predictors, while participant
demographics predictors were less important across the models. Models built with the bagging
algorithms had better in-sample accuracy compared to the single decision tree. The models had
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moderate out-of-bag errors, indicating that there are likely unevaluated, missing predictive
factors. There are two novel contributions of the present study: 1) different machine learning
techniques were used to allow for comparison of the results and 2) the outcome of the models
was a multi-dimensional category of UL performance. These findings contribute to the
understanding of what factors early after stroke may partially influence the subsequent UL
performance categories.
Using different machine learning techniques provided information about which predictors
were most important to the outcome for this sample and those that generalize to the population.
Consistent with efforts to predict an individual’s subsequent UL impairment or UL capacity
category,21,52-56 these results point to the importance of measures of UL impairment and capacity
for predicting subsequent UL performance category. The UL impairment (SAFE score, UEFM)
and capacity (ARAT) measures were generally the most important predictors regardless of the
algorithm or input data set used. Depressive symptomology (CES-D) and overall stroke severity
(NIHSS) increased the overall predictive ability of the models. The NIHSS is a measure of
global stroke severity and it is possible that the non-motor aspects of this measure are driving the
added value of this predictor. Collectively these results indicate that the subsequent UL
performance categories were most influenced by UL impairment, capacity, presence of
depression, and overall stroke severity. These are different secondary predictors than were
identified in a previous study predicting a single UL performance variable, where non-motor
clinical measures of hemispatial neglect and cognitive impairments along with participant
demographic information were found to be important.20,57 It is reasonable that different factors
emerged as predictors of a single UL performance variable vs. a multivariate category of UL
performance. A key finding in the current analysis is the substantial out-of-bag estimate of error
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(0.48 to 0.55), indicating that there other factors (predictors) that likely contribute to UL
performance that were not assessed in the cohort studied here. Other possible factors that could
influence UL performance include: biopsychosocial, cognitive constructs (e.g. apraxia),
neurobiology (e.g. motor evoked potential [MEP]), and other demographics (e.g. employment
status). Future research should explore how these factors captured early after stroke are
associated with subsequent UL performance.
The purpose of the present analysis was not to make perfect predictions, but rather to
explore the associations between these variables using different machine learning techniques.
The first model we explored was a single decision tree built with the CART algorithm. While the
graphical representation of this decision tree (Figure 4.2) may be easy to interpret, the output is
somewhat counterintuitive. For example, on the left side of the tree for people with a SAFE score
< 7.5 and an ARAT score > 3.5, it is counterintuitive that a UEFM score < 25.5 (more UL
impairment) would put one in a better category (C, Moderate activity/moderate integration), and
an UEFM > 25.5 would put one in a worse category (A, Minimal activity/rare integration). This
likely occurred because the tree is constructed with all of the input data and the algorithm
assigned people to the categories based on the probability of ending up in each node. It is
possible that there were a few people in this data set that had this unusual pattern of scores with
respect to UL impairment and capacity. Likewise, the tree selected the Mesulam, a non-motor
clinical measure of hemispatial neglect, for the most leftward node, but inclusion of this node
does not change the categorization. Then, two different bagging algorithms were used to build
predictive models with different sized input data sets to determine if they yielded similar versus
different results. A benefit of the bagged and random forest is the relative increase in the
explanatory and predictive power of these models because of cross-validation, even with the
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smaller sample size of our data set, as seen in Table 4.4. The in-sample accuracy for these six
models was improved compared to the single decision tree, indicating that these models are
doing a good job explaining the data we had. The out-of-bag estimate of error, however, is more
important with respect to the predictive power of these models. While the out-of-bag estimate of
error does decrease (indicating more accurate predictions) with the addition of the non-motor
clinical measures, the outcome of the models remain largely unchanged and the out-of-bag error
remains substantial. These data illustrate the point that, ultimately, prediction models are only
going be as “good” as the input data available; simply switching to a different machine learning
method with different tuning parameters may not substantially change the predictive ability of
the model. While we did not try all possible machine learning algorithms (e.g. SVM or neural
networks), this could be an important consideration for future research. The single decision tree
is a transparent model because one can see how the decisions are made in the tree where the
bagged and random forest models are harder to interpret, because the classification is based on
thousands of trees. These ensemble classifiers, however, can still be clinically useful. As we
move to a world where electronic health records are integrated into advanced information
management systems with data visualization and machine learning capability,58 the possibilities
are endless to imagine how clinical measures and participant demographics early after stroke
could be used to predict meaningful outcomes for people with stroke and their families.
Implementation of these techniques into routine care will require extremely large data sets to
build and then to validate models. Sample sizes will need to be at least an order of magnitude
bigger than the larger data sets available today (i.e. in the thousands, not tens or hundreds of
participants).24,25 For these machine learning methods to be clinically-available in the future,
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research groups need to start now on pooling participant data, data sharing, and/or using common
data elements across studies.
There are a few limitations to consider when interpreting our findings. First, these results
should be interpreted as exploratory or “hypothesis-generating”. Additional studies are required
to validate these results. Second, due the small sample size the data could not be split into test
and training sets. Nonetheless, we were still able to capitalize on the computing power of these
techniques to provide additional information that contributes to our understanding of how typical
information captured early after stroke was associated with a subsequent UL performance
category. Finally, the predictor sets only included clinical measures and participant demographic
information because we were limited by the data collected for the prospective, observational,
longitudinal cohort study and the variability of the predictors across the cohort.28 One example of
a potential predictor variable not collected here is a positive motor evoked potential (MEP),
which has been identified as an important factor predicting UL capacity for persons with greater
UL impairment in their paretic UL.20,21,52 As an example of lack of variability in potential
predictors, we also collected a survey quantifying self-perception of UL performance recovery.
Scores on these measures were highly homogenous across participants, making it impossible for
this factor to contribute to the variance in the outcome. Future studies will need to be designed
with a more comprehensive set of potential predictors, including neurobiological and
psychosocial factors.

4.6 Conclusion

Machine learning techniques can be used to understand how clinical measures and

participant demographics captured early are associated with subsequent post stroke UL
performance category. UL clinical measures were the most important predictors of the
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subsequent UL performance category in this exploratory analysis regardless of the machine
learning algorithm used. Other non-motor clinical measures emerged as important predictors to
maintain the accuracy of the models, but including these measures had little impact on out-ofbag estimate of error. These results reinforce that UL performance, in vivo, is not a simple
product of body functions nor the capacity for UL movement, instead being a complex
phenomenon dependent on many physiological and psychological factors. Utilizing machine
learning, this exploratory analysis is a productive step towards prediction of UL performance.
Future research is required to explore other factors associated with UL performance along with
the role of predictive models in rehabilitation after stroke.
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Chapter 5: Summary of Major Findings

115

5.1 Summary of specific Aims
In Chapter 2, we tested how well an algorithm with clinical measures, developed for use
in New Zealand, applied to persons with stroke within the US. Our first hypothesis was that UL
capacity would be predicted and algorithm accuracy would fall within a range of 70-80% in a
cohort of US participants with first ever stroke. Our second hypothesis was that that participants
with inaccurate predictions would be within one category of their expected at three months. Our
first hypothesis was partially supported; the algorithm successfully predicted participants into the
four UL capacity categories, however overall accuracy of the algorithm with clinical measures
only was 61% (CI: 46%-75%). Our second hypothesis was supported; 39% (19/49) of the total
number of participants had inaccurate predictions, 79% (15/19) were one category away from
their actual category at three months post stroke. The findings of the present study indicate that
use of this algorithm, with clinical measures only, is better than chance alone (chance =25% for
each of the four categories) at predicting the category of UL capacity three months after stroke.
The moderate to high values of sensitivity, specificity, PPV, and NPV demonstrates some
clinical utility of the algorithm within the US healthcare setting.
In Chapter 3, we explored if categories of UL performance, as quantified from
accelerometer recordings, could be identified and defined. Our first hypothesis was that three
categories of UL performance would be identified across a host of accelerometer variables,
spanning the possible ranges of UL performance in daily life. Our second hypothesis was that the
categories that emerged would have clinical meaning of expected UL performance in daily life.
Our first hypothesis was refuted; five categories of UL performance were identified from five
UL performance variables in cohorts of adults with and without neurological UL deficits. Our
second hypothesis was supported; the five categories that emerged have stratified people into
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groupings with similar overall UL performance, representing a profile of arm activity in daily
life. Individuals within each category have similar ranges on each performance variable included
(e.g. duration, magnitude, variability, and symmetry) in each of the five clusters. As such, the
names of the five categories were chosen for their overall activity and integration of the ULs into
their daily activity, and are named: Minimal Activity/Rare Integration, Minimal Activity/Limited
Integration, Moderate Activity/Moderate Integration, Moderate Activity/Full Integration, and
High Activity/Full Integration.
In Chapter 4, we explored if a model could be developed to predict categories of UL
performance in daily life at three months post stroke. Our first hypothesis was that a model could
be derived from a collection of clinical measures to predict a category of UL performance post
stroke. Additionally, our second hypothesis was that the developed model would predict UL
performance with a minimum of 70% accuracy. Our first hypothesis was supported; the
categories of UL performance identified in Aim 2 were predicted using different machine
learning techniques. Measures of UL impairment and capacity were the most important
predictors of the subsequent UL performance category, regardless of the machine learning
algorithm used. Other non-motor clinical measures emerged as key predictors, while participant
demographic predictors were less important across the models. Our second hypothesis was
partially supported; the in-sample accuracy across the seven models ranged from 70% to 100%.
The out-of-bag estimate of error, however, ranged from 48% to 55%. The out-of-bag estimate of
error is a better assessment of model accuracy with respect to the predictive power because it is
calculated from data not used to build the model. These values of the out-of-bag estimate of error
can be compared to overall accuracy with the inverse values, such that, the overall accuracy of
these models ranged from 42% to 55%.
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5.2 Significance of Findings
In the validation and development of novel clinical tools available to stroke rehabilitation
providers, we report multiple findings that add to the current scientific body of knowledge.

5.2.1 Importance of quantifying UL performance
Chapters 2-4 highlight the value of measurement of UL recovery after stroke across the
ICF domains, because of the differences observed in UL impairment, capacity, and performance.
Wearable sensor data has provided evidence to challenge the status quo, because clinicians and
researchers have seen that improvements in UL capacity observed in the clinic do not necessarily
translate to improvements in UL performance in daily life.1-6 In Chapter 3, five categories of UL
performance were formed from five UL performance variables in persons with and without
neurological UL deficits. Each of the five categories differ with respect to the duration,
magnitude, variability, and symmetry of UL activity in daily life. In the five category solution,
two categories emerged that could be considered to have “normal” UL performance (Moderate
Activity/Full Integration and High Activity/Full Integration) as indicated by the presence of
many neurologically-intact adult controls in those categories. People assigned to these two
categories engage both ULs into activities to a similar degree, as evidenced by similar mean
values of the use ratio. The use ratio values in both categories approach 1.0, indicating that
people in these two categories have relatively equal contributions of both ULs to daily activity.
The differences between the two categories (and why they are two separate categories) is that
people in these categories have different values on variables measuring the duration, magnitude,
and variability of UL movement. Taken together, people in these categories have different levels
of overall UL activity, ranging from moderate to high UL activity. People assigned to the High
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Activity/Full Integration category having the highest values on these variables, while those
assigned to the Moderate Activity/Full Integration have lower values.
Of the participants with stroke included in this analysis, 20% (27/135) of people
ended up in the two categories with the highest overall UL performance. This is a
positive finding, as it indicates these individuals have either experienced a full recovery
of their ULs following their stroke, or they have figured out how to use their available
capacity for activity in order to integrate their paretic limb and be active in daily life.7
What is highly interesting is that people assigned to these categories do not necessarily
have the highest values of scores on measures of UL impairment and capacity. One can
see from Table 5.1 that people in these two categories had similar median values of UL
capacity (ARAT) at the same time point post stroke time point as when the accelerometer
data were collected for the two studies.8 Interestingly, only 26% (7/27) of the
participants with stroke in these two categories achieved a score of 57, the highest
possible score on the ARAT. Even more interesting is the wide range of values of UL
capacity of people in these performance categories. Stinear et. al.9, 10 formed categories of
UL capacity based on ranges of ARAT scores (see Table 2.1) and only 41% (11/27) of
people in these top two performance categories would have been in the highest UL
capacity category of Excellent. Of the remaining participants 52% (14/27) would have
been in the Good category and 7% (2/27) in the Limited category. This is important
because all of these people are using their ULs with similar duration, magnitude,
variability, and symmetry as adults without neurological UL deficits. A similar finding
emerged when examining the subset of people in the top two categories with impairment
measures (N = 20), i.e. SAFE and UEFM scores captured between six and 12 weeks post
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stroke. Again, one can see that people assigned to both of these categories displayed similar
median values and wide ranges of scores on the UL impairment measures (UEFM and SAFE).
These findings taken together contribute to our understanding that UL capacity and impairment
measures are not a direct indicator of UL performance after stroke.
Table 5.1. Median (ranges) of UL capacity and impairment measures
Moderate
High
Measure name and ICF
Total†
Activity/
Activity/
domain*
N=27
Full Integration
Full Integration
or N=15
N=20
N=7
UL Capacity
ARAT
47 (24-57)
47 (33-57)
46 (24-55)
UL Impairment
UEFM
62 (42-66)
63 (59-66)
61 (42-66)
SAFE
9 (7-10)
10 (8-10)
9 (7-10)
*UL capacity and impairment measures were collected at the same time point used to form the UL performance
categories in Aim 2
† Both stroke cohorts completed the UL capacity measure (N=27) and only stroke cohort completed the UL
impairment measures (N=15)

5.2.2 Lessons learned

The first lesson learned is about the importance of carefully defining study aims and
hypotheses to match the intended purpose of the analysis. Upon reflection, to simply state
“develop a prediction model” as written in Aim 3 was too simplistic. We quickly learned that
with the plethora of analysis choices, it is certainly possible to develop a model. It is now
apparent that one must consider how that model will be used given the available data. For
example, we lacked the sample size to split our data into training, validation, and test sets that are
typically required of machine learning methods, therefore our results and thus prediction models
were exploratory in nature and should be interpreted as a first step to understanding factors
associated with UL performance after stroke.11 The novelty of this Aim was the comparison of
the results from three unique machine learning algorithms, the single decision tree, the bagged
tree, and the random forest. In this comparison, we realized that our second hypothesis was
lacking specificity because the in-sample prediction (e.g. explanation) of the models was well
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above 70% however, the out-of-bag accuracy (e.g. predictive power) was much lower. An
unexpected finding from this Aim was the identification of which variables measured early after
stroke are most important to the five UL performance categories. The in-sample prediction and
the above chance (20% for each of the five categories) out-of-bag estimate of error revealed that
we in fact included some variables important to the UL performance categories, but we failed to
build a predictive model with 70% accuracy as our hypothesized benchmark.
The second lesson learned was that there is a lack of detail in the quality of reporting the
“whys” and “how’s” in stroke rehabilitation prediction studies that is limiting science in the
field. Historically, methodological approaches to prediction rely on linear and logistical
regression models.12, 13 These models are by nature inflexible, because they yield temporally
fixed predictions from temporally fixed input data.12, 14, 15 Another limitation of these models is
the assumption of linearity between the dependent variable and the independent variables. There
is rapid growth with respect to UL recovery the first three months after stroke that may not be
appropriately modeled with linear regression techniques.7, 15-17 For example, a ten-point gain
observed on the lower end of an UL impairment or capacity measure may not be the same as a
ten-point gain at the higher end of that same scale.17 Other non-linearity that might not be
detectable by linear regression models include how the influence of different non-motor
impairments (e.g. visual neglect) impact UL motor recovery.12, 15 These non-linearities are likely
not detectable by linear regression models, regardless of the amount or quality of data
available.17 As in other fields, unfortunately, the majority of the prediction modeling in
rehabilitation has employed these analytic techniques.14, 15, 18-24 To overcome the limitations of
regression techniques, others have used the CART algorithm for prediction modeling.12, 13 This
method was used to develop the PREP2 algorithm that we attempted to externally validate in
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Aim 1.9, 25 External validation studies of prediction models are critical because a model’s
predictions may not be reproducible on samples external to the model.26-29 Certainly poor
predictions of the model in a new data set of persons with stroke could arise from differences
between the settings of the new and derivation samples, including differences in health-care
systems, methods of measurement, and participant characteristics.30 However, another source
that contributes to poor predictions is due to the CART algorithm itself. To build a single
decision tree, the CART algorithm used the entire data set and therefore only the exact values of
scores on clinical measures and participant characteristics are considered. Lundquist et.al.25
replicated PREP2 within two weeks of stroke onset to accommodate differences in the timing of
transitions of care between Denmark and New Zealand. The overall accuracy (accuracy: 60%;
CI: 50%-71%)25 was lower than they hypothesized. Similar to our analyses in Aim 1 (Chapter
2), most people in their study with inaccurate predictions were still within one category of their
predicted at three months post stroke. Because of the low overall accuracy values, a separate
CART analysis was conducted on this sample from Denmark and the same measures selected in
PREP2 emerged as important predictors in the decision tree but the values of participant age and
stroke severity changed.25 We noted similar issues with the cut-off values in our sample as well.
If we had run a separate CART analysis too, it is likely that the cut-off values would again
change, since they are completely dependent on the input data. While using the CART algorithm
is appealing because it results in the easy to interpret single decision (e.g. Figure 4.2), the
limitations of the CART analytic method itself may not be able to generate a single UL capacity
prediction algorithm for use around the world. In Chapter 4, the CART algorithm was one of the
machine learning techniques used to predict the categories of UL performance from early clinical
measures. Different predictors emerged in the single decision tree that did not emerge when
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using the bagging algorithms. For example, the Mesulam was selected in the single decision tree
but had little to no improvement in accuracy or node purity of the bagged trees or random forest
models (Figure 4.3 and 4.4 in Chapter 4). As prediction models of post stroke outcomes
continue to be explored, it will be important for researchers to explore the full range of analytic
options available. Additionally, researchers should be transparent when reporting how and why
decisions were made to build the prediction model including highlighting the strengths and
weaknesses of each analytic choice.
The third lesson learned from this work is that there are important factors that influence
UL performance after stroke that are not currently being measured and therefore have not been
included in recent prediction efforts. All of the attempts to predict UL performance in daily life
after stroke have explained a portion of the variance (48% – 55%), alluding to the fact that there
are missing variables in our models and others.19, 31 In one previous study, a multivariate model
that included an UL impairment measure (UEFM), the presence or absence of a motor evoked
potential (MEP) measured by transcranial magnetic stimulation (TMS), and the presence or
absence of visual neglect within two weeks of stroke accounted for 55% of the variance in a
single UL performance variable, the use ratio, three months post stroke.31 In Chapter 4, models
built with the medium sized data set and the bagged tree or random forest algorithm had an outof-bag estimate of 0.47 and 0.46, respectively when predicting a multivariate category of
eventual UL performance. While variance explained is not the same as accuracy these results
highlight that there are missing predictors important to UL performance in all of these studies.
Other groups have begun exploring how various cognitive constructs (e.g. apraxia, spatial
neglect) may contribute to UL performance after stroke.32 Our data sets did not include any
thorough cognitive assessments, nor did it include thorough social or emotional assessments –
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which also may impact UL performance.7 For example, we did not have access to a measure of
apraxia, characterized by spatiotemporal deficits in imitation, pantomime of tool use movements,
and/or tool use, even with the non-paretic UL.32, 33 It is possible that the presence and severity of
apraxia and other cognitive and emotional impairments could substantially limit UL performance
in daily life.
The fourth lesson learned was that we do not yet know whether the same factors that
influence daily performance of walking or other activities influence UL performance after stroke.
Despite recent efforts, UL performance after stroke is a relatively unexplored area and it is
undetermined if the factors that affect lower limb performance are similar to those affecting the
UL. With respect to lower limb performance, measures of walking capacity, 34-39 depressive
symptomology,40-42 the environment,34, 35, 43 participant demographics,43-45 and biopsychosocial
factors35, 43, 46, 47 contribute to walking performance after stroke in varying degrees. Age and
other demographic factors did not emerge as important predictors in Chapter 4, whereas they
have in models predicting UL capacity.9, 19, 22 In the present analysis, superficial measures of the
physical and social (e.g. ADI, pre- and post-stroke living status) environment were included as
demographic predictors, but neither were important to the accuracy or node purity of the models.
It is plausible that other aspects of the social environment, such as marital status or employment
status may influence UL performance, as they have been shown to influence walking
performance after stroke.35, 43 Balance self-efficacy is a biopsychosocial factor important to
walking performance after stroke43, 48-51 and in the prospective, observational, longitudinal cohort
study (data used in Chapter 3 and Chapter 4) a survey was administered to quantify a persons’
belief, confidence, and motivation to use the paretic UL in daily life.7 We did not include these
data in the analysis in Chapter 4 because of the high, unwavering levels of these three
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psychosocial constructs.52 Perhaps the influence of belief, confidence, and motivation is different
for UL activity than for walking activity because of the low risk of using the paretic UL in
everyday life. There is a much higher risk associated with poor walking performance (e.g. falls,
fracture) and therefore balance self-efficacy may matter more in what people choose to do every
day.35

5.3 Future directions
In Chapter 2, the algorithm with clinical measures predicted a category of UL capacity
with lower overall accuracy than hypothesized and people with inaccurate predictions were
typically within one category of their predicted category at three months post stroke. There are a
few possible solutions that could be explored to combat the limitations of the systematic
differences in the healthcare systems, differences in stroke rehabilitation populations, and
limitations of the algorithms used to develop prediction models. First, it could be possible to
pool data from persons with stroke across the world, including clinical measures and participant
demographic information along with the geographical location and time post stroke.53 A new
model predicting UL capacity could be created using the same CART algorithm with pruning
and cross validation to create a model that could potentially be used around the world. Others
have advocated for the importance of including the neurophysiologic assessment of the integrity
of the corticospinal tract (via Transcranial Magnetic Stimulation) especially for people with less
initial strength in their paretic UL.25, 54, 55 Unfortunately, access to this test in the US and other
countries is not possible outside of academic medical centers.54, 56 Therefore it may be necessary
to develop two models, one that uses this assessment for use in countries that have access to this
test early after stroke (e.g. New Zealand) and another for countries that do not have access.
Repeated model building and testing could then yield models with similar predictive and
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exploratory power suitable for use in a large portion of the world.25 Future studies should also
investigate using machine learning ensemble methods, such as bagged trees and random forests,
to compare the important variables that emerge from single decision trees predicting UL capacity
to the variable importance measures available from these methods. A second solution would be
to provide the software capabilities to medical centers (by state, region, nation, or country) and
provide education and training to create a unique version of prediction models of UL capacity
that would be realistic to use within each geographical area. This solution would likely produce
the most accurate prediction models, however it is unrealistic that these efforts could be
implemented on such a large scale. Finally, the rehabilitation field must come together to educate
clinicians and researchers of the strengths and limitations of these models, and to offer resources
on how to use these algorithms can be used in other countries. Suggestions could include
conducting a reassessment at various time points within the first three months post stroke to
update predictions and interventions to maximize a person’s full potential for recovery of UL
capacity post stroke.14
In Chapter 3, five categories of UL performance were formed from five UL performance
variables in people with and without neurological UL impairments. Future studies could
investigate if the same number of input performance variables and the same number of categories
emerge when including larger, more heterogeneous data from people with and without other UL
problems. Wearable sensors have provided the ability to measure UL performance in daily life,
however there has been limited progress to integrate this data into standard rehabilitation
research and therapies.57 One reason is because currently a large number of single variables have
been proposed in various research studies in an attempt to capture similar or related constructs of
UL movement in daily life.58 These variables can be mathematically complex and are
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challenging to interpret from a clinical perspective. Of these single variables, validation efforts
are scarce and even less work has been done to determine if these variables are sensitive to
change.59 Another limitation is that the variables that have been proposed to date tend to align
with only one specific patient population, with much of the development occurring in the stroke
rehabilitation population. For example, the use ratio quantifies the relative time, in hours, that
one UL is active compared to the other. This single variable is most relevant to rehabilitation
populations with asymmetric effects,60, 61 such as stroke, hemiparetic cerebral palsy, and limb
amputation/prosthetic use. There are many other clinical populations that present with UL
problems that would benefit from the ability to measure UL performance in daily life, but do not
have asymmetrical deficits. Given these limitations it seems unrealistic to continue
proposing/developing, validating, and determining sensitivity to change of single variables
across clinical populations with UL problems. The categories that were formed in Chapter 3 have
the potential to streamline implementation of wearable sensor data into routine rehabilitation
care. They could be a tool for clinicians to measure UL performance in daily life. UL
performance is a complex construct that is likely multi-dimensional 58, 62, 63 and therefore may
not be well-represented by a single performance variable.62, 63 The five categories from Aim 2
were formed from five UL performance variables that measure aspects of the duration,
magnitude, variability, and symmetry of UL activity in daily life. As a result, the categories of
UL performance capture the multi-dimensional complexities of UL activity in daily life of
people with and without neurological UL deficits. UL disability stems from a range of biological
causes including neurological (e.g. stroke, multiple sclerosis), musculoskeletal (e.g. UL
fractures, adhesive capsulitis), and other medical conditions (e.g. post breast cancer treatment).
People with and without UL problems generally need to complete similar UL activities to
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function in their daily life. Because of these reasons, it seems realistic that these categories could
be validated across multiple rehabilitation populations with health conditions that cause UL
disability. Additional studies will be required to determine what constitutes a meaningful change
in UL performance, either of multivariate categories or of single variables. There have been
some efforts to identify the minimal clinically important difference (MCID) of a single variable
from wearable sensors (e.g. activity counts),64, 65 but much more work is needed. An efficient
approach might be to validate the categories first and then determine what a meaningful change
in UL performance categories would be. Categories could provide more accessible information
to people with health conditions and their health providers compared to single variables. In other
biomedical science fields, formation of categories which encompass multi-dimensional measures
have facilitated research and clinical decision making for persons with health conditions such as,
spinal cord injury,66 heart failure,67, 68 and chronic obstructive pulmonary disease (COPD).69
Categories also are used for general physical activity levels, such as, “sedentary” through “highly
active”.70-72 With the physical activity categories, individuals assigned (by a clinician or via
consumer-grade wearable sensors) to any one category have a variety of biological conditions,
impairments, capacity limitations, and personal and environmental factors, but the category helps
set goals to improve physical activity.
Use of validated multi-dimensional UL performance categories have the potential to ease
the burden on rehabilitation clinicians that work with clients with UL problems of various
causes. Typically rehabilitation professionals do not see clients with UL problems due to a single
condition. Instead, a clinician’s case load may include people with stroke, spinal cord injury,
cardiac problems, and amputation.73, 74 People with health conditions generally access services
when they have difficulty performing activities in daily life.75, 76 Regardless of the cause of a
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person’s UL problems, self-identified rehabilitation goals are almost always directed at
improving performance of activities in daily life.77 UL performance categories, therefore, have
the potential to measure the outcome of interest for clinicians and people with health conditions
that cause UL problems. Once the categories are validated, future studies could involve
stakeholder engagement of rehabilitation providers and people with health conditions that impact
the ULs to understand the barriers and facilitators to using categories to convey UL performance
information. A future option could be to offer a user-friendly, software package to rehabilitation
clinicians that would calculate the UL performance variables from data extracted from wristworn accelerometers. Based on a person’s values across the variables, a category of UL
performance could be determined and used to communicate current UL performance and used to
set goals for future UL performance. Based on the aspects of movement (duration, magnitude,
variability, and symmetry) selected to form the categories, it is possible that these categories
could be highly relevant for many clinical conditions affecting UL performance in daily life, not
just those with stroke.
In Chapter 4, we used machine learning techniques to predict the categories of UL
performance from clinical measures and participant demographic information. We identified
some factors important to UL performance after stroke, but there is still a large portion of
unexplained variance. In this analysis, we lacked the capability to partition the data into training,
validation, and testing sets because of the limited sample size. Our results are a first attempt at
exploring the relationship of early clinical measures and participant demographics to the
subsequent UL performance categories. Future studies with larger data sets should continue to
explore what other factors could influence UL performance in daily life. We suspect that other
personal factors will need to be explored, such as employment status (pre- and post- stroke),
129

marital status, and other social supports. It has also been suggested that UL performance is
influenced by both intrinsic and extrinsic sources of motivation.15, 78, 79 Intrinsic motivation has
led to better long-term behavioral outcomes for medication adherence,80 weight loss
maintenance,81 and persistence and enhanced subjective well-being.82 A serious challenge is that
measuring intrinsic motivation is difficult, and new measures may need to be developed to
understand the influence of intrinsic motivation on UL recovery after stroke. Other personal
factors that should be explored to understand their impact on UL performance after stroke
include self-regulation,82-84 outcome expectation, 84 and perceived control.83

5.4 Conclusion
This dissertation work has conducted an external validation of an existing prediction
model, developed categories of UL performance in people with and without neurological UL
deficits, and explored how early clinical measures and participant demographic information were
associated with subsequent categories of UL performance after stroke. Our findings provide
strong support for the importance of measuring recovery of the UL across ICF domains, not just
with impairment and capacity level measures. The UL performance categories formed in
Chapter 3 offer the future opportunity to transition measurement of UL performance in daily life
for person’s receiving UL rehabilitation away from the current confines of rehabilitation research
labs and into standard of care. In Chapter 4, different machine learning techniques were explored
to predict the categories of UL performance from information routinely captured after the onset
of a stroke. Collectively this work provides preliminary measurement tools that could eventually
be available to rehabilitation clinicians following subsequent validation efforts. Additionally, this
work provides a rich exploration into the strengths, weaknesses, and limitations of analytical
methods and their impact on validation efforts.
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Appendix A

The table below is the Supplemental table of the loadings of the UL performance variables
included in the final solution from Chapter 3. A total of two principal components explained the
most variance in the UL performance variables. Interestingly, as more UL performance variables
were included less total variance was explained.
Supplementary Table 3.1. Loadings on principal component one and two of the five UL performance variables
included in the final solution
Variable Name

PC1 Loadings

PC2 Loadings

Paretic/ND Hrs

0.48

-0.31

Non-paretic/D Hrs

0.34

-0.78

Median acceleration paretic/ND
(counts)*

0.45

0.39

Acceleration variability of paretic/ND
(counts)*

0.48

0.22

Use Ratio

0.47

0.30

76.4%

17.6%

Total Variance Explained
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Appendix B

This study fulfilled the degree requirement for the Masters of Science in Clinical Investigation
(MSCI) degree. These results may be of interest to the committee because they highlight that
while accelerometry is a tool that, while measuring quantity of movement, can also reflect the
use of general compensatory movement patterns of the upper limb in persons with chronic
stroke.

This study has been published:
Barth J, Klaesner JW, Lang CE. Relationships between accelerometry and general compensatory
movements of the upper limb after stroke. Journal of NeuroEngineering and Rehabilitation.
October 2020; 17(138): 1-10.
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B.1 Abstract
Background: Standardized assessments are used in rehabilitation clinics after stroke to measure
restoration versus compensatory movements of the upper limb. Accelerometry is an emerging
tool that can bridge the gap between in- and out-of-clinic assessments of the upper limb, but is
limited in that it currently does not capture the quality of a person’s movement, an important
concept to assess compensation versus restoration. The purpose of this analysis was to
characterize how accelerometer variables reflect upper limb compensatory movement patterns
after stroke.
Methods: This study was a secondary analysis of an existing data set from a Phase II, singleblind, randomized, parallel dose-response trial (NCT0114369). Sources of data utilized were: 1)
a compensatory movement score derived from video analysis of the Action Research Arm Test
(ARAT), and 2) calculated accelerometer variables (quantifying time, magnitude and variability
of upper limb movement) from the same time point during study participation for both in-clinic
and out-of-clinic recording periods.
Results: Participants had chronic upper limb paresis of mild to moderate severity. Compensatory
movement scores varied across the sample, with a mean of 73.7 + 33.6 and range from 11.5 to
188. Moderate correlations were observed between the compensatory movement score and each
accelerometer variable. Accelerometer variables measured out-of-clinic had stronger
relationships with compensatory movements, compared with accelerometer variables in-clinic.
Variables quantifying time, magnitude, and variability of upper limb movement out-of-clinic had
relationships to the compensatory movement score.
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Conclusions: Accelerometry is a tool that incorporates aspects of both quantity of upper limb
movement and general compensatory movement patterns of the upper limb in persons with
chronic stroke. Individuals who move their limbs more in daily life with respect to time and
variability tend to move with less movement compensations and more typical movement
patterns. Likewise, individuals who move their paretic limbs less and their non-paretic limb more
in daily life tend to move with more movement compensations at all joints in the paretic limb
and less typical movement patterns.

B.2 Introduction
As advances in medicine persist, more people are surviving a stroke. Over 80% of those
affected will have persistent hemiparesis of their upper limb.1 These people will be left with
chronic disability when trying to complete their activities of daily living (ADL), and an even
larger number will not resume their normal daily activities completed prior to stroke.2 At this
time, physical and occupational therapy is the only option available to improve upper limb use
after stroke. The ultimate goal of these therapies is to restore the use of the upper limb to the
same level it was used before the stroke. Most individuals, however, only partially regain
function of their upper limb requiring compensations of the upper limb to complete daily tasks.
The differentiation between restoration of upper limb movement and compensation is an area of
high interest in stroke rehabilitation.3 Compensatory movements can be thought of on multiple
levels, including a change in behavior (e.g. completion of an activity by a spouse rather than the
individual) and a change in context (e.g. using a built up spoon for self- feeding). For the
purposes of this paper, compensatory movements will refer to completion of the same movement
but with an alternative movement pattern. Specifically, this level of compensatory movements
typically describe accessory movements of the head, trunk and upper limb that an individual
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incorporates in order to accomplish tasks. A simple example is that if an individual lacks
shoulder flexion, or the ability to raise their arm in front of them, the individual lifts their arm by
raising it more to the side and bending forward with the trunk.4,5 Many in the neurorehabilitation
field view compensation and restoration as a dichotomy, where individuals will either be
classified as using compensatory movement patterns or restored movement patterns. Return of
upper limb function may be better conceptualized as a gradient, with individuals having degrees
of compensatory movement patterns.6
Currently, many in-clinic standardized assessments have some aspects that measure use
of compensatory movement patterns. For example, the Reaching Performance Scale specifically
assesses compensatory movements of the upper limb during reaching in people with
hemiparesis.7 The Wolf motor function tests, functional ability scale reduces scores if
movement compensations were observed during item completion.8 The Fugl-Meyer arm motor
scale, an impairment scale, focused on movement patterns, takes points off where specific
compensatory movements are observed on each item.9 Additionally the Action Research Arm
Test (ARAT) scores individuals completing functional reaching tasks with consideration of the
quality of the reach and grasp pattern along with the fluidity or precision of the task.10,11
Standardized assessments have the ability to measure upper limb functional capacity and
compensatory movements of the upper limb after stroke, however these assessments only capture
one piece of upper limb recovery after stroke.
The current gold standard in the field to measure quality of movement or compensatory
movements is through the use of 3D kinematics.12 Kinematics provides the most detailed
assessment of how an individual moves after stroke. It is not realistic, however, to use
kinematics in the clinic for all patients due to cost of equipment, time required to test, and
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training of personnel. This leaves standardized assessments to be the alternative and most
accessible measure of compensatory movement patterns. This gap in measurement has lead our
lab to question how we might utilize our existing accelerometry methodology to capture some of
these changes in compensatory movement.
In-clinic assessments are limited in that they measure the individual’s ability to use the
limb in a standardized, structured setting, leaving the individuals actual activity of the limb
during daily life unaccounted for. Over the past five years, methodology has been developed to
measure upper limb activity in daily life using wearable sensors (accelerometers).13,14
Accelerometry can quantify how much and how often a person uses their affected limb during
their daily life, bridging the gap between in and out-of-clinic assessment. Current accelerometer
metrics quantify time, magnitude and variability of movement of the upper limb.15-19 A limitation
of current accelerometry methods is that they quantify the amount of movement, but do not
capture the quality of a person’s movement, an important concept to assess compensation versus
restoration.
The purpose of this secondary analysis was to characterize how accelerometer variables
reflect upper limb compensatory movement patterns after stroke. Relationships between
compensatory movement patterns and accelerometer variables were calculated for both in-clinic
and out-of-clinic time points. Both time points were included as the in-clinic time includes
completion of standardized assessments and participation in an intensive upper limb therapy
protocol. Due to the nature of the therapy protocol, we anticipated there may be different
relationships because during the in-clinic time participants are intentionally training their
affected limb. The out-of-clinic recordings captures the individual in their free-living
environment, providing a more realistic picture of how the individual uses their upper limb in
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daily life. It is hypothesized that quantitative metrics from accelerometers both in and out-ofclinic will have moderate associations with compensatory movement patterns of the upper limb.

B.3 Methods
This study was a secondary analysis of an existing data set from a Phase II, single-blind,
randomized, parallel dose-response trial (NCT0114369).20 Sources of data utilized were: 1) a
compensatory movement score derived from video analysis of the Action Research Arm Test
(ARAT), and 2) calculated accelerometer variables from the same time point during study
participation.

B.3.1 Participants
Inclusion criteria were (1) ischemic or hemorrhagic stroke as determined by neurologist
and consistent with neuroimaging; (2) time since stroke > 6 months; (3) cognitive skills to
actively participate, as indicated by scores of 0 to 1 on items 1b and 1c of the National Institutes
of Health Stroke Scale (NIHSS); (4) unilateral upper limb weakness, as indicated by a score of 1
to 3 on items 5 (arm item) on the NIHSS; and (5) mild-to-moderate functional motor capacity of
the paretic upper limb, as indicated by a score of 10 to 48 on the ARAT. 10,11 Exclusion criteria
were (1) participant unavailable for 2 month follow-up (2) inability to follow-2-step commands;
(3) psychiatric diagnoses; (4) current participation in other UL stroke treatments (ex/Botox); (5)
other neurological diagnoses; (6) participants living further than 1 hour away or were unwilling
to travel for assessments and treatment sessions; and (7) pregnancy. The clinical trial was
approved by the Washington University Human Research Protection Office and all subjects
provided informed consent prior to trial participation.
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B.3.2 Compensatory movement score
A compensatory movement score was derived from video recordings of available
baseline or subsequent ARATs. We first developed a checklist to quantify the degree of
movement compensations of the upper limb. Compensatory movement information was
synthesized from 9 standardized assessments of the upper limb measuring quality of movement
or compensatory movement patterns. 7,8,10,21-26 Descriptions of compensatory movement patterns
of the upper limb were extracted from the assessments and organized to generate the list of items
on the checklist. The checklist was piloted and refined following feedback from licensed
physical and occupational therapists. The Supplemental Table provides the final checklist.
Items selected for the checklist were compensatory behaviors specific to each joint.
Compensatory behaviors on the checklist 7,8,10,21-26 included movements at the head, trunk,
shoulder, elbow, forearm, wrist, fingers, and fluidity/movement precision. The administration of
the ARAT adhered to the standardized instructions recommended by Yozbatiran et al. 10,
participants were not provided with instructions regarding how the task should be completed.
Compensations were scored as present or absent from the videotaped completion of the ARAT.
For example, potential trunk compensations could be: excessive trunk flexion or excessive trunk
side bending/rotation. In addition to compensations at each joint, an item labeled fluidity and
precision of moment was added to capture jerky or uncoordinated sub-movements and multiple
attempts to complete a task.7,8,10,21-26
Raters were current physical therapy students and one undergraduate summer intern.
Non-licensed individuals were selected to decrease bias. In piloting, we found that licensed
therapists tended to rate compensatory movement scores higher due to anticipation of expected
movement patterns, whereas students simply rated if a compensatory movement was present (+1
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point) or absent (0 points). Raters were trained prior to beginning scoring videos for data
collection. Raters were provided with a manual that described the movement compensations.
Then, raters scored a video side-by-side with a trainer (JB), where they discussed and highlighted
each type of movement compensation. Finally, raters independently scored 3 videos of subjects
with varying degrees of movement compensations. When the rater scoring was deemed to be
acceptably close to the trainer (+10 points) they were allowed to score independently. If the score
varied by more than +10 points (+/- 3% error), the rater continued to review videos with the
trainer. This process continued until the rater became independent. Once training was complete,
each video was scored by 2 raters, if total scores differed by over +10 points, a third rater scored
the video. Scores were averaged for use in the final analysis. Possible scores range from 0 to 261
points, with lower scores indicating fewer observed compensations, or better movement quality.

B.3.3 Accelerometer variables
Data were extracted from bilateral, wrist worn accelerometers (wGT3X+, Actigraph,
Pensacola, FL, USA) for 24 hours at the selected time point matching the video that was scored.
Sleep was not excluded from the analysis, persons with stroke have irregular sleep patterns
which would prove challenging to extract definitive time for sleep from the data.27,28
Accelerometers are a valid and reliable instrument to capture upper limb movement in daily life
in individuals after stroke16,18,29-32 and non-disabled adults.13,14,28
For the selected time point, accelerometers were donned at the beginning of their
session, prior to their in-clinic assessments and intensive upper limb therapy, then worn for an
entire day afterward. Accelerometers were returned on the next treatment session and the data
were downloaded using ActiLife 6 software (Actigraph Corp, Pensacola, FL, US).
Accelerometers measure UL movement along 3 axes with activity counts, where 1 count=
146

0.001664g. Data were sampled at 30Hz. Data were binned into 1-second epochs, and activity
counts across each axis were combined creating a single vector magnitude value.17 Using
custom-written software in MATLAB (Mathworks Inc, Natick, MA, USA), ten variables were
calculated for in-clinic and out-of-clinic time from the recorded data. Recording time was
separated into 1.5 hours of in-clinic time which included upper limb assessments and intensive
therapy (targeting repetitions of upper limb movement) and then 22.5 hours of out-of-clinic
wear. Variables quantified different aspects of upper limb movement and can be conceptualized
into variables measuring movement time, movement magnitude, and movement
variability.13,14,18,33,34 Table B.1 provides a summary of variables. In addition, two newly
proposed variables were calculated, the jerk asymmetry index35 and the spectral arc length.36,37
These variables were calculated as they have been proposed to measure smoothness of
movement, an aspect of quality of movement, by others in the field.
Table B.1. Accelerometer variables

Variable Name
Time
Isolated Non-Paretic Limb Activity28

Time, in hours, that the non-paretic limb is moving, while the paretic limb is still.

Isolated Paretic Limb Activity28

Time, in hours, that the paretic limb is moving, while the non-paretic limb is still.

Bilateral Activity28,38
Use Ratio16,30,39

Time, in hours, that both upper limbs are moving together.
Ratio of hours of paretic limb movement, relative to hours of non-paretic limb
movement.

Magnitude
Paretic Limb Magnitude40,41
Bilateral Magnitude28,38
Magnitude Ratio28,38,41

Variability
Variability of Paretic Movement 40,41
Variability of Bilateral
Movement40,41
Variation Ratio40,41

Description

Magnitude of accelerations of the paretic limb, in activity counts.*
Intensity, or magnitude of accelerations, of movement across both arms, in activity
counts.*
Ratio of the magnitude of paretic UL accelerations relative to the magnitude of the nonparetic UL accelerations. This ratio reflects the contribution of each limb to activity,
expressed as a natural log.
Standard deviation of the magnitude of accelerations across the paretic limb, reflecting
the variability of paretic limb movement, in activity counts*
Standard deviation of the magnitude of accelerations across both limbs, reflecting the
variability of bilateral upper limb movement, in activity counts.*
Ratio of the variability of paretic limb accelerations relative to the variability of the nonparetic limb accelerations, reflecting the relative variability in the paretic limb.

Smoothness
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Unimanual Jerk Asymmetry Index 35

Ratio of the average jerk magnitude between the paretic upper limb and the non-paretic
upper limb. Higher jerk represents less smooth movement, and an index value of 0
represents similar smoothness of movement in the paretic and non-paretic limbs. Values
are bounded between -1 to +1.

Spectral Arc Length36,37

A measure of movement smoothness that quantifies movement intermittencies
independent of the movement’s amplitude and duration. Longer spectral arc lengths are
reflective of less smooth or less coordinated movement.

* Activity counts are computed by the Actilife proprietary software such that 1 activity count=0.001664g

B.3.4 Analysis
All data were analyzed in R, an open source statistical computing program. The main
analyses evaluated the relationships between the compensatory movement scores and each
calculated accelerometer variable. Spearman rank correlations were chosen because relationships
between compensatory movement scores and accelerometer variables were not assumed to be
linear. Criteria for statistical significance was set at α < 0.05. The following criteria were used
to interpret correlation coefficients: coefficients of rho > 0.25 or below were considered low,
coefficients ranging from 0.26 to 0.50 were considered moderate, coefficients from 0.51 to 0.75
were considered good, and those greater than 0.75 were considered excellent.42 Beyond the
individual relationship analysis, an exploratory, step-wise multiple regression evaluated how
multiple accelerometer variables might collectively explain the variance in compensatory
movement scores.

B.4 Results
Participants
Demographics of the participants are provided in Table B.2 and have been reported
elsewhere.20 Overall, the sample had chronic upper limb paresis post stroke of mild to moderate
severity. Compensatory movement scores were highly variable across the sample, with a mean of
73.7 + 33.6, and a range from 11.5 to 188. This range indicates that none of the subjects were
free from compensatory movements, and no subject used the maximum amount of
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compensations defined by the checklist. The majority of movement compensations were
observed at the shoulder (28%). The second highest observed compensations were at the trunk
(22%), followed by the fingers (21%), fluidity and movement precision (14%), elbow (5%),
wrist (4%), head (3%), and finally forearm (2%).
Table B.2: Characteristics of Sample, Values are means + SD (range) or % of total sample unless otherwise
specified.
Descriptors (n= 78)
Age (Years)
61.9 + 10.5
(32, 85)
Gender
35% Female
65% Male
Type of Stroke

72% Ischemic
13% Hemorrhagic
15% Unknown
Ethnicity
99% Non-Hispanic/Latino
1% Hispanic/Latino
Months post stroke (median, min/max)
12 , 5/221
Affected Limb
46% Left
54% Right
% Concordance*
51%
% Independent with ADL
79%
Baseline ARAT score
32.4 + 11.2
(10 - 48)
Compensatory Movement Score
73,7 + 33.6
(11.5 - 188)
Baseline Use Ratio
0.66 + 0.23
(0.22 - 1.32)
*Concordance is the percent of individuals whose paretic UL was their dominant UL

Relationships of variables to compensatory movement
Overall, moderate correlations were observed between the compensatory movement
scores and each accelerometer variable. Figure 1 shows the correlation coefficients and their
95% confidence intervals for each accelerometer variable, calculated from both in-clinic and outof-clinic time. For most of the accelerometer variables, higher scores are better, making most of
the correlation coefficients negative.

149

Figure B.1. Relationships (x-axis) of compensatory movement scores to accelerometer variables (y-axis). Open
symbols are in-clinic calculations, and closed symbols are out-of-clinic calculations. Error bars are 95% confidence
intervals for each correlation coefficient. Lack of statistical significance occurs when error bars cross the vertical
dashed line at 0.

More than half of the accelerometer variables had similar relationships with
compensatory movement scores when calculated from both in-clinic and out-of-clinic time.
Figure 2 is a scatterplot of one such variable, variability of bilateral movement, where Figure 2A
illustrates its relationship to the compensatory movement score in-clinic (rho = -0.35, p < 0.001),
and Figure 2B its relationship out-of-clinic (rho = -0.32, p < 0.01). This moderate relationship
indicates that individuals with more movement compensations tended to have less movement
variability of the upper limbs, regardless of in which environment they were moving.
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Figure B.2. Relationship of bilateral movement during in-clinic time (a. rho= -0.32, p<0,001) (b. rho= -0.35,
p<0.01). This accelerometer variable has a similar moderate relationship both in and out-of-clinic.

Other accelerometer variables had a stronger relationship with compensatory movement
scores, when calculated from time out-of-clinic versus in-clinic. Figure 3 shows scatterplots of
two variables, isolated non-paretic limb activity and use ratio plotted relative to the
compensatory movement score. Figure 3A illustrates the relationship of isolated non-paretic limb
activity to compensatory movement score in-clinic (rho = 0.14, p = 0.23), and Figure 3B its
relationship out-of-clinic (rho = 0.61, p < 0.0001). The stronger positive relationship out-ofclinic indicates that individuals with more compensatory movements moved their non-paretic
limb only more while out-of-clinic. The use ratio also had a stronger negative relationship with
the compensatory movement score out-of-clinic. Figure 3C illustrates the use ratio in-clinic to
the compensatory movement score (rho = -0.15 p = 0.18), and Figure 3D its relationship out-ofclinic (rho = -0.57, p < 0.0001). The strong relationship out-of-clinic indicates that, at home,
individuals with more compensatory movements had a lower use ratio, indicating less relative
paretic limb activity. None of the accelerometer variables had a stronger relationship during inclinic time versus out-of-clinic time.
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Figure B.3. Relationship of isolated use of the non-paretic limb to compensatory movement score, both in-clinic
(3A, rho = 0.14, p = 0.23) and out-of-clinic (3B, rho = 0.61, p < 0.0001). Relationship of the use ratio to the
compensatory movement score in-clinic (3C, rho = -0.15, p = 0.18) and out-of-clinic (3D, rho = -0.57, p = 0.18)
These variables both had a little to no relationships in-clinic, yet good relationships out-of-clinic.

Two variables have been proposed to reflect movement smoothness as an aspect of
quality of movement.35-37 Figure 4 shows the relationship of the compensatory movement score
to the jerk asymmetry index (Figure 4A, rho = -0.19, p = 0.09) and to the spectral arc length of
the paretic limb (Figure 4B, rho = 0.29, p < 0.01). Both variables had low relationships with the
compensatory movement score.
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Figure B.4: Relationship of two newly proposed metrics that quantify quality of upper limb movement. 4A:
Relationship of the Jerk Asymmetry Index to compensatory movement scores (rho = -0.19, p = 0.09). 4B:
Relationship of the spectral arc length of the paretic limb to compensatory movement scores (rho = 0.29, p < 0.01).
In 4B, one outlier with a spectral arc length of > -6 has been omitted from the plot. Both variables are from out-ofclinic time and had a low relationship with the compensatory movement score.

Last, an exploratory multiple regression evaluated which combination of accelerometer
variables explained the most variance in the compensatory movement score. Using a stepwise
approach to select variables, two time-based variables explained the most variance. The use ratio
out-of-clinic and the hours of isolated non-paretic limb use out-of-clinic together explained 37%
of the variance in the compensatory movement score (R2 = 0.37, p ≤ 0.0001).

B.5 Discussion
This study was a secondary analysis of an existing dataset that explored the relationships
between accelerometer variables and compensatory upper limb movements in individuals with
chronic hemiparesis. Individuals in the sample had a range of compensatory movements
observed during the video scoring. Most accelerometer variables had a moderate relationship
with the degree of compensatory movements of the upper limb for both in and out-of-clinic time
points. This study used a novel approach to quantify compensatory movement patterns of the
limb at a single time point, during completion of a standardized assessment. The developed
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checklist is proposed as an idea for a new scale that would need further work in terms of
examining its psychometric properties. These results indicate that accelerometry incorporates
aspects of both quantity of upper limb use and general compensatory movement patterns of the
upper limb.
Most accelerometer variables had moderate relationships with compensatory movement
scores. The variables more strongly associated with compensatory upper limb movements
quantified time, magnitude, and variability of upper limb movement while participants engaged
in activity out-of-clinic. For example, the strong relationship of movement compensations to
isolated use of the non-paretic limb aligns with clinical expectations3,38,43 that individuals who
have more movement compensations of the paretic upper limb, frequently use their non-paretic
limb to complete daily tasks at home. Likewise, individuals who use more movement
compensations have less variability in both paretic and bilateral limb movements. In general,
reduced movement variability is considered to align with “an unhealthy pathological state or an
absence of skill.” 44 Individuals who use more compensatory movements have fewer options for
movement available.45,46
Some accelerometer variables tended to be have stronger relationships with
compensatory movement scores when quantified from out-of-clinic recordings vs. in-clinic
recordings. This is illustrated visually in Figure 1, where more closed triangles are further from
the zero line than open circles are. The in-clinic recordings here are from participation in an
intensive, progressive, upper limb trial, where individuals are trained to use their affected paretic
limb for functional activities.20 Weaker relationships of some variables in-clinic confirms that
therapy sessions were promoting activity of the affected upper limb. We note that the intent of
the training protocol was to improve upper limb functional capacity, not to reduce movement
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compensations.20 During in-clinic recordings, the accelerometer variables measure what an
individual does during the training protocol. The out-of-clinic time measures how an individual
moves their upper limbs during daily life.31,47 Based on the moderate or strong relationships,
out-of-clinic, accelerometer variables reflect not just quantity of upper limb movement, but also
collective use (more vs. less) of compensatory movements of the upper limb.
Limitations
Several limitations should be considered when interpreting these data. First, video
recordings of a standardized assessment were used to quantify movement compensations as a
proxy for compensatory movements that would occur throughout the recording period. Given
that research and therapy participants often try to do their best on tests in front of an assessor,
28,48-50

using these videos to quantify compensatory movements may be an under-estimate of the

compensatory movements participants engage in throughout the day. Second, video-recording of
the assessment was chosen to quantify compensatory movements over the video-recording of the
therapy session. This decision was made because the assessment was the same for all, while the
therapy sessions involved individualized therapeutic activities of different amounts, i.e. making it
hard to compare across subjects. While the ARAT standardized assessment captures most upper
limb movement components,51 one cannot rule out the possibility that alternative compensations
might be observed within the therapy session or at home. Collectively these two limitations mean
that we may have underestimated upper limb compensatory movements, and perhaps also
underestimated the strength of the relationships of the accelerometer variables to the
compensatory movement score. A third limitation is the use of coding from videos instead of
using kinematic analysis of movement compensations. 12 Kinematic data from this sample does
not exist. It is anticipated that using a kinematic analysis would not diminish the relationships of
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accelerometer variables to movement compensations of the upper limb, rather future studies
using kinematics could be used to validate the relationships found here. Additionally, kinematic
analysis could expand upon those relationships by indicating the specific movement
compensations an individual is using with their upper limb, not just the general quantification
used here. The round table currently suggests kinematics as the gold standard, in the future we
envision that accelerometry may be a way to measure specific movement compensations of the
upper limb if sensors were cheaper and smaller.

B.6 Conclusion
This study quantified movement compensations of the upper limb and determined their
relationship to accelerometer variables. Individuals who move their limbs more in daily life with
respect to time and variability tend to move with less movement compensations and more normal
movement patterns. Likewise, individuals who move their paretic limbs less and their nonparetic limb more in daily life tend to move with more movement compensations at all joints in
the paretic limb and less normal movement patterns. These results suggest that, for people with
upper limb paresis due to chronic stroke (> 6 months), movement quality is not be an
independent construct from movement quantity. While accelerometers as a tool can provide
some information on movement quality, more work is needed to improve the methodology.
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B.7 Supplemental Table
Table B.1. Compensatory movement scoring checklist
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Items to create this checklist were synthesized from the following assessments, Reaching Performacne Scale 7,
Upper Extremity Fugl- Meyer 52, Wolf Motor Function Test, 8 Action Research Arm Test, 51 Chedoke McMasters, 23
Stroke Rehabiliation Assessment of Movement (STREAM), 22 Motor Evaluation Scale for Upper Extremity in
Stroke Patients (MESUPES), 25 Motor Assessment Scale (MAS), 24and Quantative assessment of upper extremity
function.26 Compensatory behaviors on the checklist included movements at the head, trunk, shoulder,elbow,
forearm, wrist, fingers and fluidity/movement. Compensations were scored as present or absent from the videotaped
completion of the ARAT.

B.8 References
1.

Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics-2018
Update: A Report From the American Heart Association. Circulation. Mar 20
2018;137(12):e67-e492. doi:10.1161/cir.0000000000000558

2.

Dobkin BH. Rehabilitation after stroke. New England Journal of Medicine.
2005;352(16):1677-1684.

3.

Levin MF, Kleim JA, Wolf SL. What do motor “recovery” and “compensation” mean in
patients following stroke? Neurorehabilitation and neural repair. 2009;23(4):313-319.

4.

Lum PS, Mulroy S, Amdur RL, Requejo P, Prilutsky BI, Dromerick AW. Gains in upper
extremity function after stroke via recovery or compensation: Potential differential effects
on amount of real-world limb use. Top Stroke Rehabil. Jul-Aug 2009;16(4):237-53.
doi:10.1310/tsr1604-237

5.

Roby‐Brami A, Feydy A, Combeaud M, Biryukova E, Bussel B, Levin MJAns. Motor
compensation and recovery for reaching in stroke patients. 2003;107(5):369-381.

6.

DeJong SL, Birkenmeier RL, Lang CE. Person-specific changes in motor performance
accompany upper extremity functional gains after stroke. Journal of applied
biomechanics. 2012;28(3):304-316.

7.

Levin MF, Desrosiers J, Beauchemin D, Bergeron N, Rochette A. Development and
validation of a scale for rating motor compensations used for reaching in patients with
hemiparesis: the reaching performance scale. Physical therapy. 2004;84(1):8-22.

8.

Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor
function test as outcome measure for research in patients after stroke. Stroke.
2001;32(7):1635-1639.

9.

See J, Dodakian L, Chou C, et al. A standardized approach to the Fugl-Meyer assessment
and its implications for clinical trials. Neurorehabilitation and neural repair.
2013;27(8):732-741.

10.

Yozbatiran N, Der-Yeghiaian L, Cramer SC. A Standardized Approach to Performing the
Action Research Arm Test. Neurorehabilitation and Neural Repair. 2008;22(1):78-90.
doi:10.1177/1545968307305353
158

11.

Van der Lee JH, De Groot V, Beckerman H, Wagenaar RC, Lankhorst GJ, Bouter LM.
The intra-and interrater reliability of the action research arm test: a practical test of upper
extremity function in patients with stroke. Archives of Physical Medicine and
Rehabilitation. 2001;82(1):14-19.

12.

Kwakkel G, Wegen EV, Burridge J, et al. Standardized measurement of quality of upper
limb movement after stroke: Consensus-based core recommendations from the Second
Stroke Recovery and Rehabilitation Roundtable. International Journal of Stroke.
2019:1747493019873519.

13.

Bailey RR, Klaesner JW, Lang CE. An accelerometry-based methodology for assessment
of real-world bilateral upper extremity activity. 2014;9(7):e103135.

14.

Bailey RR, Lang CE. Upper extremity activity in adults: referent values using
accelerometry. Journal of rehabilitation research and development. 2014;50(9):1213.

15.

Uswatte G, Miltner WH, Foo B, Varma M, Moran S, Taub E. Objective measurement of
functional upper-extremity movement using accelerometer recordings transformed with a
threshold filter. Stroke. 2000;31(3):662-667.

16.

Uswatte G, Giuliani C, Winstein C, Zeringue A, Hobbs L, Wolf SL. Validity of
Accelerometry for Monitoring Real-World Arm Activity in Patients With Subacute
Stroke: Evidence From the Extremity Constraint-Induced Therapy Evaluation Trial.
Archives of Physical Medicine and Rehabilitation. 2006/10/01/ 2006;87(10):1340-1345.
doi:https://doi.org/10.1016/j.apmr.2006.06.006

17.

Bailey RR, Lang CE. Upper-limb activity in adults: referent values using accelerometry.
Journal of Rehabilitation Research and Development. 2013;50(9):1213-1222.
doi:10.1682/JRRD.2012.12.0222

18.

Bailey RR, Birkenmeier RL, Lang CE. Real-world affected upper limb activity in chronic
stroke: an examination of potential modifying factors. Topics in stroke rehabilitation.
2015;22(1):26-33.

19.

Doman CA, Waddell KJ, Bailey RR, Moore JL, Lang CE. Changes in upper-extremity
functional capacity and daily performance during outpatient occupational therapy for
people with stroke. American Journal of Occupational Therapy.
2016;70(3):7003290040p1-7003290040p11.

20.

Lang CE, Strube MJ, Bland MD, et al. Dose response of task‐specific upper limb training
in people at least 6 months poststroke: A phase II, single‐blind, randomized, controlled
trial. J Annals of neurology. 2016;80(3):342-354.

21.

Fugl-Meyer AR JL, Leyman I, Olsson S, Steglind S. FUGL-MEYER ASSESSMENT
UPPER EXTREMITY (FMA-UE) Assessment of sensorimotor function. 1975;

159

22.

Daley K, Mayo N, Wood-Dauphinée S. Reliability of scores on the Stroke Rehabilitation
Assessment of Movement (STREAM) measure. Physical therapy. 1999;79(1):8-23.

23.

Gowland C, Stratford P, Ward M, et al. Measuring physical impairment and disability
with the Chedoke-McMaster Stroke Assessment. Stroke. 1993;24(1):58-63.

24.

Carr JH, Shepherd RB, Nordholm L, Lynne D. Investigation of a new motor assessment
scale for stroke patients. Physical therapy. 1985;65(2):175-180.

25.

Van de Winckel A, Feys H, van der Knaap S, et al. Can quality of movement be
measured? Rasch analysis and inter-rater reliability of the Motor Evaluation Scale for
Upper Extremity in Stroke Patients (MESUPES). Clinical rehabilitation.
2006;20(10):871-884.

26.

Carroll D. A quantitative test of upper extremity function. Journal of Chronic Diseases.
1965;18(5):479-491.

27.

Sadeh A, Acebo C. The role of actigraphy in sleep medicine. Sleep medicine reviews.
2002;6(2):113-124.

28.

Bailey RR, Klaesner JW, Lang CE. Quantifying real-world upper-limb activity in
nondisabled adults and adults with chronic stroke. Neurorehabilitation and Neural
Repair. 2015;29(10):969-978. doi:10.1177/1545968315583720

29.

Dobkin BH, Martinez C. Wearable Sensors to Monitor, Enable Feedback, and Measure
Outcomes of Activity and Practice. Curr Neurol Neurosci Rep. Oct 6 2018;18(12):87.
doi:10.1007/s11910-018-0896-5

30.

Uswatte G, Foo WL, Olmstead H, Lopez K, Holand A, Simms LB. Ambulatory
Monitoring of Arm Movement Using Accelerometry: An Objective Measure of UpperExtremity Rehabilitation in Persons With Chronic Stroke. Archives of Physical Medicine
and Rehabilitation. 2005/07/01/ 2005;86(7):1498-1501.
doi:https://doi.org/10.1016/j.apmr.2005.01.010

31.

Waddell KJ, Strube MJ, Bailey RR, et al. Does task-specific training improve upper limb
performance in daily life poststroke? J Neurorehabilitation. 2017;31(3):290-300.

32.

Waddell KJ, Strube MJ, Tabak RG, Haire-Joshu D, Lang CE. Upper Limb Performance
in Daily Life Improves Over the First 12 Weeks Poststroke. Neurorehabilitation and
neural repair. 2019;33(10):836-847.

33.

Bailey RR, Klaesner JW, Lang CEJN, repair n. Quantifying real-world upper-limb
activity in nondisabled adults and adults with chronic stroke. 2015;29(10):969-978.

34.

Urbin M, Bailey RR, Lang CEJJonptJ. Validity of body-worn sensor acceleration metrics
to index upper extremity function in hemiparetic stroke. 2015;39(2):111.
160

35.

de Lucena DS, Stoller O, Rowe JB, Chan V, Reinkensmeyer DJ. Wearable sensing for
rehabilitation after stroke: Bimanual jerk asymmetry encodes unique information about
the variability of upper extremity recovery. IEEE; 2017:1603-1608.

36.

Balasubramanian S, Melendez-Calderon A, Roby-Brami A, Burdet E. On the analysis of
movement smoothness. Journal of Neuroengineering. 2015;12(1):112.

37.

Balasubramanian S, Melendez-Calderon A, Burdet E. A robust and sensitive metric for
quantifying movement smoothness. IEEE transactions on biomedical engineering.
2012;59(8):2126-2136.

38.

Bailey RR, Klaesner JW, Lang CE. An accelerometry-based methodology for assessment
of real-world bilateral upper extremity activity. PLOS ONE. 2014;9(7):e103135.
doi:10.1371/journal.pone.0103135

39.

Lang CE, Waddell KJ, Klaesner JW, Bland MD. A method for quantifying upper limb
performance in daily life using accelerometers. JoVE (Journal of Visualized
Experiments). 2017;(122):e55673.

40.

Urbin MA, Waddell KJ, Lang CE. Acceleration metrics are responsive to change in upper
extremity function of stroke survivors. Archives of Physical Medicine and Rehabilitation.
2015/05/01/ 2015;96(5):854-861. doi:https://doi.org/10.1016/j.apmr.2014.11.018

41.

Urbin M, Bailey RR, Lang CE. Validity of body-worn sensor acceleration metrics to
index upper extremity function in hemiparetic stroke. Journal of neurologic physical
therapy: JNPT. 2015;39(2):111.

42.

Portney LG. Foundations of Clinical Research: Applications to Evidence-Based Practice.
FA Davis; 2020.

43.

Krakauer JW. Arm function after stroke: from physiology to recovery. Citeseer;
2005:384-395.

44.

Stergiou N, Decker LM. Human movement variability, nonlinear dynamics, and
pathology: is there a connection? Human movement science. 2011;30(5):869-888.

45.

Krabben T, Prange GB, Molier BI, Rietman JS, Buurke JH. Objective measurement of
synergistic movement patterns of the upper extremity following stroke: An explorative
study. 2011:1-5.

46.

Sethi A, Patterson T, McGuirk T, Patten C, Richards LG, Stergiou N. Temporal structure
of variability decreases in upper extremity movements post stroke. Clinical
Biomechanics. 2013/02/01/ 2013;28(2):134-139.
doi:https://doi.org/10.1016/j.clinbiomech.2012.11.006

47.

Andrews K, Steward JJR. Sroke recovery: he can but does he? 1979;18(1):43-48.
161

48.

Kunkel A, Kopp B, Müller G, et al. Constraint-induced movement therapy for motor
recovery in chronic stroke patients. Archives of Physical Medicine and Rehabilitation.
1999/06/01/ 1999;80(6):624-628. doi:https://doi.org/10.1016/S0003-9993(99)90163-6

49.

André JM. “Functional motor amnesia” in stroke (1904) and “learned non‐use
phenomenon”(1966). Journal of rehabilitation medicine. 2004 36(3):138-140.
doi:10.1080/16501970410026107

50.

Johnson M. Quantifying learned non-use after stroke using unilateral and bilateral
steering tasks. 2011:1-7.

51.

Lyle. A performance test for assessment of upper limb function in physical rehabilitation
treatment and research. International journal of rehabilitation research. 1981;4(4)

52.

Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic
patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975
1975;7(1):13-31.

162

